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ABSTRACT 
 
Background: Several risk factors are associated with hypothyroidism, which are divided 
into socio- demographic factors, lifestyle factors, family history of autoimmune disease, 
and medical condition such as having diabetes type 1. Obesity was also shown to be a risk 
factor for having hypothyroidism and vice versa.  However, no study focused on 
hypothyroidism in Palestine which makes it a rich area for investigation due to its 
importance in preventing its occurrence and/or any of its complications. 
Aim:  The aim of the study was to determine the risk factors associated with hypothyroidism 
among patients attending the primary health care clinics in Hebron District. The main 
objective was to examine the  associations between socio- demographic factors; lifestyle 
factors; family history of autoimmune disease; history of diagnosis; medical condition; and 
medication with the incidence of hypothyroidism. 
Study methodology: The study was carried out in two main endocrinology clinics; the 
Karantina and Dora clinics. The study was done in two stages: descriptive analysis (stage 
1) and a case-control study (stage 2).  In stage 1,  All files present in the two selected clinics 
were included in the study.  In the second stage, 206 participants; including 103 cases and 
103 controls participated in the study. The control group comprised of patients attending 
other sub specialist clinics.  Data were collected through  face-to-face interview using a 
structured questionnaire. TSH test was done to all control participants in order to exclude 
the probability of having undiagnosed hypothyroidism.  
All data were analyzed using IBM-SPSS software.  For stage 1, frequencies of all variables 
were calculated and data were presented in figures and tables.  For stage 2, univariate 
analysis were presented showing the association between hypothyroidism and the studied 
determinants. T-test was used to examine the difference of TSH levels between cases and 
controls. Also, multiple logistic regression was done to all statistically significant variables 
in the univariate analysis to obtain the odds ratio (OR) and 95% confidence interval. For all 
analysis significance was set with  p-values (P<0.05). 
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Results: Stage 1 results showed that hypothyroidism was the most diagnosed endocrine 
disorder with the prevalence of 17.1% among patients attending the clinics. In addition, 
hypothyroidism subtypes rates were 87.0% for primary hypothyroidism, 5.2% for 
secondary hypothyroidism and 7.8% for congenital hypothyroidism.  These types of 
hypothyroidism were shown to be associated with turner syndrome, thyroid cancer, goiter, 
thyroidectomy, postpartum thyroiditis, diabetes type 1, hypopituitarism and beta 
thalassemia. 
In stage 2, the multiple regression model showed that living area, working status and 
household monthly income were associated with hypothyroidism (P <0.05).  furthermore, 
daily physical activity and smoking by others in closed places were significantly associated 
with hypothyroidism (P<0.05). Moreover, consumption of carrots, banana, and red meat 
were associated with hypothyroidism (P <0.05). While, iron intake was the only food 
supplement intake that was significantly associated with hypothyroidism (P <0.05). 
Conclusion and Recommendation: Although this study is a clinical based study, its results 
emphasized on the role of positive effect ( i.e. monthly income, passive smoking, 
consumption of carrots and red meat intake) and negative effect ( i.e. working status, living 
area, physical activity rate, consumption of bananas and iron supplement intake) in 
acquiring hypothyroidism. These factors are important in setting preventive measures for 
hypothyroidism. 
The study results are important for future planning of policies including setting a national 
screening program for hypothyroidism & risk factors that will help to prevent and/or delay 
of its complications or any of its related disabilities. Further population based 
epidemiological studies are needed to establish the accurate prevalence and predominant 
etiological factors of thyroid disorders. 
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 يف الأولية الصحية الرعاية عيادات يراجعون الذين المرضى بين الدرقية الغدةبقصور  المرتبطة العوامل
 .والشواهد الحالات دراسة: الخليل محافظة
 مصطفى برهمإعداد: 
 اسم المشرف: د. نهى الشريف
 الدراسة  ملخص
 :، والتي تنقسم إلىالخطرالعديد من عوامل بيرتبط مرض قصور الغدة الدرقية  :خلفية الدراسة
العوامل الاجتماعية والديموغرافية، وعوامل نمط الحياة، والتاريخ العائلي لأمراض المناعة الذاتية، 
. أيضا،أظهرت العديد من السكري من النوع الأول بداء ضيمركونه  مثل للمريض والحالة الصحية
 . ومع ذلك، لمبقصور الغدة الدرقية، والعكس صحيحأحدي العوامل المرتبطة أن السمنة هي ب الابحاث
قصور الغدة الدرقية، مما يجعل من هذه الدراسة بـأمراض في فلسطين تعنى أي من الدراسات الصحية 
 . وقاية من حدوث قصور الغدة الدرقية أو أي من مضاعافاتهاذات اهمية كبيرة لل
الغدة الدرقية بين المرضى  المرتبطة بقصور الخطرتحديد عوامل  هو الدراسة هذهان الهدف الرئيس ل: أهداف الدراسة
ختبار افتتلخص بفرعية ال . اما الاهداففي محافظة الخليلالحكومية الذين يراجعون عيادات الرعاية الصحية الأولية 
الديموغرافية، وعوامل نمط الحياة، والتاريخ العائلي لأمراض المناعة الذاتية، وتاريخ  العلاقة بين العوامل الإجتماعية
 ، ومدى حدوث قصور الغدة الدرقية.التي يتناولها ، والأدويةللمريض التشخيص، والحالة الصحية
الغدد الرئيسة في محافظة الخليل: وهي عيادة الكرنتينا، وعيادة  أجريت هذه الدراسة في عيادتي: منهجية الدراسة
 .والشواهد -تالحالا والثانية دراسة ،التحليل الوصفي دورا وقد أجريت الدراسة على مرحلتين: الأولى
 206 نمعينة الدراسة  نتوتكتضمنت المرحلة الأولى جميع سجلات المرضى في العيادتين، أما المرحلة الثانية فقد 
عينة ضابطة من كأشخاص  103، فيما تم اختيار (الحالات) مرضى مصابين بقصور الغدة الدرقية 103مشاركا، 
ه وجها لوج المرضى الذين يراجعون العيادات المتخصصة الفرعية الأخرى. وقد تم جمع البيانات من خلال المقابلة
لجميع المشاركين في العينة الضابطة من ) HST( الدرقية الغدةهرمون مستوى ، فيما تم إجراء فحص باستخدام استبيان
 .لديهمأجل استبعاد احتمال وجود قصور الغدة الدرقية 
ففي المرحلة الأولى،  تم حساب التكرارات  . MBI-SSPSالبيانات وتحليلها باستخدام برنامجادخال تم إدخال جميع 
لفحص العلاقة  اتمتغيرنية، أما في المرحلة الثانية تم البيا لجميع المتغيرات، وقد عرضت البيانات في جداول وأشكال
)، كما تم حساب فحص العامل 50.0< P( الاحصائية بين قصور الغدة الدرقية مع عوامل الإختطار عند مستوى الدلالة
 جبين حالات الدراسة والمجموعة الضابطة، كذلك تم حساب نموذ HSTلرصد اختلاف مستويات  )tset-t(المستقل  
) في تحليل وحيد المتغير للحصول على 50.0< P( لجميع المتغيرات عند الدلالة الاحصائية المتعدد اللوجيستي الانحدار
 ).%95نسبة الترجيح ودرجة الثقة (
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أظهرت نتائج تحليل البيانات في المرحلة الأولى من الدراسة في ملفات المرضى أن مرض قصور : النتائج الرئيسية
بين أمراض الغدد التي تم تشخيصها بين المرضى الذين يراجعون عيادات الرعاية الصحية  االأكثر تشخيصالغدة الدرقية 
في الكرنتينا،   %9.61(  %3..3المراجعين  بينالأولية في محافظة الخليل، وكان معدل انتشار قصور الغدة الدرقية 
كما أظهرت النتائج أن أنواع قصور الغدة الدرقية هي على النحو الأتي: قصور الدرقية  .في دورا )  %9..3
وكانت هذه الأنواع مرتبطة مع  ،%0..، وقصور الغدة الدرقية الخلقي %6.9وقصور الدرقية الثانوي ، %0..0الأولي
، 3رطان الغدة الدرقية، والدراق، والتهاب الغدة الدرقية ما بعد الولادة، ومرض السكري النوع متلازمة تيرنر، وس
 ومرض قصور الغدة النخامية، ومرض الثلاسيميا.
الدخل العمل وأن منطقة المعيشة و المتعدد اللوجيستي الانحدار نموذج من الدراسة أظهرت نتائج ةالثانيوفي المرحلة 
، بالإضافة %9الدلالة الإحصائية أقل من  قيمة مستوى جاءت يرتبط مع قصور الغدة الدرقية، حيثالشهري للأسرة 
إلى أن معدل النشاط البدني اليومي والتدخين من قبل الآخرين في أماكن مغلقة يرتبط مع قصور الغدة الدرقية، حيث 
ط استهلاك الجزر واستهلاك الموز واستهلاك ، وعلاوة على ذلك ارتب%9الدلالة الإحصائية أقل من  قيمة مستوى جاءت
، وإضافة إلى ذلك %9الدلالة الإحصائية أقل من  قيمة مستوى اللحوم الحمراء مع قصور الغدة الدرقية، حيث جاءت
 قيمة مستوى كان تناول مكملات الحديد هو الوحيد بين مكملات الفيتامينات مرتبطا مع قصور الغدة الدرقية، حيث جاءت
 .%9الإحصائية أقل من  الدلالة
 دورلا أكدت على على الرغم من أن هذه الدراسة هي دراسة تطبيقية سريرية، إلا أن نتائجها: الاستنتاج والتوصيات
 كل منل السلبي والدور ،الحمراء اللحوم استهلاكو الجزر السلبي واستهلاك والتدخين الشهري لدخلالكل من  لايجابيا
 ،درقيةال قصور الغدة تحديد في مكملات الحديد وتناول الموز واستهلاك البدني النشاط ومعدل والعمل  المعيشة منطقة
 .الدرقية الغدة لقصور وقائية تدابير وضع في مهمة العوامل هذه
ل وضع برنامج ، مثالمتعلقة بامراض الغدد الصماء فإن نتائج هذه الدراسة ذات أهمية كبيرة للتخطيط المستقبلي للسياسات
حدوث قصور الغدة الدرقية أو يحد من مضاعفاتها، كما أن هناك حاجة إلى   الفحص الوطني الذي من شأنه أن يمنع
 المزيد من الدراسات الوبائية السكانية من أجل تحديد معدلات الانتشار الدقيق والعوامل المسببة لأمراض الغدة الدرقية.
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Chapter 1: Introduction 
1.1 Background  
Hypothyroidism  is defined according to the American Thyroid Association  as" an 
underactive thyroid gland, means that the thyroid gland cannot make enough thyroid 
hormone to keep the body running normally ". The  common causes are autoimmune disease, 
surgical removal of the thyroid, and radiation treatment (ATA, 2012a).  
Hypothyroidism is classified into two types: primary and secondary hypothyroidism.  
Primary hypothyroidism is the most common type and it is caused by disorder of thyroid 
gland itself. Central or secondary hypothyroidism  results from hypothalamic or pituitary 
disease (Jayakumar, 2011). Also, hypothyroidism can be classified on the basis of severity 
into subclinical hypothyroidism and overt or frank hypothyroidism. Subclinical 
hypothyroidism is referred to as mild hypothyroidism, as an abnormal serum thyroid-
stimulating hormone level and free thyroxin and triiodothyronine levels within their 
reference ranges (Wilson and Curry, Jr., 2005b). The overt or frank hypothyroidism, is 
defined as an elevated TSH and a low serum free T4 (Aminorroaya et al., 2009). 
The prevalence of hypothyroidism varies around the world.  In the general population of the 
USA, UK and Scotland it  ranges from 3.8%–4.6% (Chakera et al., 2012); the subclinical 
ranges  from 1% to higher than 20 %  and 1-2% for overt hypothyroidism (Aminorroaya et 
al., 2009). In  developed countries like USA, Japan, United Kingdom, and Northern Europe, 
the prevalence ranges from 0.6 -12  per 1000 women  and between 1.3 - 4.0 per 1000 men 
(Vanderpump, 2011). In developing countries like Iran,  the overall prevalence of 
hypothyroidism is 4.8% in men and 12.8% in women (Aminorroaya et al., 2009). In Libya 
the prevalence of subclinical hypothyroidism is 6.18% (Nouh et al., 2008). 
Several risk factors are associated with hypothyroidism, that are divided into: socio- 
demographic factors (e.g. age, gender) (Mao et al., 2010b,Aoki et al., 2007b), lifestyle 
factors (e.g. iodine intake in food and smoking), family history of autoimmune disease 
(Strieder et al., 2003,Dittmar et al., 2011), medical condition (e.g. diabetes type1) (Ardestani 
et al., 2011,Denzer et al., 2013) and medication (e.g. radioactive iodine) (Lankarani et al., 
2008).  
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In Palestine, there is no national screening program for hypothyroidism or any other thyroid 
diseases.  Moreover no study was concerned with hypothyroidism, which makes it a rich 
area for research due to its importance in preventing its occurrence and/or the expression of 
its complications.  
1.2 Study justification 
Hypothyroidism is diagnosed by physical examination, a medical and family history.  
Diagnosis is confirmed by measuring blood levels of thyroid hormones, are TSH (thyroid 
stimulating hormone) and T4. TSH is the most sensitive test for the diagnosis of 
hypothyroidism (AACE, 2006). 
Hypothyroidism might lead to several complications such as cardiovascular disease (Mayer, 
Jr. et al., 2006) which put patients at risk of developing atherosclerosis and myocardial 
infarction (Hak et al., 2000), hypertension (Stabouli et al., 2010), diabetes (Kakleas et al., 
2009), anemia (Mehmet et al., 2008), infertility in both men and women (Krassas et al., 
2010), and it might lead to depression (Haggerty, Jr. et al., 2008).  Therefore, determining 
the risk factors of hypothyroidism puts the represent a cornerstone towards the prevention 
of hypothyroidism or at least decrease related disability consequences. 
The American Thyroid Association (ATA) recommends that adults should be screened for 
thyroid dysfunction by measuring serum thyrotropin concentration, beginning at age 35 
years and every 5 years thereafter (Ladenson et al., 2000b). The screening of thyroid 
dysfunction is more favorable  recommended among high risk population who might have 
goiter, iodine deficiency disorder, any autoimmune disorder,…etc (Staub et al., 1992). In 
Palestine, the MOH still screen all newborn children at the fourth day of the birth for 
congenital hypothyroidism. However, there is no screening program specialized for 
individuals at higher risk for developing thyroid dysfunction at other ages. 
The epidemiology of thyroid dysfunction is neglected in Palestine. Moreover, the annual 
reports of the MOH lack data about the prevalence, incidence rate, and type of thyroid 
disorders. In addition, no study was concerned with hypothyroidism.  Therefore, this study 
represents a pilot study at major MOH primary health care center "Karantina" endocrinology 
clinic in Hebron city.  In this study, we screened all patients' files  to estimate the prevalence 
of hypothyroidism among patients attending that clinic. Our study revealed  that 
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hypothyroidism is the most thyroid disorder diagnosed and followed in that clinic.  Its 
prevalence was 16.9% among patients attending Karantina endocrinology clinic from year 
2008 until the April 2012 (see figure 1).  
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Figure 1: distribution of patients attending the endocrine clinic at the karantina 
          
 In Palestine, the risk factors associated with hypothyroidism are unknown, and there are no 
previous studies about risk factors for hypothyroidism. Therefore, this study was carried out 
to determine the risk factors associated with hypothyroidism among patients attending a 
primary health care clinics in Hebron district.  The results of this study provide a preliminary 
baseline for policy makers for setting national policy for controlling hypothyroidism and its 
complication. 
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1.3 Study problem: 
Hypothyroidism can be associated with several adverse health effects. These adverse effects 
can create a huge human and economic burden that can be prevented by early screening for 
the high risk population and the adoption of appropriate preventive or therapeutic measures. 
Having hypothyroidism might lead to several complications; therefore, having a screening 
program for hypothyroidism will  help in preventing any of the above complications, if this 
disorder is detected in its early stages. However, in Palestine the prevalence of 
hypothyroidism and the risk factors associated with this disorder are unknown. This study 
can be used as a baseline study for future planning of policies such as setting a national 
screening program that will or might prevent and/or delay of its complication or any of its 
other related disabilities.  
1.4 Study aim 
The overall aim of this study is to determine the risk factors associated with hypothyroidism 
among patients attending the primary health care clinics in Hebron district. 
1.5 Study objectives: 
1. To identify the type of endocrine diseases among patients attending the two study 
clinics (Dura and karantina) 
2. To determine the association between socio-demographic factors ( e.g. age and sex) 
and hypothyroidism.  
3. To investigate the association between family history of autoimmune diseases and 
hypothyroidism. 
4. To examine the relationship between patients' health status (e.g. diabetes mellitus, 
vitiligo, pernicious anemia, turner syndrome and  down syndrome ) and 
hypothyroidism. 
5. To identify the association between lifestyle factors (e.g. iodine intake in food, 
smoking and alcohol consumption) and hypothyroidism. 
6. To examine association between patients' diagnosis history at primary health care and 
hypothyroidism. 
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1.6 Study limitation: 
1. Recall bias might be a major bias in this study. A lot of questions answered by patients 
about their health status, medication, family history,  life style as well as types of food 
that consumed. This type of design has its limitations and possible not to give the correct 
information 
2. The present study is a case control- clinical based study; therefore, it may not represent 
the whole population. 
3. The present study is based only on TSH, therefore, it could have been strengthened if 
free T
3
, free T
4, 
Total T
4
, Total T
3
, anti-thyroperoxidase (anti-TPO) were also measured. 
4. Medical files did not contain all information about patients. 
1.7 Expected outcome: 
We expect that the study will provide evidence and recommendations to decision makers for 
setting national policy for controlling hypothyroidism and its complication by identifying 
high risk individuals. 
1.8 Thesis chapters’ description: 
This thesis is presented in 6 chapters, listed as follows: 
Chapter one: Introduction  
  
This chapter contains the background, study justification, study problem, objectives, and 
expected outcome and study limitations.   
Chapter two: Literature review   
 
This chapter includes the literature review of previous studies that are related to research 
topic.  
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Chapter three: Conceptual frame work   
This chapter presents definitions of hypothyroidism, causes, diagnosis, treatment, and 
factors associated with hypothyroidism. These factors include: socio-demographic factors, 
life style factors, genetic factors and family history, medical, medication and history of 
diagnosis of hypothyroidism. 
Chapter four: Methodology  
  
In this chapter, the research methodology is presented.  The study area, study population, 
study type, design, tools, the sampling method, statistical analysis, ethical consideration, and 
variables operational definitions are presented. 
Chapter five: Results  
 
In the chapter, results are presented in 3 parts. The first part presents a descriptive analysis 
of patients’ files and study cases. The second part presents a descriptive analysis of the study 
population. And in the third part the univariate and multivariate analysis model are shown. 
Chapter six: Discussion, Conclusion and Recommendations  
 
In this chapter, the main study findings are interpreted and discussed. In the last part of this 
chapter, the study's conclusion and recommendations are presented. 
 
 
  
  
 
 
7 
Chapter two: Literature Review 
2.1 Introduction 
Literature showed that several factors are associated with hypothyroidism.  These factors are 
divided into: socio- demographic factors such as age, gender (Mao et al., 2010a) (Aoki et 
al., 2007a), lifestyle factors such as iodine intake in food and smoking (Carle et al., 
2006,Knudsen et al., 2002), family history of autoimmune thyroid diseases (Parle et al., 
1991a), and person medical condition such as having diabetes (Kakleas et al., 2009); and 
anemia (Mehmet et al., 2011).  Also, obesity was shown to be associated with having 
hypothyroidism and vice versa  (El Mansoury et al., 2005b). In this chapter we are presenting 
the literature review concerning those risk factors.  
2.2  Socio-demographic factors 
Several epidemiological studies showed that age and sex as risk factors for increased risk of 
hypothyroidism.  These studies are summarized in table 2.1.  
According to Vanderpump M, the prevalence rate of  hypothyroidism is higher in elderly 
people, especially in older women compared to men (MC, 2012,Vanderpump, 2011). 
According to  Myo clinic,  women  are more likely to have hypothyroidism especially those 
older than 60  years of age compared to men (MC, 2012). In the USA, the National Health 
and Nutrition Examination Survey (NHANSE) reported that the prevalence of 
hypothyroidism (TSH > 4.5 mIU/L) in the general population was 3.7%.  Among women of 
reproductive age (12-49 years) hypothyroidism was 3.1%.  Individuals aged 80 years and 
older had five times greater odds for having hypothyroidism compared to younger aged 
individuals (12- 49 years) (Aoki et al., 2007b). The prospective population-based study in 
Denmark showed that hypothyroidism was three times  predominant  in women and there 
was a steep increase in the incidence of hypothyroidism in females aged  40–50 years, while 
among males, the increase seemed to occur two or three decades later in life (Carle et al., 
2006). The population-based study in China showed that the prevalence of diagnosed with 
hypothyroidism was 1.7% in females and 0.3% in males. Subclinical hypothyroidism was 
more common in females (males 2.4% versus females 5.8%, P < 0.001) and with increasing 
age (P < 0.001) (Mao et al., 2010b).  
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 Similar finding was seen among Arabs populations In Saudi Arabia, a hospital  based study 
showed that of 391 patients 196 (54 male and 142 female) had hypothyroidism (Lamfon, 
2008). 
2.3  Lifestyle factors  
Table 2.2 summarizes epidemiological studies that investigated lifestyle factors that are 
associated with hypothyroidism.  Iodine intake, selenium, tobacco smoking, alcohol 
consumption and physical activity factors are reviewed in the coming sections.  
2.3.1 Iodine intake  
According to the American thyroid association, approximately 40% of the world’s 
population remains at risk for iodine deficiency. Thus, iodine deficiency can lead to 
enlargement of the thyroid (goiter), hypothyroidism, and mental retardation in infants and 
children whose mothers were iodine deficient during pregnancy. Even excess iodine can also 
lead to hypothyroidism  (ATA, 2012b). 
In china, a comparative population-based cross-sectional study showed that the population 
with iodine intake ( MUI 261 μg/l ) in Rongxing had higher prevalence of  subclinical 
hypothyroidism than a population with (MUI 145 μg/l ) in Chengshan (5.03 vs. 1.99%, 
P<0.001) (Teng et al., 2011).  In Denmark, a comparative study demonstrated that thyroid 
abnormalities in populations with low iodine intake in Jutland (approximately 40 to 70 μ 
g/d)  and those with high iodine intake develop in Iceland  (approximately 400–450 μ g/d) 
were in opposite directions: higher goiter and hyperthyroidism when iodine intake is 
relatively low, and higher hypothyroidism when iodine intake is relatively high (Laurberg et 
al., 1998).  
2.3.2 Selenium   
A comparative study in Zaire reported severe selenium deficiency associated  with endemic 
myxedematous cretinism in the core of endemic- area with iodine deficiency  (Vanderpas et 
al., 1990). A prospective, randomized, placebo-controlled study in Italy has shown that 200 
microg/d selenium  supplementation during pregnancy and in the postpartum period reduced 
thyroid inflammatory activity and the incidence of hypothyroidism  (Negro et al., 2007). 
These findings  have been supported by a prospective, placebo-controlled clinical study in 
Germany. The study demonstrated, that a substitution of 200 microg sodium selenite for 
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three months in patients with autoimmune thyroiditis reduced thyroid peroxidase antibody 
(TPO-Ab) concentrations significantly (Gartner and Gasnier, 2003). 
2.3.3 Tobacco smoking  
Studies evaluating Tobacco smoking and thyroid disorders have yielded conflicting results. 
Studies report either negative association, or a positive association between smoking and 
hypothyroidism. In Iran, a cross-sectional community based survey suggested  that smoking 
was  associated with lower risk of hypothyroidism and possibly with a lower frequency of 
thyroid autoimmunity (Mehran et al., 2012b). These findings also have been supported by 
the cross-sectional population-based study in Norway which showed that  smoking was 
negatively associated with hypothyroidism but positively associated with 
hyperthyroidism.(Asvold et al., 2007). In contrast, a case-control study in Denmark  found 
that smoking was  a powerful risk factor for thyroid disease, especially in populations with 
a high smoking frequency (Vestergaard et al., 2002).  In Japan, a retrospective study 
suggested that smoking may increase the risk of hypothyroidism in patients with 
Hashimoto's thyroiditis (Fukata et al., 1996).  
2.3.4 Alcohol consumption  
A few studies have demonstrated the direct effect of alcohol consumption on the prevalence 
and incidence of hypothyroidism, but on the other hand there are other studies that have 
addressed other effect of alcohol on the thyroid gland.  
A nested case-control studies in the prospective Amsterdam AITD cohort study  revealed  
that moderate alcohol consumption was to be protective for the development of overt 
hypothyroidism in subjects susceptible for developing autoimmune thyroid disease (AITD) 
(Effraimidis et al., 2012). These findings also have been supported by the population-based 
case-control study in Denmark. The study found that  alcohol, in doses up to 3 units/day, 
may have a protective role in the development of overt autoimmune hypothyroidism in both 
men and women aged 60 years or below (Carle et al., 2012).  
2.3.5 Physical activity  
A few scientific studies have addressed the impact of physical activity on thyroid function.  
In Brazil,  a double-blind, randomized study revealed that  that sub-maximal 
cardiopulmonary exercise performance improved after six months of TSH normalization 
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could help enhance the ability to carry out daily life activities in patients with subclinical 
hypothyroidism (Mainenti et al., 2009).  In Italy,  a double-blind, randomized, placebo-
controlled trial found  that exercise altered both the tolerance and pattern of blood glucose, 
lactate, pyruvate, free fatty acid and glycerol concentrations in subclinical hypothyroidism 
patients compared to healthy subjects  (Caraccio et al., 2005b).   
2.4 Genetics, Family history of autoimmune thyroid disease (AITD) 
Table 2.3 summarizes epidemiological studies that investigated genetic factors and family 
history that are associated with hypothyroidism 
 Several epidemiological studies revealed that Hashimoto’s thyroiditis is one of the most 
prevalent causes of hypothyroidism, its  influenced by both genetic and environmental 
factors (Erkan Sar et al., 2011). In Germany, a familial study showed that increased familial 
risk of developing autoimmune thyroid disease (AITD), especially for the first-degree 
relatives with (AITD), compared with the general population.  Also, the study  found  that 
in particular,  children and siblings of patients with Hashimoto’s thyroiditis had a 32-fold 
and 21-fold increased risk, respectively, for developing  immunethyroiditis  (Dittmar et al., 
2011).  A prospective  cohort study in Netherlands found that the  prevalence rate of 
autoimmune thyroid disease ( AITD) was 27% among first- and second-degree relatives of 
AITD patients (Strieder et al., 2003). In  USA, observational study  shown that the sibling 
risk ratios (λs) were 16.9 % in siblings of autoimmune thyroid disease (AITD) patients  for 
developing AITD compared to the general population (Villanueva et al., 2003). A 
population-based twin study in Denmark showed that significantly higher concordance rates 
of autoimmune hypothyroidism in monozygotic compared to dizygotic pairs, indicating that 
genetic factors play a role in the etiology of Hashimoto's thyroiditis (HT), and atrophic 
thyroiditis (AT) (Brix et al., 2000). 
2.5 Medical conditions and hypothyroidism   
Many epidemiological studies showed that many NCDs are associated with the occurrence 
of hypothyroidism.  Persons having diabetes mellitus type 1; pernicious anemia; turner 
syndrome; down Syndrome; vitiligo; rheumatoid arthritis; systemic lupus erythematosus; 
celiac disease; multiple sclerosis; Sjögren's syndrome and adrenal insufficiency were at 
greater risk to develop hypothyroidism, and vice versa, compared to others without having 
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these diseases.  Also, goiter, obesity and pregnancy were shown to be associated with having 
hypothyroidism.  These studies are summarized in table 2.4  
2.5.1 Diabetes and hypothyroidism  
Studies demonstrated that diabetes and thyroid disorders tend to coexist in patients. A cross-
sectional study in Germany showed that the prevalence rate of subclinical hypothyroidism 
was 7.2% in children, adolescents, and young adults (age <25 years) with type 1 
diabetes (Denzer et al., 2013). In the USA, a longitudinal study found  that  hypothyroidism 
was more common in female (41%) than in male (19%) subjects with type 1 diabetes,  
especially those  patients with positive TPO (Umpierrez et al., 2003). Similar finding were 
shown in studies in less economically developed countries. In Iran a cross-sectional study 
showed that children and adolescents with T1DM had higher prevalence of subclinical 
hypothyroidism than nondiabetic (Ardestani et al., 2011). A retrospective study in Saudi 
Arabia reported that 15.83% of children and adolescents with T1DM had hypothyroidism 
(Al-Agha et al., 2011). 
In Mexico,  a retrospective cross-sectional study showed that  the rate of hypothyroidism 
three times higher  in patients with T2DM than nondiabetic (Tamez-Perez et al., 2012). In 
India a study revealed that the prevalence rate of hypothyroidism was 23.75% among type 2 
diabetes (T2D)  (Singh et al., 2011). In Greece, a cross sectional study  showed that 
prevalence rate of subclinical hypothyroidism was 5.2% in males and 8.4% in females with 
T2D (Papazafiropoulou et al., 2010). 
2.5.2 Pernicious anemia and hypothyroidism 
In China, a prospective longitudinal study revealed that primary hypothyroidism was the 
main thyroid dysfunction encountered in pernicious anemia (PA) patients (Chan et al., 2009). 
In USA, a study showed that the prevalence of hypothyroidism was 11.7% among  patients 
with pernicious anemia (Carmel and Spencer, 1982). See table 2.5 for more details. 
2.5.3 Turner syndrome and hypothyroidism 
A cohort study in Denmark revealed  that the overall risk of  autoimmune disease among 
women with Turner’s syndrome was twice than women in the general population (Jorgensen 
et al., 2010). A  large Cohort study in Sweden showed that hypothyroidism was common in 
adult women with Turner syndrome (TS) and significantly more common than in the random 
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population sample, with an annual incidence 3.2% after 5-year follow-up  (El Mansoury et 
al., 2005a). See table 2.6 for more details. 
2.5.4 Down syndrome and hypothyroidism  
The prospective study  in Nepal reported  that the prevalence of  hypothyroidism in Downs’ 
children  was 15%,  of  which 12.5%  had a compensated hypothyroidism while the other 
had a 3.1% uncompensated hypothyroidism  (Shaw et al., 2006). The longitudinal study in  
Sweden found that hypothyroidism developed  in one third of patients with Down’s 
syndrome before the age of 25 years (Karlsson et al., 1998). See table 2.7 for more details. 
2.5.5 Vitiligo and hypothyroidism  
In Brazil, a cross-sectional study found that the prevalence of autoimmune thyroid diseases 
was 22.4% in patients with vitiligo. (Nunes and Esser, 2011).  A case-control study in India 
found that the incidence  rate  of hypothyroidism among patients with vitiligo was 12%  
compared with healthy subjects (Gopal et al., 2007).  See table 2.8 for more details.  
2.5.6 Rheumatoid arthritis and hypothyroidism  
The case-control study in Egypt revealed that thyroid dysfunction, especially 
hypothyroidism were more frequently in systemic lupus erythematosus and  rheumatoid 
arthritis patients compared with  the general population (Mousa et al., 2012). The study- 
population in Netherlands showed that clinical hypothyroidism was threefold in female 
rheumatoid arthritis (RA) patients than females in the general population. (Raterman et al., 
2008).  For details, see table 2.9 (Annex a). 
2.5.7 Systemic lupus erythematosus and hypothyroidism  
In India a prospective study showed that thyroid dysfunction was more frequent in systemic 
lupus erythematosus (13.1%) than in rheumatoid arthritis (5.1%). In Systemic lupus 
erythematosus (SLE) patients. Subclinical hypothyroidism occurred in 17.1%, while clinical 
hypothyroid was present in 73.2%.  In Rheumatoid arthritis (RA)  patients subclinical 
hypothyroid was seen in 20% , while clinical hypothyroid was 60%  (Porkodi, 2004). A 
retrospective study in the UK showed that the prevalence of hypothyroidism in systemic 
lupus erythematosus (SLE) patients was (5.7%)  higher than the normal population (1%) 
(Pyne and Isenberg, 2002). For details, see table 2.9 (Annex a). 
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2.5.8 Sjögren's syndrome and hypothyroidism 
A case-control study in Kuwait showed that the frequency of subclinical hypothyroidism, 
especially among female patients with  primary Sjogren's syndrome (PSS) were significantly 
higher  than in the healthy controls (Al Awadhi et al., 2008). In Italy, a case control study 
reported that the prevalence rate of hypothyroidism was (13.4%) among primary Sjögren's 
syndrome patients (Punzi et al., 1996). For details, see table 2.10 (Annex a). 
2.5.9 Celiac disease and hypothyroidism  
A cross-sectional study in Pakistan reported a high prevalence of subclinical hypothyroidism 
in Celiac pediatric  patients (Butt et al., 2011). In Italy, a multi-center study showed that the 
prevalence of hypothyroidism in celiac patients was  (8.1%) higher than control subjects 
(3.5%) (Ansaldi et al., 2003b).  For details, see table 2.10 (Annex a). 
2.5.10  Multiple sclerosis and hypothyroidism  
A  prospective study in Spain found that a significant higher prevalence of subclinical 
hypothyroidism in multiple sclerosis (MS) patient group compared with the control group 
(6.45% vs. 2.24%, P 0.03) (Munteis et al., 2007). A follow-up study in Italy reported that at 
baseline the prevalence of subclinical was 2.8% among patients with Multiple sclerosis 
(Caraccio et al., 2005a).  
2.5.11 Adrenal insufficiency and hypothyroidism 
Several epidemiological studies have been recognized both primary and secondary adrenal 
insufficiency as risk factors for developing hypothyroidism. A cohort study in South Africa 
found that primary hypothyroidism were the most common autoimmune thyroid diseases 
associated with primary adrenal insufficiency (Addison’s disease) (Ross et al., 2010). 
Similar results also have been seen in a national registry-based cohort study in Norway. The 
result showed that a higher prevalence rate of  hypothyroidism among patients with   primary 
adrenal insufficiency (Addison’s disease) (Erichsen et al., 2009). 
In Poland, a study report of 111 cases with secondary adrenal insufficiency. They found that 
primary hypothyroidism were the most frequent autoimmune diseases associated with 
secondary adrenal insufficiency (Kasperlik-Zaluska et al., 2003). Pregnancy and 
hypothyroidism.  
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According to the publication of an  American thyroid association postpartum thyroiditis 
occurs in approximately 5-10% of women, also approximately 20% of those women with 
postpartum thyroiditis that go into hypothyroidism phase will remain hypothyroid (ATA, 
2012d). Furthermore, literature showed that 20–40% of women with postpartum thyroiditis 
develop permanent hypothyroidism over the ensuing 3–12 years (Stagnaro-Green, 2012). In 
Australia, a study found that hypothyroidism was present in 38% (71 women) who had 
postpartum thyroiditis (PPTD) at baseline  with a significant adjusted odds ratio 9.7 for 
postpartum hypothyroidism (Stuckey et al., 2010). In Finland,  prospective population-based 
cohort study in revealed that overt and subclinical hypothyroidism and thyroid antibodies 
detected in early pregnancy seem to predict later thyroid disease morbidity of the mother 
(Mannisto et al., 2010). 
2.5.12 Obesity and hypothyroidism  
Epidemiological studies have  found that obesity is a risk factor for hypothyroidism and vice 
versa. In Italy, a cross-sectional study was performed in a tertiary care center revealed that 
obesity can increase the risk of thyroid autoimmunity, this being associated with leptin level 
(Marzullo et al., 2010). A cross sectional community based survey in Iran suggested  that a 
significant positive association exists between TSH and BMI in euthyroid nonsmokers 
(Mehran et al., 2012a). A retrospective, observational study  in India found that primary 
hypothyroidism was more prevalent in individuals with extreme obesity as compared to 
moderate obesity patients  ( 56% versus 41%) (Verma et al., 2008).  
2.5.13 Goiter and hypothyroidism  
A case-control study in India found  that hypothyroidism (subclinical and clinical) was  in  
3.2 per cent in children with goiter and 2.4 per cent without goiter (Das et al., 2011). A cross-
sectional study in Iran showed the hypothyroidism was three times higher among  goitrous 
adult compared to non-goitrous adult (Aminorroaya et al., 2010).  
2.6     Medication and hypothyroidism  
Epidemiological studies have demonstrated that some medications such as:  interferon, 
amiodarone, lithium, radioactive iodine, thyroid surgery and thionamides ( 
methimazole,  propylthiouracil, carbimazole) were associated with increased  risk of 
developing  hypothyroidism.  These studies are summarized in table 2.6.  
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2.6.1 Interferon and hypothyroidism  
A cohort study in Pakistan found that patients of chronic hepatitis C undergoing treatment 
with interferon and ribavirin were eleven times more likely to develop thyroid dysfunction 
as compared to patients with chronic hepatitis C without treatment (Nadeem and Aslam, 
2012). A prospective study in Brazil showed  that patients with chronic hepatitis C (HCV)  
had a relative risk of 3.5 for developing hypothyroidism during the first treatment with α-
interferon course  (Pavan et al., 2011).  
2.6.2 Amiodarone and hypothyroidism 
A retrospective population-based cohort study in Canada  reported that the rate of  
hypothyroidism was  15.8%  among patients using the brand-name of amiodarone and 16.6% 
among patients using generic formulations of amiodarone (Tsadok et al., 2011). The 
retrospective study in China found that the prevalence of hypothyroidism was 22% among 
patients who had been prescribed amiodarone for at least 6 months. Also, they found TSH 
hormone of 4 mIU/L or above appeared to be predictive of amiodarone-induced 
hypothyroidism, in which  associated with a 4.7-fold increase in the risk of developing 
hypothyroidism among patients using amiodarone  (Lee et al., 2010). 
2.6.3 Lithium and hypothyroidism  
In France, a cross sectional study reported that the prevalence of hypothyroidism was 37% 
in men, and 9% in women  patients with bipolar disorder who had been treated with lithium 
(Henry, 2002). In Scotland,  a retrospective study  found that the prevalence of clinical 
hypothyroidism during lithium treatment was 10.4%(Johnston and Eagles, 1999). 
2.6.4 Radioactive iodine and hypothyroidism  
A retrospective cohort study in USA found that the prevalence of hypothyroidism was 40% 
among patients  were  treated with RAI therapy at 6-8 weeks (Stan et al., 2013). In Qatar, a 
retrospective study found that the incidence rate of hypothyroidism among patients  were  
treated with RAI therapy was  55.8% at 6 months and 67.9% at one year (Ghadban et al., 
2003).  
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2.6.5 Thyroid Surgery and hypothyroidism  
A retrospective study in Korea found that the incidence of hypothyroidism following thyroid 
lobectomy was 21.1% within 35.7 months of follow-up (Cho et al., 2011d).  In Iran, a cross 
section hospital based study reported that 35.2% of cases of thyroidectomy developed 
hypothyroidism on average 5 ± 3.2 months after surgery (Lankarani et al., 2008). 
2.6.6 Thionamides (Methimazole, Propylthiouracil, Carbimazole) and 
hypothyroidism  
A prospective randomized study in Thailand found that the incidence rate of hypothyroidism 
among  hyperthyroidism patients were  treated with a fixed-15 mg daily dosage of  
Methimazole  ( MMI ) for 12 weeks was  31.4%, while hypothyroidism  not seen in  patients 
were treated with Propylthiouracil (PTU) (Homsanit et al., 2001). A  prospective open 
multicentre trial in the United Kingdom showed that Carbimazole (CBZ) -related 
hypothyroidism developed in approximately in 25% of patients who received 40 mg 
CBZ/day for 4 weeks compared to the  patients who received 20 mg CBZ/day  (Page et al., 
1996). 
2.7    History of diagnosis   
A descriptive case study in Pakistan included 100 consecutive cases of hypothyroidism from 
birth to twelve years. The study found that delayed diagnosis was among 42%  (n=100) of 
cases and were between 1-5 years of age, also 66% of these cases had developmental delay. 
The authors concluded that early diagnosis of hypothyroidism is recommended to prevent 
the effects of delayed diagnosis. (Malik and Butt, 2008c). Another longitudinal study of 20 
children  in Turkey, revealed that height prognosis in late diagnosed congenital 
hypothyroidism (Kandemir and Yordam, 2001). 
2.8    Studies in Arab countries  
The studies in Arab countries investigated the risk factors that are associated with 
hypothyroidism including: excessive iodine intake (Alsayed et al., 2008), genetic factors 
(Bougacha-Elleuch et al., 2011), family history of thyroid disease  (Abdel-Rasoul et al., 
2011), diabetes type 1 (Al-Agha et al., 2011), diabetes type 2 (Al wazan et al., 2010), down 
syndrome (Rabah M Shawky, 2005),  vitiligo (Mousa et al., 2012),  rheumatoid arthritis 
(Mousa et al., 2012,Al Awadhi et al., 2008) systemic lupus erythematosus (Mousa et al., 
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2012,Al Awadhi et al., 2008),  sjögren's syndrome (Al Awadhi et al., 2008), goiter (Qari, 
2005) , obesity (Nouh et al., 2008) and pregnancy (Alkafajei et al., 2012). 
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Table 2.1: Summary of studies on socio-demographic variables association with hypothyroidism.  
 
Author, 
Country of 
study 
Type of study Sample  Objectives  Main finding Conclusion 
(Aoki et al., 
2007b), USA 
National Health 
and Nutrition 
Examination 
Survey 
(NHANES) 
2156 participants 
aged ≥12 years 
To describe thyrotropin 
(TSH) and thyroxine 
(T4) levels in the U.S. 
population and their 
association with selected 
participant 
characteristics. 
- Individuals aged 80 years and older 
had five times greater odds for 
hypothyroidism compared to 12- to 
49-year-old (adjusted odds ratio [OR] 
= 5.0, p = 0.0006). ORs were adjusted 
for sex, race, and annual income. 
Hypothyroidism was 
more common in 
females, and with 
increasing age. 
(Carle et al., 
2006), 
Denmark 
A prospective 
population-
based study 
Aalborg (moderate 
iodine deficiency, n = 
311,102) and 
Copenhagen (mild 
iodine deficiency, n = 
227,632) 
To study the incidences 
of sub types of primary, 
overt hypothyroidism in 
a Danish population 
cohort and compared 
incidences in two sub-
cohorts with different 
levels of iodine intake. 
 -Hypothyroidism was more common 
among females with a female/male 
incidence rate ratio of 3.5. 
-A steep increase in the incidence of 
hypothyroidism in females aged  40–
50 years , while among males, the 
increase seemed to occur two or three 
decades later in life. 
 
Hypothyroidism was 
more common in 
females, and the 
incidence of 
hypothyroidism 
increase with age. 
(Mao et al., 
2010b), China 
A population-
based study 
10405 >20 years To determine the 
prevalence of major 
thyroid dysfunctions 
including overt and 
subclinical hyper- and 
hypothyroidism in a 
stable cohort. 
-Subclinical hypothyroidism was 
more common in females (male 2.4% 
vs. female 5.8%, P < 0.001) and with 
increasing age (P < 0.001). 
Subclinical 
hypothyroidism was 
more common in 
females, and with 
increasing age. 
(Lamfon, 
2008), Saudi 
Arabia 
A cross-
sectional study 
153 patients To study the prevalence 
of thyroid diseases 
among patients. 
352 patients have hypothyroidism ( 92  
male and 142 female). 
Hypothyroidism was 
more common in 
female patients than 
male patients. 
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Table 2.2:  Summary of studies that investigated lifestyle factors association with hypothyroidism 
Author\years  
Place of study 
Kind of 
study 
Sample size Objectives  Main finding Conclusion 
(Teng et al., 2011),  
China 
A 
population-
based cross-
sectional 
study 
3813 individuals Explore the associations between 
more than adequate iodine intake 
levels and the development of 
thyroid diseases in two Chinese 
populations. 
The prevalence of 
subclinical hypothyroidism 
was significantly higher in 
Rongxing than Chengshan 
(5.03 vs. 1.99%, P<0.001). 
High iodine intake 
associated with thyroid 
function and thyroid 
autoimmunity. 
(Laurberg et al., 
1998), 
 Denmark 
A 
comparative  
study 
423subjects from 
Jutland, And 
100subjects from 
Iceland 
Evaluate the effect of differences 
in the population iodine intake on 
the prevalence rate of various 
thyroid disorders in the elderly. 
-The prevalence of 
subclinical hypothyroidism 
in Iceland was 4 times than 
Jutland. 
Low and high iodine 
intake levels correlated 
with thyroid 
abnormalities. 
(Vanderpas et al., 
1990), 
 Zire 
A 
comparative  
study 
52 school children 
(Aged 9-18 y) and 
28 cretins (aged 
3-25 y) 
To determine the selenium status 
in a population living in the core of 
the endemic-goiter belt of northern 
and in a Zairian area without 
endemic goiter. 
-Serum selenium in subjects 
living in the core of the 
endemic goiter belt was 
seven times lower in 52 
schoolchildren and 
similarly low in 23 cretins. 
 
 Selenium deficiency 
associated with of 
endemic 
myxedematous 
cretinism. 
(Negro et al., 2007), 
 Italy 
A 
prospective, 
placebo-
controlled 
clinical 
study 
2143 euthyroid 
pregnant women 
(7.9% were 
TPOAb) 
To examine whether Selenium 
(Se) supplementation, during and 
after pregnancy, influences the 
thyroidal autoimmune pattern and 
function. 
-Permanent hypothyroidism 
was significantly lower in 
group women received 
selenomethionine 200  
microg/d (group S1) 
compared with women 
received placebo  (11.7 vs. 
20.3%, P  0.01). 
Selenium(Se) 
supplementation 
during pregnancy and 
in the postpartum 
period reduced the 
incidence of 
hypothyroidism. 
 
(Gartner and 
Gasnier, 2003), 
Germany 
A 
prospective, 
placebo-
controlled 
clinical 
study 
70 patients with 
autoimmune 
thyroiditis 
To demonstrate that a substitution 
of 200 microg sodium selenite for 
three months in patients with 
autoimmune thyroiditis.  
 -TPOAb concentration 
decreased significantly to 
63.6% (P = 0.013) in the 
selenium group vs. 88% 
(P = 0.95) in the placebo 
group. 
Selenium substitution 
may improve the 
inflammatory activity 
in patients with 
autoimmune 
thyroiditis. 
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Table 2.2 continues 
Author\years  
Place of study 
Kind of study Sample size Objectives/hypothesis  Main finding Conclusion 
(Mehran et al., 
2012c), Iran 
A cross sectional 
community based 
survey 
38903 randomly selected 
subjects with no history 
of thyroid disorders. 
Association between 
smoking and serum 
TSH concentration and 
the presence of 
thyroperoxidase 
antibody (TPO Ab) in 
adults. 
- Hypothyroidism was lower in the 
ever smoker group compared to the 
never smoker (odds ratio 0.4, 95% 
CI=0.2-0.8). 
 
Smoking negatively 
associated 
hypothyroidism. 
(Asvold et al., 
2007), Norway 
A cross-sectional, 
population-based 
study 
60 2.5 women and 10 
355 men without 
previously known 
thyroid disease 
Association between 
tobacco smoking and 
thyroid function. 
-The prevalence of overt 
hypothyroidism was lower in 
current smokers compared with 
never smokers (odds ratio, 0.60; 
95% CI, 0.38-0.95). 
Smoking inversely 
associated with 
hypothyroidism. 
(Vestergaard et 
al., 2002), 
Denmark 
A case-control 
study 
217 ( 926  females) 
hyperthyroidism and 408 
(364 females) with 
hypothyroidism 
Association between 
smoking and thyroid 
disease. 
 
-In women,  autoimmune 
hypothyroidism was higher  in ever 
smoking compared to never 
smoking (OR = 1.5, 95% CI: 1.1-
2.1)  not in men 
Smoking is a powerful 
risk factor for thyroid 
disease 
(Fukata et al., 
1996), Japan 
A retrospective 
study 
  238 randomly chosen 
women patients with 
nodular goiters and 166 
control women 
Relationship between 
smoking history and 
thyroid function in 387 
women patients with 
Hashimoto's 
thyroiditis. 
-The prevalence of hypothyroid was 
76.4%   among smoker, 34.8% 
among nonsmokers, and 61.9% 
among the excess-smokers. 
Smoking may increase 
the risk of 
hypothyroidism.  
(Effraimidis et 
al., 2012), 
Netherlands 
Two nested case-
control study 
Study A (521 euthyroid  
participants 
Study B (38 cases with 
hypothyroidism) 
Alcohol consumption 
reduce the risk of 
developing 
autoimmune thyroid 
disease. 
- Light alcohol drinkers:  (1–10 
units/week),  OR for 
hypothyroidism = 0.58  
- High alcohol consumers ( > 11 
units/week) was 0.40  
- Non drinker, OR do not change   
- Multivariate sowed that smoking 
habits (OR=0.59) and family history 
was inversely associated 
hypothyroidism (OR= 0.41) 
Alcohol consumption 
may protect against 
overt autoimmune 
hypothyroidism 
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Table 2.2 continues 
 
Author\years  
Place of study 
Kind of study Sample size Objectives/hypothesis  Main finding Conclusion 
(Carle et al., 
2012), 
Denemark 
A population-
based case-control 
study 
140 patients diagnosed 
with overt 
Autoimmune 
hypothyroidism and 560 
controls 
To study the 
association between 
alcohol consumption 
and autoimmune 
hypothyroidism. 
-In patients who do not consume 
alcohol the OR for the development 
of hypothyroidism was twice (2.12; 
95% CI, 1.31 to 3.4) that in patients 
who consumed 1 to 10 units of 
ethanol per week (n = 85). 
Alcohol consumption may 
protect against development of 
overt autoimmune 
hypothyroidism.  
(Mainenti et al., 
2009), Brazil 
Trial study  23 patients with 
subclinical 
hypothyroidism were 
randomized into treated 
with levothyroxine (L-
T4) replacement (no=11) 
and untreated (no=12) 
To verify possible 
cardiopulmonary 
changes during 
exercise in patients 
with subclinical 
hypothyroidism on L-T 
(4) replacement with a 
normal serum TSH for 
six months. 
-Oxygen uptake, carbon dioxide 
production, minute ventilation, and 
heart rate at sub maximal exercise 
intensity had significant 
improvements in treating patients, 
while in untreated no changes  
 
Submaximal cardiopulmonary 
exercise  after  L-T (4) 
replacement had a positive 
effect in subclinical patients  
 
 
 
(Caraccio et al., 
2005b), Italy  
A double-blind, 
randomized, 
Placebo-
controlled fashion 
61  subclinical 
hypothyroidism patients 
and 10 matched 
euthyroid controls 
To evaluate the energy 
and substrate response 
to exercise in 
subclinical 
hypothyroidism 
patients using a 
standardized protocol 
and to test the effect of 
L-T (4) replacement. 
-Exercise was significantly impaired 
in subclinical hypothyroidism.  In 
terms maximal power output (P = 
0.02) and VO (2) max (P = 0.04) 
were reduced in subclinical 
hypothyroidism patients. 
 
 Exercise affected to 
subclinical hypothyroidism.  
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Table 2.3: Summary of studies that investigated genetic factors and family history association with hypothyroidism  
Author\years 
Place of study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Dittmar et al., 
2011), 
Germany  
Familial study  86 AITD index 
cases with their 
139 children 
and 106 AITD 
index cases 
with their 
157 siblings 
were included. 
To determine familial prevalence 
and recurrence 
risk ratio of autoimmune thyroid 
diseases 
(AITD) in Germany. 
- The prevalence AITD were  in 
14% of children and 15% of 
siblings of patients with AITD. 
 
- children and siblings of index 
cases with Hashimoto's 
thyroiditis had a 32-fold and 
21-fold increased risk, 
respectively, for developing 
immunthyroiditis 
Screening of off spring 
and siblings of AITD 
patients for the presence of 
immunethyroidits. 
(Strieder et al., 
2003),  
Netherlands 
Started with 
Prospective 
cohort study,’ 
then cross 
sectional 
study  
803 subjects, 
440 came from 
families with 
More than one 
patient with 
documented 
AITD. 
To determine risk 
Factors for developing 
autoimmune thyroid disease 
(AITD). 
- At baseline AITD  was 89% 
on subjects  had at least one 
first degree with AITD and  
11% on  subjects with at least   
one second-degree relative 
with AITD. 
- The prevalence rate of 
hypothyroidism was 3.6%. 
Genetic factors play a role 
on co-occurrence of 
Hashimoto's thyroiditis 
and Graves' disease within 
one family.  
(Villanueva et 
al., 2003), USA  
Observational 
study  
131 patients 
with Graves' 
(GD) and 24 
patients  with 
Hashimoto's 
thyroiditis (HT) 
To measure of the magnitude of 
genetic contribution to the 
development of  AITD through 
using results of 
Nutrition Examination Survey III 
- 9 probands had siblings with 
GD and 13 probands had 
siblings with HT. 
- The sibling risk ratios (λs) for 
developing AITD was 16.9 for 
AITD, 11.6 for GD, and 28.0 
for HT.  
Significant contribution of 
genetic factors to the 
development of AITD. 
(Brix et al., 
2000), 
Denmark 
Population-
based twin 
study 
5890 twin pairs To elucidate whether there is a 
genetic influence in the etiology 
of Hashimoto's thyroiditis (HT), 
and atrophic thyroiditis (AT). 
The prevalence of autoimmune 
hypothyroidism between 
monozygotic and dizygotic 
twins (0.42% and 0.40%, 
respectively).  
Genetic factors play a role 
in the etiology of HT/AT.   
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Table 2.4: Summary of studies that investigated diabetes and hypothyroidism 
 
Author\year
s  
Place of 
study 
Kind of 
study 
Sample size Objectives  Main finding Conclusion 
(Denzer et al., 
2013), 
Germany 
A cross-
sectional 
analysis 
668.2. children, 
adolescents, and young 
adults (age <25 years) 
with type 1 diabetes 
 To investigate the prevalence 
of subclinical hypothyroidism 
(SCH) and associated lipid 
levels in young diabetic 
patients. 
-  The prevalence rate of SCH 
was 7.2% in children, 
adolescents, and young adults 
with type 1 diabetes. 
Subclinical hypothyroidism was 
common in children, 
adolescents, and young adults 
with type 1 diabetes. 
(Umpierrez et 
al., 2003), 
USA 
Longitudinal 
study 
58 patients (26 men and 
32 women) 
To determine the natural 
history of thyroid dysfunction 
in patients with type 
1 diabetes 
- Hypothyroidism was more 
common in female (41%) than in 
male (19%) subjects with type 1 
diabetes. 
 
Confirms the association 
between autoimmune thyroid 
dysfunction and type 1 diabetes. 
(Ardestani et 
al., 2011), 
Iran 
A cross 
sectional 
study  
100 patients with T1DM 
and 184 healthy school 
children  
To study the prevalence of 
thyroid disorders such as 
autoimmunity of thyroid (AIT), 
thyroid dysfunction, and goiter 
in children and adolescents 
with T1DM, compared with 
age- and sex-matched healthy 
controls in Isfahan. 
-The prevalence of subclinical 
hypothyroidism in T1DM 
patients and non-diabetic 
subjects was 1% and 0.7%, 
respectively. 
 
Children and adolescents with 
T1DM had higher levels of 
subclinical hypothyroidism than 
non-diabetic ones. 
(Al-Agha et 
al., 2011), 
Saudi Arabia 
A 
retrospective 
cross-
sectional 
study 
398 children and 
adolescents with T1DM 
aged from 1 to 18 years 
To review the prevalence of 
T1DM among children and 
adolescents with T1DM and 
determine the factors affecting 
its prevalence in our 
population. 
- The prevalence of 
hypothyroidism was 15.83% 
among children and adolescents 
with T1DM (92% subclinical 
hypothyroidism, 7.94% clinical 
hypothyroidism). 
 
Screening programs for 
hypothyroidism among children 
and adolescents with T1DM. 
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Table 2.4 continues….. 
Author\year
s  
Place of 
study 
Type of 
study 
Sample size Objectives  Main finding Conclusion 
(Tamez-
Perez et al., 
2012), 
Mexican 
  A 
retrospective 
cross-
sectional 
study 
3020  adult patients with 
T2DM were compared 
with 1131  non-diabetic 
patients 
To identify the rate of diabetic 
patients treated for 
hypothyroidism and compare 
them with a group without type 
2 diabetes mellitus (T2DM) 
-The rate of hypothyroidism 
three times higher in patients 
with T2DM than nondiabetic. 
 
 
 
A strong association between 
T2DM and hypothyroidism. 
(Singh et al., 
2011), India 
A cross 
sectional 
study 
00  type 2 diabetic 
subjects and 80 healthy 
non diabetic subjects 
To evaluate the  prevalence 
of thyroid dysfunction in 
subjects with type 2 diabetes 
and the effect of type 2 diabetes 
mellitus on other bio-chemical 
variables. 
-Hypothyroidism was present in 
23.75% (15% subclinical 
hypothyroidism and 8.75% 
Primary hypothyroidism) of 
diabetic subjects. 
 
High incidence of abnormal 
thyroid hormone level among 
type 2 diabetic subjects. 
 
(Papazafirop
oulou et al., 
2010), Greek 
A cross 
sectional 
study 
1,092 patients with T2D To determine the 
Prevalence of thyroid 
dysfunction in patients with 
type 2 diabetes (T2D) attending 
an outpatient clinic. 
-Subclinical hypothyroidism was 
5.2% in males and 8.4% in 
females with T2D.  
A higher prevalence Subclinical 
hypothyroidism among diabetic 
females 
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Table 2.5:   Summary of studies that investigated pernicious anemia and hypothyroidism 
 
Author\years  
Place of study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Chan et al., 
2009), China  
 Hospital-based 
longitudinal study 
of 
126 patients with 
pernicious anemia  
To determine 
thyroid 
autoimmunity in 
Chinese patients 
with pernicious 
anemia (PA). 
- The overall rate of Autoimmune 
thyroid disease (AITD before and 
after (PA) were occurred in 23% 
and in 5.7% of PA patients with 
and without antibodies (P = 004). 
 
-9 patients PA developed  primary 
hypothyroidism during  follow-up 
and was associated with high 
TPO/Tg antibody titer. 
Screen thyroid antibodies 
and monitor thyroid function 
in PA patients during follow 
up. 
(Carmel and 
Spencer, 1982), 
USA 
Observational study 62 patients with 
pernicious anemia  
To observe on 
abnormal thyroid-
stimulating 
hormone levels and 
on a possible 
association of blood 
group O with 
hyperthyroidism. 
- The prevalence of 
hypothyroidism was 11.7% among 
patients with pernicious anemia. 
 
 TSH screening in patients 
with pernicious anemia. 
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Table 2.6:   Summary of studies that investigated turner syndrome and hypothyroidism 
 
Author\years  
Place of 
study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Jorgensen et 
al., 2010), 
Denmark 
Cohort study 798 Danish women with 
Turner’s syndrome 
To investigate 
whether the 
autoimmune 
disease profile in 
women with 
Turner's 
syndrome 
- The overall risk of autoimmune disease 
among women with Turner’s syndrome was 
twice that 
among Danish women in general 
(Standardized incidence ratios 
 (SIR) 2.1 [95% CI 1.6–2.7]). 
 
Women with 
Turner’s syndrome 
were at excess risk 
of autoimmune 
diseases. 
(El Mansoury 
et al., 2005a), 
Sweden 
 
 
A large cohort 
study  
91 women with TS were 
compared with an age-
matched 228 female 
random population  
To study the 
prevalence and  
incidence of 
thyroid disease in 
adults with Turner 
syndrome 
-The prevalence of hypothyroidism 
among TS women was 37% after the 5-yr 
follow-up. 
 
Autoimmune 
hypothyroidism 
was common in 
Turner syndrome. 
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Table 2.7:  Summary of studies that investigated Down’s syndrome and hypothyroidism 
 
 
 
 
 
  
Author\years  
Place of 
study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Shaw et al., 
2006), Nepal 
A prospective 
study 
16  children with 
Down syndrome  
To know the 
prevalence of 
thyroid dysfunction 
in Down Syndrome 
children below the 
age of 14 years and 
to correlate the 
features of Down 
Syndrome with 
those of thyroid 
dysfunction 
-The prevalence of 
hypothyroidism in Downs’ 
children was 15%, of which 
12.5% had a compensated 
hypothyroidism while the other 
3.1% had uncompensated 
hypothyroidism.   
  
 
Screen Down syndrome 
children for thyroid 
dysfunction. 
(Karlsson et 
al., 1998), 
Sweden 
Longitudinal 
study 
85 children with 
Down’s syndrome 
To study 
longitudinally 
thyroid function in 
patients with 
Down’s syndrome 
up to the age of 25 
years. 
-Hypothyroidism was developed 
in one third of patients with 
Down’s syndrome before the age 
of 25 years. 
Hypothyroidism was 
common in Down’s 
syndrome patients.  
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Table 2.8:  Summary of studies that investigated vitiligo and hypothyroidism 
 
 
 
 
 
 
Author\years  
Place of 
study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Nunes and 
Esser, 2011), 
Brazil. 
A cross-
sectional study 
09  patients with 
vitiligo 
To describe the epidemiological profile of 
vitiligo patients and to estimate the prevalence 
of the association of vitiligo with autoimmune 
thyroid diseases. 
 -The rate of thyroid 
autoimmune diseases was 
founded in 22.4% of patients 
with vitiligo (80% 
corresponded to 
hypothyroidism and 6.7% to 
subclinical hypothyroidism). 
Autoimmune 
thyroid diseases 
common in patients 
with Vitiligo. 
(Gopal et al., 
2007), India  
Case control 
study  
390 cases of 
various types of 
vitiligo were 
compared with  
100 nonvitiligo 
cases 
A study of the genetic factors, systemic 
associations as well as ocular and auditory 
abnormalities of vitiligo. 
-Hypothyroidism was present 
in 12 % of  vitiligo patients but 
in none of  the controls 
 
Vitiligo was a part 
of the systemic 
autoimmune 
process. 
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Table 2. 9:  Summary of studies that investigate rheumatoid arthritis, systemic lupus erythematosus and hypothyroidism 
 
Author\years  
Place of 
study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Mousa et al., 
2012), Egypt 
Case-control 
study 
116 SLE patients 
(128 females, 4 
males) and 217 RA 
patients (174 
females, 43 males) 
were compared with 
120 controls (90 
females, 30 males)  
To investigate the frequency of 
thyroid dysfunction in Rheumatoid 
Arthritis (RA) and Systemic Lupus 
Erythematosus (SLE) and whether 
these dysfunctions could be an 
additional risk factor for the 
development of cardiovascular 
diseases. 
-The prevalence rate of clinical 
hypothyroidism was (8.3% SLE, 4.1% 
RA patients). 
 
Hypothyroidism 
was common SLE 
and RA patients.  
(Raterman et 
al., 2008), 
Netherlands 
A cross-
sectional study 
358 RA patients To determine the prevalence of 
hypothyroid disorders in rheumatoid 
Arthritis (RA) patients. 
Clinical hypothyroidism was 
significantly 3 times higher in female 
RA patients than in the general 
population.  
Clinical 
hypothyroidism 
was common in 
RA.  
(Porkodi, 
2004), India 
Prospective 
study   
391  SLE patient and  
.50  RA patients 
 
To study the prevalence of thyroid 
dysfunction in Systemic lupus 
erythematosus (SLE) and 
Rheumatoid 
Arthritis (RA). 
 - In SLE patients subclinical 
hypothyroid occurred in 17.1%, while 
clinical hypothyroid was present in 
73.2%. 
   
-In RA patients subclinical hypothyroid 
was seen in 20%, while clinical 
hypothyroid was 60%.   
Thyroid 
dysfunction 
occurred more 
frequently and in a 
younger age group 
in patients with SLE 
as compared to RA. 
(Pyne and 
Isenberg, 
2002), UK 
Retrospective 
study 
100  patients with 
SLE 
To report the prevalence of 
autoimmune thyroid disease and 
thyroid antibodies in 300 patients 
with SLE. 
-The prevalence of hypothyroidism in 
SLE patients (5.7%) was higher than the 
normal population (1%). 
Systemic lupus 
erythematosus had 
a prevalence of 
hypothyroidism, 
greater than in the 
normal population. 
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Table 2.10   Summary of studies that investigated sjögren’s syndrome,  celiac and hypothyroidism 
 
Author\years  
Place of 
study 
Type of study Sample size Objectives  Main finding Conclusion 
(Al Awadhi et 
al., 2008), 
Kuwait 
Case-control 
study 
3.. patients with 
rheumatoid arthritis 
(RA), 60 with systemic 
lupus erythematosus 
(SLE) , 25 with primary 
Sjogren's syndrome 
(pSS), and  9..  healthy 
controls 
To examine the 
frequencies of abnormal 
thyroid function tests and 
serum thyroid 
autoantibodies in healthy 
Kuwaitis and those with 
autoimmune diseases. 
- Subclinical hypothyroidism was seen in 
16% of pSS patients and in   1.7% of healthy 
controls. 
 
- Overt hypothyroidism was seen in 1.4% of 
controls, and in 4% of pSS patients. 
 
Thyroid function 
tests for primary 
Sjogren's syndrome 
patients.  
(Punzi et al., 
1996), Italy 
Case-control 
study 
363 with primary 
Sjogren's syndrome and 
74 with rheumatoid 
arthritis and  202 controls 
To evaluate the frequency 
of thyroid disorders in 
primary Sjogren’s 
syndrome. 
- Hypothyroidism was more common 
among Sjogren's syndrome patients 
(13.4%) than rheumatoid arthritis patients 
(3.1%) (P < 0.05). 
 
Thyroid disorders 
common in primary 
Sjogren's 
syndrome. 
(Butt et al., 
2011),  
Pakistan 
Analytical cross 
sectional study 
50  patients with Celiac 
Disease 
and  25 healthy non class 
children 
To assess the thyroid 
functions in Celiac 
Disease patients. 
-The prevalence of subclinical 
hypothyroidism was 10% in patients with 
celiac disease  
 
Assessment of 
thyroid function in 
patients with Celiac 
Disease 
(Ansaldi et 
al., 2003a), 
Italy 
multi-center 
study 
121 pediatric  patients 
with CD and 230 healthy 
subjects as control 
To establish the 
prevalence of autoimmune 
thyroid involvement in a 
large series of pediatric 
patients with Celiac 
Disease (CD). 
-The prevalence of hypothyroidism in celiac 
patients was (8.1%) higher than control 
subjects (3.5%). 
- 
Thyroid status 
assessment at 
diagnosis and at 
follow-up 
evaluation of 
children with CD. 
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Table 2.11   Summary of studies that investigated multiple sclerosis and hypothyroidism 
Author\years  
Place of 
study 
Type of study Sample size Objectives  Main finding Conclusion 
(Munteis et 
al., 2007), 
Spain 
Prospective 
study 
51  untreated MS 
patients and 401 
healthy subjects 
To determine the prevalence of 
thyroid autoimmune disorders 
in a cohort of untreated multiple 
sclerosis (MS) patients and 
compare it with a stratified 
sample of an adult population. 
- The prevalence of subclinical 
hypothyroidism in Multiple sclerosis 
(MS) patient was significantly higher 
than healthy subjects (6.45% vs. 
2.24%, P 0.03). 
 
Subclinical hypothyroidism  
were common in Multiple 
sclerosis (MS) syndrome. 
(Caraccio et 
al., 2005a), 
Italy 
Follow-up 
study  
302  multiple 
sclerosis patients 
To assess the actual occurrence 
of thyroid dysfunction and 
autoimmunity during long-term 
IFN-beta therapy 
-At baseline  the prevalence of 
hypothyroidism was  2.8% in  
 302  multiple sclerosis patients. 
Both incident thyroid 
autoimmunity and 
dysfunction frequently occur 
in multiple sclerosis (MS) 
patients during IFN- therapy. 
(Ross et al., 
2010), South 
Africa   
Cohort study 74 patients with 
Addison's 
disease 
To determine whether 
autoimmunity is the 
predominant cause of Addison's 
disease in South Africa and 
whether human leukocyte 
antigen (HLA) DQ association 
exists. 
-The prevalence rate of primary 
hypothyroidism was 47% among 
patients with Addison's disease. 
Hypothyroidism frequently 
coexists  in Addison's disease    
(Erichsen et 
al., 2009),  
Norway 
Registry-based 
cohort study 
426 patients with 
Addison’s 
disease 
To determine the clinical, 
immunological, and genetic 
features of Primary adrenal 
insufficiency [Addison's 
disease]. 
- The prevalence rate of primary 
hypothyroidism was 41% among 
patients with Addison's disease. 
Hypothyroidism associated 
with Addison's disease    
(Kasperlik-
Zaluska et al., 
2003), Poland 
Reported 111 
cases  
111 patients’ 
with  adrenal 
insufficiency 
To determine on whether  of 
adrenal insufficiency 
-57% of  patients with 
secondary adrenal insufficiency   had 
thyroid diseases , especially primary 
hypothyroidism  
Primary hypothyroidism was 
common on secondary 
adrenal insufficiency  
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Table 2.12:  Summary of studies that investigated pregnancy and hypothyroidism 
 
 
 
 
 
  
Author\years  
Place of 
study 
Type of study Sample size Objectives  Main finding Conclusion 
(Stuckey et 
al., 2010), 
Australia 
A 12-year 
longitudinal 
study 
205  women 
(including 71 
with PPTD) 
To ascertain the long-term risk 
of hypothyroidism in women 
following postpartum 
thyroiditis (PPTD). 
-Hypothyroidism was present in 38% (71 women) 
who had postpartum thyroiditis (PPTD) at baseline 
with a significant adjusted odds ratio 9.7 for 
postpartum hypothyroidism. 
A strong predictor 
of hypothyroidism 
in the long-term. 
women who 
present with 
postpartum 
hypothyroidism  
(Mannisto et 
al., 2010), 
Finland  
A prospective 
population-
based cohort 
5805 Mothers  To evaluate the association 
between maternal thyroid 
dysfunction/antibodies during 
pregnancy and pregnancy 
complications or later 
maternal hypertension, 
diabetes, and thyroid disease. 
-Overt hypothyroidism was associated with 
subsequent maternal thyroid disease [hazard ratio 
(HR) (95% confidence interval), 17.7 (7.8-40.6). 
 
 
Thyroid 
dysfunction and 
antibodies during 
pregnancy seem to 
predict later 
thyroid disease. 
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Table 2.13:  Summary of studies that investigated obesity and hypothyroidism 
Author\years  
Place of study 
Kind of study Sample size Objectives  Main finding Conclusion 
(Marzullo et al., 2010), 
Italy 
A cross-
sectional 
study 
129  obese and 118 
lean subjects 
To clarify whether a leptin 
excess of obesity could increase 
the susceptibility to develop 
autoimmune thyroid disease 
(AITD). 
- Obese had 
greater prevalence 
of hypothyroidism 
compared to 
control (P<0.05). 
 
Obesity increases the risk AITD 
with an emerging role for leptin. 
(Mehran et al., 2012a), Iran Cross-
sectional 
community-
based survey 
3903  randomly 
subjects who had no 
histories of thyroid 
disorders 
To evaluate the association 
between normal levels of serum 
TSH and BMI, taking into 
consideration the effect of 
smoking tobacco. 
-  TSH 
concentrations 
within the 
reference range 
were positively 
associated with 
BMI (P < 0.002.) 
 
Positive association exists 
between TSH and BMI in 
euthyroid nonsmokers. 
(Verma et al., 2008), India Retrospective 
Observational 
study 
(Group I) 269 
consecutive primary 
hypothyroidism 
patients, and (Group 
II) 450 patients 
Obese 
To establish relationship 
between obesity and 
hypothyroidism and to analyze 
the frequency the frequency of 
primary hypothyroidism in obese 
patients and frequency of obesity 
in primary hypothyroidism 
patients. 
- Primary 
hypothyroidism 
was more 
prevalent in 
individuals with 
extreme obesity as 
compared to 
moderate obesity 
patients (56% 
versus 41%). 
 
Thyroid dysfunction was more 
common in obese.  
 
 
Table 2.14:   Summary of studies that investigated goiter and hypothyroidism 
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Author\years  
Place of 
study 
Type of study Sample size Objectives  Main finding Conclusion 
(Das et al., 
2011), India 
Case-control 
study 
353 children with 
goiter and 165 
children without 
goiter 
To examine the prevalence of 
goiter in the post-iodization 
phase and the relationship of 
goiter with micronutrient status 
and thyroid autoimmunity in 
school children. 
- 1.6 per cent children with goiter and 2.4 
per cent without goiter had hypothyroidism 
(subclinical and clinical). 
Goiter associated 
with 
hypothyroidism  
(Aminorroaya 
et al., 2010), 
Iran 
Cross-sectional 
study 
68961  adults 
aged > 20 years 
To investigate the prevalence of 
goiter in Isfahan, 15 years after 
the initiation of universal salt 
iodization. 
- The prevalence of hypothyroidism was 
6.4% and 18.6% in non-goitrous and 
goitrous participants, respectively.  
Goiter associated 
with 
hypothyroidism 
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Chapter 3: Conceptual Frame Work 
3.1 Introduction  
This chapter presents definitions of hypothyroidism, causes, diagnosis, treatment, and 
factors associated with hypothyroidism (i.e. the components of the conceptual framework). 
These factors including: socio-demographic factors (e.g. age and sex), life style factors ( e.g. 
iodine intake in food, selenium,  smoking, alcohol consumption, physical activity and 
weight), genetic factors and family history, medical conditions ( e.g. type 1 diabetes, 
autoimmune thyroid disease, systemic lupus erythematosus, pernicious anemia, rheumatoid 
arthritis, Sjögren's, vitiligo syndrome & autoimmune adrenal insufficiency),  medication ( 
e.g. radioactive iodine or anti-thyroid medication), and history of diagnosis. 
3.2  Hypothyroidism definition and classification 
Hypothyroidism is a condition where the thyroid gland produces too little thyroxine for the 
body’s needs. It is also known as an under-active thyroid (ATA, 2012a). Hypothyroidism is 
classified into two types:  Primary and secondary hypothyroidism. Primary hypothyroidism 
is the most common type and it is caused by disorder of the thyroid gland itself. Central or 
secondary hypothyroidism  results from hypothalamic or pituitary disease (Jayakumar, 
2011). Also, hypothyroidism can be classified on the basis of severity into subclinical 
hypothyroidism and Overt or frank hypothyroidism. Subclinical hypothyroidism is referred 
to mild hypothyroidism as an abnormal serum thyroid-stimulating hormone level, free 
thyroxin and triiodothyronine levels within their reference ranges (Wilson and Curry, Jr., 
2005a). Overt or frank hypothyroidism is defined as an elevated TSH and low serum free T4 
(Aminorroaya et al., 2009). Moreover,  hypothyroidism can  also be classified based on its 
time of onset congenital or acquired hypothyroidism  (Brown et al., 2005). 
3.3   The etiological classification of hypothyroidism 
Hypothyroidism is caused by diverse causes and conditions, in which thyroid fail to secrete 
an adequate amount of thyroid hormone.  The most etiological classification of 
hypothyroidism suggested by Devdhar, M, et, al, is summarized in the table (3.1). 
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Table (3.1):  The etiological classification of hypothyroidism  
Type  Causes 
Primary hypothyroidism 
 
Chronic autoimmune thyroiditis 
Sub-acute, silent, postpartum thyroiditis 
Iodine deficiency, iodine excess 
Thyroid surgery, I-131 treatment, external irradiation 
Infiltrative disorders 
Drugs 
Agencies and diagnosis of the thyroid 
 
Central or secondary  
hypothyroidism 
 
Pituitary tumors, metastasis, hemorrhage, necrosis, 
aneurysms 
Surgery, trauma 
Infiltrative disorders 
Infectious diseases 
Chronic lymphocytic hypophysitis 
Other brain tumors 
Congenital abnormalities, defects in thyrotropin releasing 
hormone, TSH, or both 
 
Source: (Devdhar et al., 2007) 
3.4  Hypothyroidism diagnosis 
American Thyroid Association, British Thyroid Association, and American Association of 
clinical Endocrinologists set criteria for the diagnosis of hypothyroidism include physical 
examination, medical and family history. Diagnosis of hypothyroidism is confirmed by 
laboratory tests to measure the blood levels of thyroid hormones.  Two tests are mainly used:  
TSH (thyroid stimulating hormone) test, and fT4 tests. TSH is a sensitive test for the 
diagnosis of primary hypothyroidism, while not reliable for the diagnosis of secondary 
hypothyroidism. Thus,  FT4 test  plus TSH test should be used for the diagnosis of secondary 
hypothyroidism (AACE, 2006,ATA, 2012a,BTA, 2010,Garber et al., 2012). Other tests may 
also help in the diagnosis of hypothyroidism including:  
1) Thyroid autoantibodies, for example: anti-thyroglobulin antibodies (TgAb), and   
anti-thyroid peroxidase antibodies (TPOAb).  
2) Radioactive iodine uptake (RAIU) and thyroid scanning.   
3) Ultrasonography of the neck and thyroid. 
4) fine-needle aspiration (FNA) biopsy (Philip R Orlander, 2013).  
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3.5  Hypothyroidism treatment 
Conventional treatment of hypothyroidism typically by replacing the missed thyroid 
hormone using prescription thyroid hormone replacement drugs. Levothyroxine (T4) is a 
synthetic thyroid hormone which is the primary drug of choice for treating of 
hypothyroidism (Chakera et al., 2012). The daily dosage of Levothyroxine  depend 
particularly on body weight, moreover on age, sex, and body size (Garber et al., 2012). 
However, a randomized controlled trial has recommended for the starting dose of 
levothyroxine varies considerably: from 50 μg to a full replacement dose of 1.6 or 1.7 μg/kg 
in healthy adult patients younger than 65 years, and from 25 to 50 μg/d in older patients and 
those with known ischemic heart disease (Roos et al., 2005). Treatment of primary 
hypothyroidism with using combinations of T4 and T3 is still needed for more evidence to 
recommend (Gaitonde et al., 2012). 
3.6  Hypothyroidism follow-up 
American Thyroid Association (ATA) recommends that healthy adults can be screened for 
thyroid dysfunction by measuring of serum thyrotropin concentration, beginning at age 35 
years and every 5 years thereafter (Ladenson et al., 2000a). While for patients with 
hypothyroidism, American Thyroid Association (ATA) recommends that they need to check 
TSH levels every 6 to 10 weeks after a thyroxine dose change, but babies with 
hypothyroidism must check TSH levels as they grow. And for pregnancy they need more 
often check for TSH levels (ATA, 2012a). 
3.7  Theoretical and Conceptual framework 
According to a literature review and after reviewing all models suggested for risk factors for 
hypothyroidism, the theoretical models worldwide summary; i.e. American Thyroid 
Association (ATA, 2012a), American Association of Clinical Endocrinologist (Garber et al., 
2012),  British Thyroid Association (BTA, 2010). 
The risk factors are summarized as follows:  
– Socio-demographic factors (e.g. age, sex, and race\ethnicity). 
– Life style factors (e.g. iodine intake in food, smoking and alcohol consumption). 
– Family history (e.g. having a close relative with an autoimmune disease). 
– Genetic factors. 
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– Medical conditions (e.g. diabetes mellitus, vitiligo, pernicious anemia, turner 
syndrome  and down syndrome). 
– Medication (e.g. radioactive iodine or anti-thyroid medication). 
– History of diagnosis. 
 
Conceptual framework for this study including: 
– Socio-demographic factors: ( e.g. age and sex). 
– Life style factors (e.g. iodine intake in food, smoking and alcohol consumption ).  
– Family history ( have a close relative with an autoimmune disease)  
– Medical conditions  (e.g. diabetes mellitus, vitiligo, pernicious anemia, turner 
syndrome and  down syndrome ) 
– Medication (e.g. radioactive iodine or anti-thyroid medication). 
– History of diagnosis 
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Figure 2: The study conceptual framework 
The theoretical and conceptual framework will include all risk factors for hypothyroidism 
except race\ethnicity because hypothyroidism occurs more often in white Asians than in 
African Americans. 
3.8  Hypothyroidism and socio-demographic risk factors 
3.8.1 Age 
Age is considered as a risk factor for developing hypothyroidism. The risk of  
hypothyroidism increasing with advancing age, especially in women older than age 60 
(Mayo Clinic, 2012). Increasing the risk of hypothyroidism in elderly,  principally due to the 
rising incidence and prevalence of autoimmune thyroiditis (Faggiano et al., 2011). As people 
age & aging process leads to impact of the thyroid hormone synthesis. Most studies found a 
Hypothyroidism
family 
history 
life style 
factors 
socio-
demographic 
history of 
diagnosis 
medical 
condition 
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clear age-dependent decline in stimulating hormone (TSH) and (free) T3. While, other 
studies found  in contrast  an increase in TSH levels in elderly (Peeters, 2008). Moreover, 
many studies found increasing antithyroid with aging. This is resulting in an increase 
prevalence of  hypothyroidism in elderly (Surks and Hollowell, 2007). 
3.8.2 Gender 
Gender is the strongest risk factor for hypothyroidism. A bundant epidemiological studies 
found that hypothyroidism  is much  more common  in women  than in men, with reports 10 
times more common in women than  in men (Vanderpump, 2011). The causes of higher risk 
in women are still unclear, but there are etiological factors  that may poses increased risk of  
developing hypothyroidism in women which  include: pregnancy, genetic factors (e.g. 
skewed X chromosome inactivation patterns and defects in the sex chromosomes), medical 
condition, and sex hormones (Jorgensen et al., 2010). Pregnancy is a major factor that 
increases the risk of developing of hypothyroidism in women. It affects the thyroid gland 
through physiological and hormonal changes that alter thyroid function. Two main hormonal 
changes during pregnancy affect thyroid function, which are human chorionic gonadotropin 
(HCG) and Estrogen. In addition, some women develop antibodies to their own thyroid 
during pregnancy, which causes postpartum sub-acute thyroiditis and can increase the risk 
of developing permanent hypothyroidism (ATA, 2012d). Genetic factor contributing to 
develop hypothyroidism only in women through the influence of X –chromosome 
inactivation, that's seen in Hashimoto’s thyroiditis was very prevalent among girls with 
Turner’s syndrome (XO karyotype) (Prummel et al., 2004). Towards that, a possible role of 
influence of X –chromosome inactivation may in part explain the female preponderance of  
Hashimoto’s thyroiditis (Brix et al., 2009). Some medical conditions affect only women 
could be increase the risk for developing hypothyroidism such as polycystic ovary syndrome 
(PCOS). In Germany a prospective study demonstrated that women with polycystic ovary 
syndrome (PCOS) had a threefold  prevalence of autoimmune thyroiditis (AIT) (Janssen et 
al., 2004). 
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3.9   Hypothyroidism and lifestyle factors: 
3.9.1 Iodine intake  
Iodine deficiency is the most common cause of   hypothyroidism worldwide. Although  it’s 
an essential element  for enables the thyroid gland to produce triiodothyronine (T3) and 
thyroxine (T4) hormones (ATA, 2012b). Moreover, excessive iodine intake can  also cause 
hypothyroidism due to a failure to escape from the Wolff–Chaikoff effect, by a mechanism 
of inhibiting the thyroid from synthesizing large quantities of thyroid hormones (Lee et al., 
2010). 
3.9.2 Selenium 
Several studies suggest that selenium plays an essential role in prevent the development of 
hypothyroidism. The role of selenium on thyroid gland incorporated as selenoproteins, 
which participate in the protection of thyrocytes from damage by H2O2 produced for thyroid 
hormone biosynthesis. In addition, selenium constitutes an essential part of iodothyronine 
deiodinase enzymes which catalyze thyroid hormone by activation and inactivation convert 
of thyroxine (T4) to triiodothyronine (T3) (Rasmussen et al., 2011). Furthermore, selenium 
has also an important impact on immune function which impact on inflammatory activity in 
thyroid-specific autoimmune disease (Gartner and Gasnier, 2003). 
3.9.3 Smoking 
Epidemiological studies found that smoking has either no associated or an increased risk of 
hypothyroidism. The mechanism by which smoking effect on thyroid gland  include 
interfering with thyroid gland hormonogenesis and with peripheral thyroid hormone 
action (Belin et al., 2004).  
3.9.4 Alcohol consumption 
Recent studies found that moderate alcohol consumption is associated with a decreased 
development of overt autoimmune hypothyroidism. The mechanism that alcohol  effect  on 
thyroid autoimmunity remains unclear (Laurberg et al., 2006). While other studies in the past 
have shown that alcohol dependence cause  reduction in peripheral thyroid hormones and/or 
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blunted thyroid stimulating hormone (TSH) response to deregulation in the central 
hypothalamic–pituitary–thyroid (HPT) axis (Ozsoy et al., 2006). The reduction in serum 
thyroid hormones was explained due to direct and irreversible toxic effect of alcohol on the 
thyroid gland (Valeix et al., 2008). 
3.9.5 Physical activity 
Studies suggest that moderate exercise is an important factor in treatment of hypothyroidism. 
Exercise has a greater  effect on the thyroid gland and its level of circulating thyroid 
hormones (Ciloglu et al., 2005b),  moreover it can also help in combat with the major 
symptoms of hypothyroidism such as weight gain, fatigue and depression (Thyroid Guide, 
2011). 
3.9.6 Weight  
Obesity is associated with an increased risk of hypothyroidism and vice versa.  Both types 
of hypothyroidism (subclinical and overt hypothyroidism) are frequently associated with 
weight gain, due to the increased TSH level which decreased thermo genesis and metabolic 
rate (Biondi, 2010). While obesity increases the susceptibility to harbor autoimmune 
hypothyroidism due to the effects of adipocytokine leptin on the pituitary gland (Marzullo 
et al., 2010). 
3.10 Genetic factors and family history 
 A genetic factor is known to be an important risk factor of hypothyroidism.  Genetic factors 
play a role in developing hypothyroidism through effects on the causes of hypothyroidism 
which include autoimmune thyroid disease AITD (Hashimoto’s thyroiditis), congenital 
hypothyroidism, and chromosomal disorders (e.g. Down syndrome & Turner syndrome). 
Hashimoto’s thyroiditis is one of the most prevalent causes of hypothyroidism, its  
influenced by both genetic and environmental factors (Erkan Sar et al., 2011). Several genes 
are susceptible to Hashimoto's thyroiditis such as human leukocyte antigen (HLA), cytotoxic 
T lymphocyte antigen-4 (CTLA-4), protein tyrosine phosphatase nonreceptor-type 22, 
thyroglobulin, vitamin D receptor, and cytokines gene (Zaletel and Gaberscek, 2011).  
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Congenital hypothyroidism is defined as thyroid hormone deficiency present at birth. It may 
causes by mutations in PAX, TSHR, DUOX2, SLC5A5, TG, TPO, and TSHB gene. These 
mutations can cause loss of thyroid function in one of two ways: disrupt the normal 
development of the thyroid gland (dysgenesis) before birth, or a disorder of thyroid hormone 
biosynthesis (dyshormonogenesis)  (Rastogi and LaFranchi, 2010). 
3.10.1 Family history of autoimmune diseases (AITD):  
Family history of autoimmune thyroid disease AITD (Hashimoto’s thyroiditis) is associated 
with increased risk of hypothyroidism. The risk increased if you have a close relative such 
as a parent or grandparent with an autoimmune disease (MC, 2012). Family history of 
autoimmune thyroid disease may occur in one member or multi member of the same family 
as a result of random chance, extrinsic (environmental) factors, intrinsic (genetic) factors, or 
a combination of these factors. (Tomer and Davies, 2003). 
3.11 Hypothyroidism and medical conditions 
Abundant studies documented that certain medical conditions are risk for developing 
hypothyroidism. These conditions include: 
3.11.1 Autoimmune diseases 
Multiple autoimmune diseases including: diabetes type 1, autoimmune thyroid disease, 
systemic lupus erythematosus, pernicious anemia, rheumatoid arthritis, Sjögren's, vitiligo & 
autoimmune adrenal insufficiency (Addison’s disease). These autoimmune diseases have a 
tendency to coexistence within individuals, which lead to developing hypothyroidism. 
Explanations for the coexistence of autoimmune disorders involve immunological 
disturbances (in B and T lymphocytes), a trend to react abnormally in the presence of an 
antigen and a genetic susceptibility (Raterman and Nurmohamed, 2012a). 
3.11.2 Down syndrome 
Down syndrome is associated  with primary  hypothyroidism with  a prevalence rate ranging 
from 3% and 54% (Shaw et al., 2006). Down’s syndrome may associated with high levels 
of thyroid antibodies (Karlsson et al., 1998). There are several hypotheses that described an 
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association between down syndrome and  primary  hypothyroidism, one of these hypotheses 
suggested that over expression of the gene DYRK1A in those with trisomy 21 chromosome 
may have an effect on development hypothyroidism (Thiel and Fowkes, 2007). 
3.11.3 Turner syndrome 
Turner syndrome especially in females  is associated  with  a higher prevalence rate of 
hypothyroidism with  ranges from 0 - 40% (Jorgensen et al., 2010) . The higher risk of 
hypothyroidism in females with Turner syndrome has been addressed by several studies, one 
of these studies thought that  a gene on the long arm of X chromosome (Xq) may play an 
important pathogenic role in the development of autoimmune hypothyroidism (Elsheikh et 
al., 2001). 
3.9.7 Goiter 
Goiter is associated with increased risk of hypothyroidism, which known to be associated 
with disturbance of thyroid iodine metabolism (Aminorroaya et al., 2009). 
3.12 Hypothyroidism and medications 
Several studies demonstrated that medications such as: interferon, amiodarone, lithium, 
radioactive iodine, thyroid surgery and Thionamides (e.g. methimazole, propylthiouracil & 
carbimazole) were associated with increased risk of developing hypothyroidism. 
3.12.1 Interferon-α 
Interferon-α is a standard  therapy for hepatitis C virus infection and the most frequent side 
effect is  hypothyroidism (Pavan et al., 2011). The mechanisms of Interferon-α on thyroid 
gland include activated immune system through induced cytotoxicity, direct inhibitory 
effects on thyroid hormone synthesis, release and metabolism (Carella et al., 2004). 
3.12.2 Amiodarone 
Amiodarone is an effective anti-arrhythmic drug, iodine-rich structure, and may 
either induce thyrotoxicosis or induced hypothyroidism (Piga et al., 2008). The mechanism 
 
 
45 
of amiodarone-induced hypothyroidism through  inhibits the thyroid gland  to escape from 
the Wolff–Chaikoff effect (Lee et al., 2010). 
3.12.3 Lithium 
Lithium is widely used in the treatment of mood disorders and it has been associated with 
increased risk of hypothyroidism (Kibirige et al., 2013). The mechanism by which lithium 
induces hypothyroidism include inhibition synthesis and release of thyroid hormone, and   
promotes thyroid autoimmunity (Johnston and Eagles, 1999). 
3.12.4 Radioactive iodine (131I) 
Radioactive iodine (131I) is mostly used in the treatment of Graves’s hyperthyroidism, toxic 
multi-nodular goiter and thyroid cancer. The most common side effect of radioactive iodine 
is hypothyroidism (Ahmad et al., 2002). The mechanism of radioactive iodine involves 
destroying all or part of the thyroid gland (ATA, 2012c). 
3.12.5 Thyroid surgery 
Thyroid surgery is used to treat a variety thyroid conditions including both cancerous, and 
benign thyroid nodules, goiter, thyroid cancer and Graves hyperthyroidism. Thyroid surgery 
mainly follows with hypothyroidism with  rates between 6.5 and 45% (Cho et al., 2011c). 
The most common cause of hypothyroidism after surgery is subtotal resection of Graves 
disease or multi-nodular goiter, and autoimmune destruction of the thyroid tissue (Lankarani 
et al., 2008). 
3.12.6 Thionamides 
Thionamides (e.g. Methimazole, Propylthiouracil & Carbimazole) are a major antithyroid 
drugs used for treatment of Graves hyperthyroidism, or as preparation therapy before 
radiotherapy or surgery. The primary mechanism of these drugs is inhibiting thyroid 
hormone synthesis by inhibiting  thyroid peroxidase (Cooper, 2005). Antithyroid drug is 
associated with  hypothyroidism in which a study thought that association result from overly 
aggressive dosing in mild hyperthyroidism or failure to adjust the ATD dosage (Choo et al., 
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2010), while another study suggested that the association may due to concomitant 
autoimmune thyroiditis (Wood and Ingbar, 1979). 
3.13 History of diagnosis  
The diagnosis of hypothyroidism is based on physical examination, medical & family 
history, and laboratory investigation (Garber et al., 2012)  . Previous studies revealed that a 
delayed in the diagnosis of hypothyroidism can lead to retardation of physical and mental 
growth (Malik and Butt, 2008a).  
3.14 Summary  
In summary, the literature showed that several risk factors associated with hypothyroidism, 
which are divided into: socio-demographic factors (age and sex), environmental factors 
(iodine intake in food and smoking), family history (have a close relative with an 
autoimmune disease), medical conditions (e.g. diabetes mellitus, vitiligo, pernicious anemia 
and down syndrome), medication (e.g. radioactive iodine or anti-thyroid medication) and 
history of diagnosis. These factors were used to build this study conceptual framework. This 
chapter is the base for analysis in the coming results chapter and the study results discussion 
and conclusion.  
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Chapter Four: Study Methodology 
4.1 Introduction 
In this chapter, the research methodology is presented.  The study area, study population, 
study type, design, tools, the sampling method, statistical analysis, ethical consideration, and 
variables operational definitions are presented. 
4.2  Study area geographic and population characteristics 
The study was carried out in the  Hebron governorate. Hebron area covers northern part of 
Hebron governate and Dura covers the southern part of Hebron governate.  
Hebron governorate is the largest governorate in Palestine  located in the southern part of 
the West Bank, 30 kms south of Jerusalem and lies 930 meters above sea level (Wikipedia, 
2013). It contains in addition to the city of Hebron 28 villages and 2 refugee camps.  
Demographic trends in Hebron governorate is almost like the other governorates in the West 
Bank. According to the population statistics estimated by the Palestinian Central Bureau 
Statistics (PCBS) the total population was estimated 641,170 thousand citizens,  of which  
314,174 are females and 326,996 are males (PCBS, 2011). 
Dura area is located in the south-west of  Hebron Governorate  (Wikipedia, 2012).  The total 
area of  Dura is estimated to be 17,600 dunums, of which 7,100 dunums are built-up areas, 
8,220 dunums are agricultural lands, and 1,270 dunums are forests, uncultivated areas, or 
public lands (ARIJ, 2009).   
The demographic trends in Dura is closely related to the economic and political situation like 
the other governorates in the West Bank. According to the population statistics estimated by 
the Palestinian Central Bureau Statistics (PCBS),  the total population of  Dura in 2013 is 
estimated to be 33,914 citizens  (PCBS, 2013).    
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4.3 Primary health services in the North and South of Hebron governorate  
The main health care providers for patient in the Hebron governorate are the Ministry of 
Health, UNRWA, NGOs, Palestinian Military Medical Services (PMMS) and the private 
sector.  
The  MOH is considered the major provider of primary health care services as it operates 
126 PHC out of 146 PHC facilities, NGO’s operates 16 PHC, UNRWA operates three PHC, 
and PMMS operates  one PHC (MOH, 2011b). 
Karantina, the main primary health care clinic in Hebron, has six specialist sub-clinics,  
including an endocrinology clinic that started recently to operate by providing several 
services for inhabitants in the northern part of Hebron, including diagnosis, treatment and 
follow up of  referred patients (Abu Rmeileh, 2013). 
In the southern part of Hebron there are 94 primary health care clinics (PHC), of which 84 
are sponsored by the MOH, six by NGOs , four by UNRWA , and one by PMRS (MOH, 
2011b). 
The main health bodies in Dura town are: the Dura clinic, the UNRWA clinic, the Maternity 
& Pediatric Centre, and the Emergency Centre for Military Medical Services (ARIJ, 2009). 
Dura clinic, the main MOH clinic in the Southern part of Hebron,  has six specialist sub-
clinics and including an endocrinology clinic that provides diagnosis, treatment and follow 
up of the referred patients (MOH, 2011a). 
4.4 Health services for hypothyroidism  
Karantina and Dura clinics are the only MOH centers that provide endocrinology care 
services in Hebron governorate. These services include the diagnosis, treatment and follow 
up of endocrine referred patients (Abu Rmeileh, 2013). 
 
 
4.5 Study settings 
The study was conducted at Karantina and Dura endocrinology clinics: 
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Karantina clinic provides service for the central and the northern areas of Hebron area  
Dura clinic provides services for the central and the southern areas of Dura areas.  
4.6 Study design 
The study design was a case- control study.  
4.7 Study stages: 
The study was done in two stages:  
4.7.1  Stage 1: Descriptive analysis 
4.7.1.1 Source of data:  
The data was collected from patients' files  
4.7.1.2 Data collection from patients' files 
All files presented in the two selected clinics were included in the study.  Patients' files were 
read by the study researcher at the endocrinologist clinic to be sure of what is written in these 
files. Medical information was clarified for the researcher, so he can coded in the sheet of 
data collection.   
The collected data from these files were:  patients' file numbers, gender, place of residence, 
hypothyroidism diagnosis date and type of diagnosis. For patients diagnosed with 
hypothyroidism, the researcher extracted as well: the cause, type of hypothyroidism, 
diagnosis history, TSH level, and treatment & its dosage. 
4.7.2 Stage 2: a case-control study 
4.7.2.1 Study population:  
All patients visiting the two targeted clinics for thyroid problems between June 2012 and 
June 2013 were targeted and asked to participate in the study.  During this period 103 patients 
who met the study inclusion criteria were approached and invited to participate. Also an 
equal number of patients attending the other primary care clinics, for reasons other than 
endocrine problem were invited to participate. The study sample included 206 participants 
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(i.e. 103 study cases and 103 controls, 1:1). These characteristic were used for inclusion and 
exclusion for both cases and controls.  
4.7.2.2 Selection criteria 
1- Selection of study cases 
The study cases from Karantina and Dura endocrinology clinics were distributed as follows:  
- 42 patients with hypothyroidism were registered at the Karantina endocrinology clinic.  
- 61 patients with hypothyroidism were registered at Dura endocrinology clinic.  
2-Selection of controls: 
The controls were patients attending other specialized clinics in Karantina and Dura clinics 
e.g. gynecology clinic and internal medicine clinic.  Those controls were invited to 
participate in the study.  The control group were : 
- 37  participants from Karantina clinic. 
- 66 participants from Dura clinic.  
3-Exclusion criteria for controls:  
1- Any patient who refused to do blood drawing for TSH level measurement. 
2- Any patients who has a TSH level above 3 at the time of survey.  
3- Patients previously diagnosed with autoimmune diseases: Thyroid dysfunction, 
goiter, diabetes mellitus, vitiligo, pernicious anemia. 
4- Patients using medications:  Surgery or radiotherapy, lithium carbonate and 
iodine-containing compounds. 
5- Pregnant women. 
4.7.2.3 Case-control study tools: 
In stage two, a study questionnaire and TSH measurement were done.  
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1- Structured Questionnaire 
 
The structured questionnaire was based on previous studies questionnaire, American 
Thyroid Association guidelines for detection of thyroid dysfunction (Ladenson et al., 2000c),  
Thyroid Foundation of Canada (TFOF, 2013), University of  Wisconsin Integrative 
Medicine(WISC, 2011) and WHO (WHO, 2006). 
For lifestyle category, we used Steps Arabic questionnaire of  WHO  for  smoking and 
physical activity (WHO, 2006). Also, we used integrative treatment of  hypothyroidism of 
University of Wisconsin Integrative Medicine (WISC, 2011) and common source of dietary 
iodine of American Thyroid Association (ATA, 2012b). 
For medical conditions and medications , we used the questionnaire of the health study of 
Nord –Trondelage (HUNT) in Norway (Bjoro et al., 2000) and the American Thyroid 
Association guidelines for detection of thyroid dysfunction (Ladenson et al., 2000c). 
 
For family history of  thyroid diseases and autoimmune diseases, we used the  questionnaire 
of a study in UK (Parle et al., 1991b) and the American Thyroid Association guidelines for 
detection of thyroid dysfunction (Ladenson et al., 2000c). 
 
For women’s health, we used the thyroid assessment questionnaire of the Thyroid 
Foundation of Canada (TFOF, 2013). 
Data were collected from subjects through personal face-to-face interview. Each interview 
took about 45 minutes.  The questionnaire contained a set of questions relevant to each risk 
factor of the conceptual framework including:  (See Annex 2 for the questionnaire copy). 
1. Personal socio-demographic data such as age, gender, marital status, family size, 
living area, educational years, work and household average monthly income. 
Questions (1-23)  
2. Lifestyle, which included questions about smoking habit, alcohol drinking, weight, 
physical activity, food intake and supplements intake. Questions (24-106)  
3. Medical conditions, which included questions about chronic diseases and 
autoimmune diseases. Questions (39-89)  
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4. Medications, which included questions about the usage of medication such as 
propylthiouracil, thyroidectomy, radioactive iodine, lithium, amiodarone, interferon, 
carbimazole and methimazole.  Questions (131-136)  
5. Women’s health, which included question about menstrual cycle and pregnancy. 
Questions (138-142). 
6. Family history, which included questions about family history of autoimmune 
diseases.  Questions (150-160)  
7.  Diagnose history for cases, which included questions (only for case) about the date 
of diagnosis, age, weight, diagnosed hypothyroidism, person who did the diagnoses, 
treatment and dosage. Questions (143-149).  
Questionnaire validation and piloting  
 
The questionnaire was sent  to three  specialist endocrinologists, Dr. Aref Abu Remileh,  Dr. 
Abdel Latif Shawar and Dr. Raed AL Alami. Two of them answered and suggested to add 
one question to the medical condition. After that, pilot study was done on 10 patients with 
hypothyroidism attending  private endocrinology clinic. The interview was held with 
patients after explaining to them about of the study aim. Refining of the questionnaire was 
done according to the results of the pilot study, and the results were excluded from the whole 
study. At the end, we did Cronbach's Alpha coefficient to check the reliability of 
questionnaire. The result of Cronbach’s Alpha coefficient was as follows: 67% for food & 
supplements, 65% for medical conditions, 27% for medication, 43% for women health and 
46% for family history of autoimmune diseases.  
 
2- TSH test 
 
TSH tests were done to all control participants in order to exclude the probability of having 
undiagnosed hypothyroidism and included only participants with TSH between 0.4- 4.0 
µIU/ml. 
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Samples collection and handling: 
1. A laboratory technician collected 2.0 ml of venous blood samples obtained from the 
control participants who agreed to participate in the study by signing a consent form 
specially designed for this study.  
2. Blood was collected in plain vial tube and allowed to clot and centrifuged at 5000 
RPM for 10 minutes.  
3.  Separated serum was stored in appropriate conditions, avoiding exposure to high or 
low temperature. After that, serum was transferred using appropriate condition (ice 
box) to “Horus” specialized medical laboratories in Hebron where TSH tests were 
performed. 
4. TSH tests were assayed by IMMULITE / IMMULITE 1000 rapid TSH 
immunometric assay method.  
After patients verbal consent form (Annex 1) to participate in the study, each patient had to 
sign a special consent form. In addition, a laboratory  technicians  collected blood samples 
which was transferred in  ice box to  specialized medical laboratory in Hebron.  
4.8   Data analysis 
The collected data was coded manually then entered, cleaned and analyzed by using the 
Statistical Package for Social Sciences (SPSS version 17.0). 
Data analysis included: 
 Descriptive analysis for patients' files data, and study subjects. Frequencies were 
calculated for all variables and presented as percentages. 
 Univariate analysis was presented showing the association between hypothyroidism 
and the studied determinants with the  socio-demographic factors, lifestyle factors, 
medical conditions, medications, women health, and family history of autoimmune 
diseases.  Frequencies and Chi-squared test were calculated, and p-values were 
calculated for ordinal level measures (P<0.05)  
 T-test was done to examine the difference of TSH levels between the study cases and 
control groups.  
 Multiple logistic regressions was done to all statistically significant variables in the 
univariate analysis to obtain the odds ratio (OR) and 95% confidence interval. The 
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model includes: participants BMI; household monthly income; education level; age; 
gender; living area; working status; rate of daily physical activity; smoking by other 
in closed places; smoking by other at home; consumption of fruits; consumption of 
vegetables; consumption of carrots; consumption of canned tuna; consumption of 
canned sardines; consumption of coffee; consumption of red meat; consumption of 
yogurt; taking iron supplement; taking vitamin B12 supplement; taking calcium 
supplement; and frequency of eating banana and strawberry. 
4.9 Ethical consideration 
The Faculty of Public Health committee accepted to do the research; and the approval to 
carry out the study was obtained from the Graduate Studies Committee at Al-Quds 
University. Moreover, we obtained permission to conduct this study from the Ministry of 
health. 
All study cases and control group received a full explanation about the details of the study, 
its aim, objective and benefit. The researcher asked them to sign a consent form to show 
their approval (See Annex 1). The written consent form was attached to each questionnaire 
explaining the aim and objectives of the study and confidentiality controls had to sign their 
agreement to have a blood test for TSH level. We found that 4 of participants in the study 
have high TSH level and they were referred to an endocrinologist. In addition, we considered 
them as cases. 
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4.10 Operational definition of variables 
Clinics: (Karantina or Dura ). 
Gender: (male or female). 
Age category: composed of three categories (≤18 years, 19-40 years, >40 years). 
Marital status: composed of two categories (single or married). 
Family size: composed of two categories (≤ 5 persons, >5 persons). 
Place of residence: Place in which participant live (urban, or rural) 
Educational level: composed of four categories (≤ 6 years, 7-9 years, 10-12 years, >12 
years). 
Occupation: composed of two categories (working, not working). 
Household average monthly income: composed of four categories ( < 1000 NIS, 1000-
2000 NIS, 2001-3000 NIS, 3001-5000 NIS). 
Smoking: composed of two categories ( smoking , not smoking). 
BMI: weight in kilogram divided by the height in meter square, and composed of four 
categories ( underweight < 18.5, normal  18.5-24.99, overweight  ≥ 25-29.99, Obese  ≥ 30). 
Rate of daily activity: composed of three categories ( high, medium, low) 
Physical activity : composed of four types of exercise ( walking, running, exercises with 
equipment and exercises without equipment). 
Frequency of exercise per hour: composed of four categories (< half an hour, half an hour, 
1-2 hours, > 2 hours).  
Frequency of exercise per week: composed of four categories ( less <1, 3-2, 4-5, >6) 
Food groups: composed ( fruits, vegetables,  milk and milk products, animal products, 
beverages, water, bread, nuts and salty snacks) 
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Frequency of food intake: composed of four categories ( <1 per week, 1-4 per week, 5-7 
per week, 2-3 times daily). 
Supplements: composed (multivitamins with iodine, multivitamins without iodine, vitamin 
B complex,  vitamin B12, vitamin B6, calcium,  calcium + vitamin D, iron supplements and 
folic acid ). 
Chronic diseases: composed ( diabetes , pituitary disease, thyroid disease heart disease, 
liver disease, kidney disease, mental illness, diabetes type 1, Down syndrome, anemia, 
Sjögren's, Addison’s disease and celiac disease) 
Medication: composed (thyroidectomy, propylthiouracil lithium, amiodarone, interferon, 
carbimazole and methimazole) 
Euthyroid:  (TSH level within the normal range, 0.4 – 4 mIU/L). 
Overt hypothyroidism: (TSH>4 mIU/L and low FT4I). 
Subclinical hypothyroidism: (TSH level>4 mIU/L and normal serum FT4I). 
4.11 Summary  
This chapter presents an overview of the methodology that was used in this research.  It 
provides study justification, design. Moreover, it provides description of the study setting 
and sample, and the pilot testing of the data. The study tool and instruments that were used 
in the data collection were explained. Descriptive statistics was used in data analysis and 
univariate analysis & multivariate analysis was done to compare the relationship between 
the dependant and independent variables.  
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Chapter 5: Results 
 
5.1 Introduction  
 
In this chapter, results are presented in 3 parts. The first part presents a descriptive analysis 
of patients’ files and study cases. The second part presents a descriptive analysis of the study 
subjects. And in the third part the univariate and multivariate analysis model are shown. 
5.2  Part one:  Descriptive analysis 
 
5.2.1 Descriptive analysis of the patients' files 
 
In this study, the researcher investigated all patients' files registered at the two main 
governmental clinics (Karantina and Dura clinic) between years 2008 and April 2012 in 
Hebron governorate. Figure 5.1 reveals that hypothyroidism was the most diagnosed 
endocrine disorder with the prevalence of 17.1% among patients attending the clinics (16.9%  
Karantina and 17.5% in Dura). 
As shown in figure 5.2, the types of hypothyroidism were: 87.0% primary hypothyroidism, 
5.2% secondary hypothyroidism and 7.8% congenital hypothyroidism. 
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Figure 5.2: Distribution of endocrine disorders in the clinics 
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Figure 5.2 : Distribution of type of hypothyroidism in the clinics 
Figure 5.3 shows the first diagnosis of endocrine disorder at the registration of the patient 
before having primary hypothyroidism. Primary  hypothyroidism and medical conditions 
were 0.5% hyperthyroidism associated, 0.5% turner syndrome associated,  2.2% thyroid 
cancer associated, 1.6% goiter associated, 0.5% thyroids associated,  1.1% thyroidectomy 
associated, 0.5% postpartum thyroiditis associated and 1.1% diabetes type 1 associated. 
While between secondary hypothyroidism and medical conditions were 54.2% 
hypopituitarism associated and 4.2% thalassemia associated.  
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Figure 3.3: Association between types of hypothyroidism and endocrine disorders in 
the clinics 
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5.3 Study cases description 
 
5.3.1 History of diagnosis 
Table 5.1 shows that the mean age at the time of diagnosis of the study cases was 33.3 ± 
14.5 years (mean ± S.D). Of them, 68.9% were diagnosed with hypothyroidism. The 
diagnosis was based on the presence of hypothyroidism symptoms and blood TSH, T3 and 
T4 levels and 50% were diagnosed done by an endocrinologist. All study cases uses 
thyroxine with a maximum dose of 250 μg and a minimum dose of 25 μg to treat and control 
their thyroid gland activity.   
Table 5.1: Characteristic of the study cases  
 N (%) Mean ±SD  Minimum Maximum  
Years of diagnosis    4.58 ±  4.87 years 0.49 23.76 
Age    33.3 ± 14.5 years 0.15 64.00 
 Diagnosed 
hypothyroidism 
By chance 22 (21.4%)    
Periodic inspection 10 (9.7%    
The presence of symptoms 71 (68.9%)    
 Who diagnosed? 
General practitioner 31 (30.1%)    
Endocrinologist 51 (49.5%)    
 Internists 11 (10.7%)    
 Gynecologist 9 (8.7%)    
Nephrologist 1 (1.0%)    
 Thyroxine dose First treatment   103 (100%) 63.65 ± 38.86 25.00 200.00 
 Current treatment 103 (100%) 86.94 ± 48.25 25.00 250.00 
 
5.3.2 BMI for study cases 
Table 5.2 shows that the mean BMI of the study cases ≥18 years at study time was 29.67 ± 
5.73 and 28.54 ± 6.59 at diagnosis, indicating that the BMI of study cases decreased after 
diagnosis. Height at time of diagnosis is not present in all patients’ files. While the mean 
BMI of the study cases aged less than 18 years at study time was 19.07± 6.24.   
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Table 5.2: BMI of the study cases at study time and diagnosis 
 N Mean ±SD Minimum Maximum 
BMI (≥18 years) at study time 92 29.67±5.73 14.79 43.70 
BMI (≥18 years) at diagnosis 92 28.54±6.59 1.32 43.96 
BMI (<18 years) *at study time 11 19.07±6.24 13.33 33.53 
 
5.3.3 Family history of autoimmune diseases 
 
Table 5.3 shows that study cases had significantly  more family history of autoimmune 
diseases including vitiligo, thyroid diseases (hypothyroidism and hyperthyroidism) 
compared to the control group (P <0.05). Other variables such as diabetes type 1, down 
syndrome, pernicious anemia, sjögren's, addison’s disease and celiac disease  did not show 
any significant differences between the two groups (P > 0.05 see annex 3 ).  
Having a family history of vitiligo, thyroid diseases, hyperthyroidism were significantly 
different among study cases and control group (p<0.05).  However, having a family history 
of hypothyroidism did not show such significant difference between the two groups (table 
5.3.3). 
Table 5.3: Associations between study cases and control groups by family history of 
autoimmune diseases 
*NA: not available  
  Study cases 
N=103 
Control group 
N= 103 
Total (%) 
N=206 
Chi Square 
N (%) N (%) N (%) P value 
 Vitiligo 
Yes   5 (4.9%) 0 (0.0%) 5 (2.4%) 0.024 
No 98 (95.1%) 103 (100.0%) 201 (97.6%) 
Family history 
First degree relative 4 (80.0%) 0 (0.0%) 4 (1.9%) NA 
Second degree relative 1(20.0%) 0 (0.0%) 1 (0.5%) 
Thyroid diseases 
Yes   45 (43.7%) 26 (25.2%) 71 (34.5%) 0.005 
No 58 (56.3%) 77 (74.8%) 135 (65.5%) 
Family history 
First degree relative 31 (68.9%) 10 (43.5%) 41 (19.9%) 0.043 
Second degree relative 14 (31.1%) 13 (56.5%) 27 (13.1%) 
Hypothyroidism 
Yes   45 (43.7%) 23 (22.3%) 68 (33.0%) 0.001 
No 58 (56.3%) 80 (77.7%) 138 (67.0%) 
Family history 
First degree relative 31 (70.5%) 10 (47.6%) 41 (19.9%) 0.074 
Second degree relative 13 (29.5%) 11 (52.4%) 24 (11.7%) 
Hyperthyroidism 
Yes   4 (3.9%) 0 (0.0%) 4 (1.9%) 0.043 
No 99 (96.1%) 103 (100.0%) 202 (98.1%) 
Family history 
First degree relative 2 (50.0%) 0 (0.0%) 2 (1.0%) NA 
Second degree relative 2 (50.0%) 0 (0.0%) 2 (1.0%) 
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5.4  Part 2: Univariate analysis 
 
5.4.1 Socio-demographic factors difference between study cases and control group 
 
Table 5.4 shows that the majority of the study population were females and in the age group 
19-40 years, and 79.6% were married. Also, 65.5% had a family size of more than 5 
members, and about half were living in urban areas.  Of the study population, 35.0% 
completed 10-12 years of education and 78.6% were not working.  More than a third of the 
study population had a monthly income "between" 1000-2000 NIS.   
When comparing study cases and control group, study cases were significantly living in 
urban areas, less educated, not working and their family income was lower compared to 
control group (P<0.05).  Other variables in the table did not show significant differences 
between the two groups (P >0.05) (see table 5.2). 
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 Table 5.4: Associations between study cases and control groups by socio-demographic 
factors 
 Study cases 
N=103 
Control group 
N=103 
Total (%) 
N=206 
Chi Square 
N (%) N (%) N (%) P value 
Clinic karantena 42 (40.8%) 37 (35.9%) 79 (38.3%) 0.474 
Dura 61 (59.2%) 66 (64.1%) 127 (61.7%)  
Gender Male 8 (7.8%) 3 (2.9%) 11 (5.3%) 0.121 
Female 95 (92.2%) 100 (97.1%) 195 (94.7%)  
Age ≤18 years 11 (10.7%) 6 (5.8%) 17 (8.3%)  
19-40 years 52 (50.5%) 69 (67.0%) 121 (58.7%) 0.050 
>40 years 40 (38.8%) 28 (27.2%) 68 (33.0%)  
Marital 
status 
Married 85 (82.5%) 79 (76.7%) 164 (79.6%) 0.299 
Single 18 (17.5%) 24 (23.3%) 42 (20.4%)  
Family size ≤ 5 persons 41 (39.8%) 30 (29.1%) 71 (34.5%) 0.107 
>5 persons 62 (60.2%) 73 (70.9%) 135 (65.5%)  
Living area Urban 44 (42.7%) 76 (73.8%) 120 (58.3%) 0.000* 
Rural 59 (57.3%) 27 (26.2%) 86 (41.7%)  
Educational ≤ 6 years 25 (24.3%) 9 (8.7%) 34 (16.5%)  
7-9 years 27 (26.2%) 16 (15.5%) 43 (20.9%) 0.000* 
10-12 years 34 (33.0%) 38 (36.9%) 72 (35.0%)  
>12 years 17 (16.5%) 40 (38.8%) 57 (27.7%)  
Working 
status 
Yes 7 (6.8%) 37 (35.9%) 44 (21.4%) 0.000* 
No 96 (93.2%) 66 (64.1%) 162 (78.6%)  
Household 
average 
monthly 
income 
< 1000 NIS 34 (33.0%) 15 (14.6%) 49(23.8%)  
1000-2000 NIS 46 (44.7%) 33 (32.0%) 79 (38.3%) 0.000* 
2001-3000 NIS 18 (17.5%) 36 (35.0%) 54 (26.2%)  
3001-5000 NIS 5 (4.9%) 19 (18.4%) 24 (11.7%)  
 
 
5.4.2 Lifestyle factors 
 
5.4.2.1 Weight, physical activity and smoking 
 
Table 5.5 shows that 34 % of the study subjects were overweight and obese.  Study cases 
were significantly more obese than control group, but control group was more overweight 
(p<0.05).   
Although 70% of the study subjects believed they are physically active, but they mainly 
considered walking as being their main daily physical activity.  About 27% reported 
walking almost daily.  However, no significant difference in physical activity were found 
between study cases and control group (p>0.05). Other reported physical activity methods 
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such as running and physical training with or without using machines did not show any 
significant differences (see annex, table 4 ).  
Most of the study sample were not smokers, but, study cases reported that they are more 
affected by passive smoking (p<0.05).  
Table 5.5: Association between study cases and control groups’ BMI, physical activity 
and smoking status. 
 
 Case 
N=103 
Control 
group 
N=103 
Total (%) 
N=206 
Chi Square 
N (%) N (%) N (%) P value 
BMI 
Underweight < 18.5 8 (7.8%) 3 (2.9%) 11 (5.3%) 
0.001 
Normal  18.5-24.99 21 (20.4%) 34 (33.3%) 55 (26.7%) 
Overweight   ≥25-29.99 26 (25.2%) 44 (43.1%) 70 (34.0%) 
Obese   ≥30 48 (46.6%) 22 (21.4%) 70(34.0%) 
Rate of  daily 
activity 
High 20 (19.4%) 41 (39.8%) 61 (29.6%)  
0.001 Medium 64 (62.1%) 59 (57.3%) 123 (59.7%) 
Low 19 (18.4%) 3 (2.9%) 22 (10.7%) 
Physical 
activity 
Yes 68 (66.0%) 76 (73.8%) 144 (69.9%) 0.224 
No 35 (34.0%) 27 (26.2%) 62 (30.1%) 
Walking per 
week 
Less <1 8 (11.8%) 3 (3.9%) 11 (5.3%)  
0.004 3-2 35 (51.5%) 24 (31.6%) 59 (28.6%) 
4-5 4 (5.9%) 15 (19.7%) 19 (9.2%) 
>6 21 (30.9%) 34 (44.7%) 55 (26.7%) 
Frequency 
walking 
Less half an hour 35 (51.5%) 32 (42.1%) 67 (32.5%)  
0.375 Half an hour 20 (29.4%) 31 (40.8%) 51 (24.8%) 
1-2 hours 13 (19.1%) 12 (15.8%) 25 (12.1%) 
> 2 hours 0 (0.0%) 1 (1.3%) 1 (0.5%) 
Smoking 
Yes 4 (3.9%) 1 (1.0%) 5 (2.4%) 0.174 
No 99 (96.1%) 102 (99.0%) 201 (97.6%) 
Smoking  
while you at 
home 
Yes 64 (62.1%) 48 (46.6%) 112 (54.4%) 0.025 
No 39 (37.9%) 55 (53.4%) 94 (45.6%) 
Smoking by 
others in 
closed places 
Yes 56 (54.4%) 38 (36.9%) 94 (45.6%) 0.012 
No 47 (45.6%) 65 (63.1%) 112 (54.4%) 
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5.4.2.2 Food intake 
 
Table 5.6 shows that all study subjects use iodized salt in their houses.   The consumption of 
fruits was mostly taken by participants 1-4 times per week (60.2%) and 37.4% consumed it 
at least once daily.  The rate of consumption was significantly different between the 2 groups 
(p<0.05).  In most of the studied fruits (see annex table 5) no significant difference was found 
in all fruits consumption, except for strawberry and banana where controls reported more 
frequently intake it per week (table 5.3).  
About 75% of participants consume vegetables 5-7 times weekly, but carrots intake was 
significantly different between the 2 groups. Other vegetables did not show any significant 
different (see annex, table 5). 
Among study population, 51% consumed yogurt 1-4 times weekly and was significantly 
more frequently intake by control group (p<0.05), and study cases intake of red meat was 
more frequent (p<0.0%).  
regarding fish intake, only 18.4% and 24.8% of the study population consumes canned 
sardine and canned tuna 1-4 times weekly, respectively. The intake was significantly 
different between the 2 study groups (p<0.05).  
In addition to food intake, 29.6% of the study population drink coffee two to three times 
daily, which was significantly more frequent among the control group (p<0.05). 
5.4.2.3 Supplements intake 
 
Table 5.7 shows that vitamin B12, calcium, and iron supplements were consumed mainly by 
less than 15% of the study subjects.  This consumption was statistically significantly 
different between the 2 study groups (p<0.05), where study cases reported more use of 
calcium, but control group reported more use of vitamin B12 and iron supplement. Other 
supplements intake did not show significant differences between the two groups (P >0.05, 
see annex, table 6)  
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Table 5.6: Differences between study cases and control group in food intake  
 
 Study cases 
N=103 
Control group  
N=103 
Total (%) 
N=206 
Chi 
Square 
N (%) N (%) N (%) P value 
Iodized salt Yes 103 (100.0%) 103 (100.0%) 206 (100.0%)  
Fruits 
<1 per week 3 (2.9%) 2 (1.9%) 5 (2.4%)  
1-4 per week 67 (65.0%) 57 (55.3%) 124 (60.2%) 0.005 
5-7 per week 26 (25.2%) 44 (42.7%) 70 (34.0%)  
2-3 times daily 7 (6.8%) 0 (0.0%) 7 (3.4%)  
Strawberry 
<1 per week 69 (67.0%) 47 (45.6%) 116 (56.3%) 0.002 
1-4 per week 34 (33.0%) 56 (54.4%) 90 (43.7%)  
Bananas 
<1 per week 33 (32.0%) 23 (22.3%) 56 (27.2%)  
1-4 per week 63 (61.2%) 50 (48.5%) 113 (54.9%) 0.001 
5-7 per week 7 (6.8%) 30 (29.1%) 37 (18.0%)  
Vegetables 
1-4 per week 26 (25.2% 14 (13.6%) 40 (19.4%)  
5-7 per week 60 (58.3%) 89 (86.4%) 149 (72.3%) 0.001 
2-3 times daily 17 (16.5%) 0 (0.0%) 17 (8.3%)  
Carrots 
<1 per week 59 (57.3%) 42 (40.8%) 101 (49.0%)  
1-4 per week 33 (32.0%) 51 (49.5%) 84 (40.8%) 0.034 
 5-7 per week 11 (10.7%) 10 (9.7%) 21 (10.2%) 
Yogurt 
<1 per week 37 (35.9%) 25 (24.3%) 62 (30.1%)  
1-4 per week 53 (51.5%) 52 (50.5%) 105 (51.0%) 0.036 
5-7 per week 13 (12.6%) 26 (25.2%) 39 (18.9%)  
Red meat 
<1 per week 72 (69.9%) 85 (82.5%) 157 (76.2%) 0.033 
1-4 per week 31 (30.1%) 18 (17.5%) 49 (23.8%)  
Canned 
sardines 
<1 per week 78 (75.7%) 90 (87.4%) 168 (81.6%) 0.031 
1-4 per week 25 (24.3%) 13 (12.6%) 38 (18.4%)  
Canned tuna 
<1 per week 70 (68.0%) 85 (82.5%) 155 (75.2%) 0.015 
1-4 per week 33 (32.0%) 18 (17.5%) 51 (24.8%)  
Coffee 
<1 per week 41 (39.8%) 39 (37.9%) 80 (38.8%)  
1-4 per week 17 (16.5%) 7 (6.8%) 24 (11.7%) 0.010 
5-7 per week 24 (23.3%) 17 (16.5%) 41 (19.9%)  
2-3 times daily 21 (20.4%) 40 (38.8%) 61 (29.6%)  
  
Table 5.7:  Association between study cases and control group by using supplements. 
 Study cases 
N=103 
Control group 
N=103 
Total 
N=206 
Chi Square 
N (%) N (%) N (%) P value 
Vitamin B12 
Yes 6 (5.8%) 15 (14.6%) 21 (10.2%) 0.038 
No 97 (94.2%) 88 (85.4%) 185 (89.8%)  
Calcium 
Yes 7 (6.8%) 0 (0.0%) 7 (3.4%) 0.007 
No 96 (93.2%) 103 (100.0%) 199 (96.6%)  
 Iron 
Yes 8 (7.8%) 18 (17.5%) 26 (12.6%) 0.036 
No 95 (92.2%) 85 (82.5%) 180 (87.4%)  
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5.4.3 Medical conditions  
 
5.4.3.1 TSH levels at study time 
 
 TSH mean levels did not show a significant difference between study cases and control 
group as measured at the time of the study (T test p value =0.066 >0.05).  For details see 
table 5.8 and figure 7.  
Table 5.8: Distribution of TSH levels (uIU/L) between study cases and control group 
at study time  
 
 Study cases Control group 
Mean (95% confidence interval) 15.9 (8.9-23) 1.7 (1.5-1.8) 
Standard error 3.6 0.06 
Median 5.8 1.53 
Variance 1316 0.471 
Standard deviation 36 0.68 
Range 272 4.40 
 
 
Figure 4 : Distribution of TSH levels (uIU/L) between study cases and control group at 
study time 
 
*We found that four of participants in the study have high TSH level and we considered 
them as cases. 
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5.4.3.2 Chronic diseases 
 
Table 5.9 shows that 7.3 % of the study subjects  had diabetes type 2 and 2.9% suffer from 
pituitary disease, while 50% were diagnosed with thyroid disease.   
When comparing study cases and control group, the study cases were statistically 
significantly suffered more from diabetes type 2, pituitary disease, thyroid disease 
(hyperthyroidism, goiter and congenital hypothyroidism) compared to study control group 
(P <0.05). Other variables such as heart disease, liver disease, kidney disease, mental illness, 
diabetes type 1, down syndrome, anemia, sjögren's, Addison’s disease and celiac disease did 
not show significant differences between the two groups (P >0.05, see annex, table 7). 
Table 5.9: Differences between study cases and control group by their medical 
conditions. 
 
 Study cases 
N=103 
Control group 
N=103 
Total (%) 
N=206 
Chi Square 
 N (%) N (%) N (%) P value 
 Diabetes type 2 
Yes 15 (14.6%) 0 (0.0%) 15 (7.3%)  
0.001* No 88 (85.4%) 103 (100.0%) 191 (92.7%) 
Pituitary  
Diseases 
Yes 6 (5.8%) 0 (0.0%) 6 (2.9%)  
0.013* No 97 (94.2%) 103 (100.0%) 200 (97.1%) 
Thyroid disease 
Yes 103 (100.0%) 0 (0.0%) 103 (50.0%)  
0.001* No 0 (0.0%) 103 (100.0%) 103 (50.0%) 
Hyperthyroidism 
Yes 5 (4.9%) 0 (0.0%) 5 (2.4%)  
0.024* No 98 (95.1%) 103 (100.0%) 201 (97.6%) 
Goiter 
Yes 32 (31.1%) 0 (0.0%) 32 (15.5%)  
0.001* No 71 68.9% 103 (100.0%) 174 (84.5%) 
Congenital 
hypothyroidism  
Yes 6 (5.8%) 0 (0.0%) 6 (2.9%)  
0.013* No 97 (94.2%) 103 (100.0%) 200 (97.1%) 
 
5.4.4 Women’s health 
 
Table 5.10 shows that 15.0% (n=31 of women) of the women subjects (23) were over 45 
years and more had no menstrual cycle in the past 12 months.  Also 68.4% of them were 
pregnant at least once, and 22.8% of them were affected with postpartum thyroiditis. 
Of study cases, 22% had no menstrual cycle in the past 12 months and 75% with regular 
periods compared to 11% and 89%, respectively in  the control group (P <0.05). Also, 8.8% 
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of study cases had postpartum thyroiditis compared to none in the control group (P <0.05). 
Other variables such as abortion and bleeding postpartum did not show any significant 
differences between the two groups (P >0.05, see annex, table 8). 
Table 5.10: Differences between study cases and control group in their menstrual cycle 
and pregnancy among women 
 Study cases 
N=95 
Control group 
N=100 
Total (%) 
N=195 
Chi Square 
N (%) N (%) N (%) P value 
 During the past 12 months  menstrual 
period completely gone 
Yes 20 (22.2%) 11 (11.1%) 31 (15.0%) 
 
0.039 
No 70 (77.8%) 88 (88.9%) 158 (76.7%) 
Regular menstrual cycle 
Yes 51 (75.0%) 78 (89.7%) 129 (62.6%) 0.015 
No 17 (25.0%) 9 (10.3%) 26 (12.6%) 
Pregnant at least once 
Yes 68 (85.0%) 73 (98.6%) 141 (68.4%) 0.002 
No 12 (15.0%) 1 (1.4%) 13 (6.3%) 
Postpartum Thyroiditis Yes 6 (8.8%) 0 (0.0%) 47 (22.8%) 
 
0.009 
  No 62 (91.2%) 73 (100.0%) 106 (51.5%) 
 
5.4.5 Medications use  
 
Table 5.11 shows that 3.4% of the study subjects had thyroidectomy. Also, 2.4% of them 
take Propylthiouracil.  
When comparing study cases and control group, 6.8% of study cases had thyroidectomy and 
5% take Propylthiouracil compared to none in the control group (P <0.05). Other 
medications such as radioactive iodine, lithium, amiodarone, interferon, carbimazole and 
methimazole did not show any significant differences between the two groups (P >0.05 see 
annex, table 9). 
Table 5.11: Association between study cases and control group by medication  
 
Case 
N=103 
Control 
N=103 
Total (%) 
N=106 
Chi Square 
 N (%) N (%) N (%) P value 
Thyroidectomy 
Yes 7 (6.8%) 0 (0.0%) 7 (3.4%)  
0.007* No 96 (93.2%) 103 (100.0%) 199 (96.6%) 
 Propylthiouracil 
 
 
Yes 5 (4.9%) 0 (0.0%) 5 (2.4%)  
0.024* 
No 98 (95.1%) 103 (100.0%) 201 (97.6%) 
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5.5  Part Three: Multivariate analysis: 
 
Logistic regression models included all statistically significant variables in the univariate 
analysis in the above section. The  variables are participants BMI; household monthly 
income; education level of participant; age of participant; gender of participant; living area; 
working status; rate of daily physical activity; smoking by other in closed places; smoking 
by other at home; consumption of fruits; consumption of vegetables; consumption of carrots; 
consumption of canned tuna; consumption of canned sardines; drinks coffee; consumption 
of red meat; consumption of yogurt;  taking iron supplement; taking vitamin B12 supplement; 
taking calcium supplement; frequency of eating banana and strawberry; diabetes type 2;  
pituitary disease; thyroid disease (hyperthyroidism, goiter and congenital hypothyroidism); 
thyroidectomy; Propylthiouracil; family history of autoimmune diseases including vitiligo 
and thyroid diseases. 
From the regression analysis; table 5.12 shows that being unemployed and living in rural 
areas significantly increase the risk to have hypothyroidism compared to those working or 
living in urban areas. Also; there is a statistically significant increased risk to have 
hypothyroidism in persons with lower monthly income compared those with higher 
monthly income. Also; the risk to develop hypothyroidism is also increased among those 
present in closed place where others smoke (3 folds) and are less physically active 
compared to those living in a non smoking environment and are more physically active. 
For food intake; those who consume more bananas weekly are at lower risks to develop 
hypothyroidism compared to those who consumed less banana. While, those who consume 
more carrot and more red meat weekly are at higher risks to develop hypothyroidism 
compared to those who consumed less amounts weekly.  For supplements intake; the risk 
to develop hypothyroidism is increased among those taking iron supplements compared to 
those not taking it. 
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Table 5.12: Logistic regression analysis for hypothyroidism. 
 
 
 Sig. Adjusted odds ratio 
(AOR) 
95% confidence interval for 
AOR 
    Lower Upper 
Working status  
Yes 0.000 0.036 0.008 0.163 
No  1.00   
Living area   
Urban 0.000 0.115 0.047 0.282 
Rural  1.00   
Monthly income 
Less than 1000 NIS 0.051 5.976 0.991 36.030 
1000-2000 NIS 0.015 8.409 1.516 46.632 
2001-3000 NIS 0.412 2.060 0.367 11.565 
3001-5000 NIS  1.00   
Smoking by others in 
closed places 
Yes 0.002 3.821 1.614 9.047 
No 
 
 1.00   
Physical activity 
rate 
 
 
High 0.000 0.042 0.007 0.245 
Medium 0.001 0.064 0.013 0.309 
Low  1.00   
Bananas 
consumption 
<1/week  1.00   
1-4/ week 0.672 1.224 0.481 3.117 
5-7/week 0.004 0.122 0.029 0.520 
Carrots 
consumption 
<1/week  1.00   
1-4/ week 0.125 0.507 0.213 1.208 
5-7/ week 0.057 5.814 0.952 35.497 
Red meat 
<1/ week  1.00   
1-4/ week 0.000 15.259 4.585 50.781 
Iron supplement 
intake 
Yes 0.004 0.123 0.029 0.519 
No  1.00   
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Chapter 6: Discussion  
6.1    Introduction  
This case-control study aimed to determine the risk factors associated with hypothyroidism 
among patients attending the primary health care clinics in Hebron governorate. In this 
chapter, the main study findings are interpreted and discussed. In the last part of this chapter, 
the study's conclusion and recommendations will be presented. 
6.2 Study main findings 
In the first stage of the study, data from patients file showed that that hypothyroidism was 
the most diagnosed endocrine disorder with the prevalence of 17.1% among patients 
attending the clinics (16.9%  Karantina and 17.5% in Dura). Also, the sub types of 
hypothyroidism were 87.0% the primary hypothyroidism, 5.2% the secondary 
hypothyroidism and 7.8% the congenital hypothyroidism. These types of hypothyroidism 
were shown to be associated with diabetes type 1, turner syndrome, thyroid cancer, goiter, 
thyroidectomy, postpartum thyroiditis, hypopituitarism and thalassemia. 
In the second stage of the study, which included 103 study cases and 103 controls, the 
multiple regression model showed that living area; working status and household monthly 
income were associated with hypothyroidism.  Also, rate of daily physical activity and 
smoking by others in closed places were significantly associated with hypothyroidism. In 
addition, consumption of carrots, banana and red meat were associated with hypothyroidism. 
Moreover, iron supplement was the only vitamin intake that was associated with 
hypothyroidism.  
6.3   Part 1: Hypothyroidism descriptive analysis 
6.3.1 Prevalence of hypothyroidism 
The prevalence of hypothyroidism among patients attending the two main governmental 
clinics (Karantina and Dura) was 17.1%. Hypothyroidism prevalence varies around the 
world and it depends on ethnic and geographical factors and especially on iodine intake  
(Yadav et al., 2013). No previous study in Palestine investigated the epidemiology of 
hypothyroidism. The prevalence of hypothyroidism in the general population in USA, UK 
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and Scotland ranges from 3.8%–4.6% (Chakera et al., 2012).  Also, previous studies around 
the world  reported that the prevalence of subclinical hypothyroidism  ranges from 1% to 
higher than 20% and 1-2% for overt hypothyroidism (Aminorroaya et al., 2009). This study 
shows that the Palestinian hypothyroidism prevalence is higher compared to some selected 
previous studies worldwide (table 1), except Bangladesh. 
Possible explanation for this high rate of hypothyroidism in Palestine could be iodine 
deficiency but also might congenital factors like autoimmune diseases is a potential reason 
too.  As shown in literature, the most common causes of hypothyroidism in iodine sufficient 
area such as the United states of America is most probably due to  chronic autoimmune 
(Hashimoto’s), and in iodine insufficiency area could be due predominantly to iodine 
deficiency  (Vanderpump, 2011). 
Table 6.1: Prevalence rate of hypothyroidism in selected epidemiological studies. 
Author, Country of 
study 
Type of study Sample Prevalence of hypothyroidism 
(Aoki et al., 
2007b),USA 
National Health and 
Nutrition Examination 
Survey (NHANES) 
2156 participants 
≥12 years 
-1..% in general population 
(Bjoro et al., 2000), 
Norway 
A health study of Nord-
Trùndelag (HUNT) 
52005 participants  
≥12 years 
-0.9% in males 
- 4.8% in females 
(Mao et al., 2010b), 
China 
Population-based study 11067 participants 
≥20 years 
- 1.7% in females   
- 0.3% in males 
(Aminorroaya et al., 
2009), Iran 
A cross-sectional 
survey 
6961  men and 
women >20 years 
- 4.8% in men 
- 12.8% in women 
(Nouh et al., 2008), 
Libya 
A cross-sectional study  192  subjects 20-65 
years 
-Overt hypothyroidism was (1.12%) 
-Subclinical hypothyroidism was 
(6.18%) 
(Yadav et al., 2013), 
Nepal 
A hospital based study 3902 cases  -Hypothyroidism was (2.26%)  
-Subclinical hypothyroidism (10.50%) 
(Mannan et al., 2010), 
Bangladesh 
A hospital based study 250  endocrine 
patients 
-Hypothyroidism was 18.5% 
 
6.3.2 Prevalence of subtypes of hypothyroidism  
This study showed that hypothyroidism was the main primary type of thyroid dysfunction.  
This study result is in agreement with previous studies, which found that primary 
hypothyroidism is the most common subtype of hypothyroidism, and it composes about 95% 
of hypothyroidism types (Jayakumar, 2011). In addition, studies worldwide demonstrate that  
secondary hypothyroidism rarely occurs,  and it composes about 5% of hypothyroidism sub 
types (Jayakumar, 2011), similar to our study (5.2%). In concordance with our findings, a 
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cross sectional study in Pakistan showed that primary hypothyroidism was found in 63.3% 
of thyroid cases, but only 1.4% had secondary hypothyroidism (Mansoor et al., 2010). Also, 
a prospective population-based study in Denmark reported that the nosological type of 
hypothyroidism was 84.4% spontaneous (presumably autoimmune) and 1.6% was 
congenital hypothyroidism (Carle et al. 2006).  
6.4 Part II: Case control study 
In this section all variables in the case-control study results will be presented 
6.4.1 Hypothyroidism and socio-demographic  
In this subsections, age, gender, place of residence and others results will be discussed. 
6.4.1.1 Hypothyroidism and patients’  age and gender 
Our results showed that hypothyroidism was more prevalent (50.5%)  in  age group 19-40, 
which is contrary to previous findings that the incidence of thyroid dysfunction increases 
with advancing age (Hollowell et al., 2002). However, a study in Scotland showed that the 
tendency to develop thyroid disorders occurs comparatively among younger age group 
(Hunter et al., 2000). In Pakistan, a study  found that primary hypothyroidism was more 
common in the age group 16-40 years (Mansoor et al., 2010). Also, in Nepal, a study 
reported that higher prevalence of  hypothyroidism was observed in the age group 15-30 
years (Aryal et al., 2010). However, the National Health and Nutrition Examination Survey 
(NHANSE) in the USA  reported that individuals aged 80 years and older had five times 
greater odds for having hypothyroidism compared to younger aged individuals (12- 49 
years)(Aoki et al., 2007b). Possible explanation of our study finding was that most of 
patients were adults and only 6 patients were less than 10 years of age, which might reflect 
a sample bias. 
This study showed that the prevalence of diagnosed hypothyroidism was 92.2% in females 
(n=95), and 7.8% in males (n=8). In Denmark, a prospective population-based study  
showed that hypothyroidism was three times predominance in women than in men (Carle et 
al., 2006). In China, a population-based study, found that the prevalence of hypothyroidism 
was 1.7% in females and 0.3% in males. Subclinical hypothyroidism was more common in 
females (males 2.4% versus females 5.8%, P < 0.001) and with increasing age (P < 0.001) 
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(Mao et al., 2010b). In Pakistan, a cross sectional study, found that primary hypothyroidism 
was 4.5 times more common in female than in male (Mansoor et al., 2010). In Saudi Arabia, 
a hospital  based study showed that patients 196 (54 males and 142 females) from 391 had 
hypothyroidism (Lamfon, 2008). There is no clear explanation why females are at greater 
risk to have hypothyroidism compared to males. But pregnancy, genetic factors (skewed X 
chromosome inactivation patterns, and defects in the sex chromosomes), medical condition, 
and sex hormones are believed to play an important role in this association (Jorgensen et 
al., 2010,Prummel et al., 2004). 
6.4.1.2 Hypothyroidism and patients residency: rural versus urban  
Our results showed that living in rural areas significantly increases the risk (10 times) to 
have hypothyroidism compared to those living in urban areas. A study in India found that 
the prevalence  of thyroid disease is more in the city compared to town (James and Kumar, 
2012). Another study in the United Kingdom reported that a 2-fold excess of subclinical 
hypothyroidism was seen in patients resident in the most deprived quartile  compared with 
those in the most affluent quartile (Wilson et al., 2006). In addition, a study performed  in 
Canada  revealed  that lower socioeconomic status associated with more advanced thyroid 
cancer stage (Siu et al., 2013). 
6.4.1.3 Hypothyroidism and working status 
Our study results showed that jobless persons significantly increases the risk to have 
hypothyroidism compared to those who work (OR= 0.036, 95% CI=0.008-0.163).  The 
majority of our study population were females, married and not working, which suggests 
that being less physically active might indirectly affect their thyroid gland activity. In 
Bangladesh, a clinical based study found that the majority of female patients with endocrine 
diseases were housewives, while most of male patients with endocrine diseases  were 
businessmen (Mannan et al., 2010). Also, work shift  was found to be associated with a 
number of serious health problems.  Contradicting our results, a study in Italy found a 
significant association between shift work and autoimmune hypothyroidism (Magrini et al., 
2006).   
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6.4.1.4 Hypothyroidism and household average  monthly income 
Our study results showed that there is a statistically significant increased risk to have 
hypothyroidism in persons with lower monthly income compared to those with higher 
monthly income. A study in Canada, revealed  that lower socioeconomic status was 
associated with more advanced thyroid cancer stage (Siu et al., 2013).  Low income might 
affect the people ability to buy fish, as a source of iodine, since it is expensive and 
unavailable in the low price market in Palestine.  
6.4.2 Hypothyroidism and lifestyle factors 
6.4.2.1 Weight 
Our results showed that 34% of the study subjects were overweight and obese. And they 
were significantly more obese than control group (p<0.05), However weight was not 
statistically significant after adjustment. Many studies found that thyroid dysfunction 
contribute to the development of regional obesity and tendency to gain weight (Biondi, 
2010). Moreover, obesity was found to be a risk factor for developing  hypothyroidism 
(Verma et al., 2008). Our study results is  consistent with a study done in Norway which 
found that  hypothyroidism correlated with higher BMI and higher prevalence of obesity in 
both smokers and nonsmokers (Asvold et al., 2009). Another study in India found that 
primary hypothyroidism was more prevalent in individuals with extreme obesity when 
compared with moderate obese patients (56% versus 41%) (Verma et al., 2008). This is due 
to both types of hypothyroidism (subclinical and overt hypothyroidism) which are frequently 
associated with weight gain, as a result of high TSH level which decreased thermogenesis 
and metabolic rate (Biondi, 2010). Obesity increases the susceptibility to harbor autoimmune 
hypothyroidism due to the effects of adipocytokine leptin on pituitary gland (Marzullo et al., 
2010). 
6.4.2.2 Physical activity 
Our study results showed that 70% of the study subjects stated are physically active, but they 
mainly considered walking as being their main daily physical activity.  About 27% reported 
walking almost daily. After adjustment for age and gender, those who are physically active 
were less at risk to develop hypothyroidism by 6 times compared to those who were less to 
physically active.  
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Evidence is growing that physical activity in the form of regular exercise has a positive effect 
on thyroid gland. However, a double-blind, randomized study in Brazil revealed that sub-
maximal cardiopulmonary exercise performance improved after six months of TSH 
normalization which helped in enhancing the ability to carry out daily life activities in 
patients with subclinical hypothyroidism (Mainenti et al., 2009). Another double-blind, 
randomized, placebo-controlled fashion in Italy found that exercise altered both the tolerance 
and pattern of blood glucose, lactate, pyruvate, free fatty acid and glycerol concentrations in 
subclinical hypothyroidism patients compared to healthy subjects  (Caraccio et al., 2005b). 
This is due to exercise that has a greater  effect on the thyroid gland and the level of 
circulating thyroid hormones (Ciloglu et al., 2005a). Moreover, it can also help in combat 
with the major symptoms of hypothyroidism such as weight gain, fatigue and depression 
(Thyroid Guide, 2011). 
6.4.2.3 Smoking 
Our results indicate that most of all the study subjects were not smokers, but the cases 
reported that they are more affected by passive smoking (p<0.05). After adjustment for age 
and gender, the risk to develop hypothyroidism was 3 folds more among those who are 
present in smoking environment “passive smokers” compared to others. 
Studies evaluating tobacco smoking and thyroid disorders have  yielded conflicting results 
with either negative or positive association between smoking and hypothyroidism. A meta 
analysis of  25 studies on the association between smoking and thyroid diseases found that 
smoking was significantly associated with Graves’ disease, while the association with 
hypothyroidism did not reach statistical significance (Vestergaard, 2002). In Norway, a 
population-based study showed that  smoking was negatively associated with 
hypothyroidism but positively associated with hyperthyroidism (Asvold et al., 2007). In 
contrast, a retrospective study in Japan  suggested that smoking may increase the risk of 
hypothyroidism in patients with Hashimoto's thyroiditis (Fukata et al., 1996). In Greece, a 
study found that one hour of passive smoking at bar/restaurant levels is accompanied by 
significant increases in metabolism and thyroid hormone levels (Metsios et al., 2007).  In 
USA, a study found that active and passive exposure to cigarette tobacco smoke is associated 
with a mild inhibitory effect on the thyroid reflected in higher serum T4 and T3 in 
nonsmokers compared (Soldin et al., 2009). The effect of passive smoking on 
hypothyroidism is still of concern and further studies are needed to clarify this association. 
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6.4.2.4 Food intake  
Our findings showed that consuming more bananas weekly lower the risk for developing 
hypothyroidism by 15 times compared to fewer consumers.   
Previous studies suggested that consumption of  banana may lead to reduce the risk of 
chronic diseases including cancer, cardiovascular, Alzheimer’s, depression, and diabetes 
(Kumar et al., 2012). However, banana is the best source of vitamin B6, and it’s provide 
41% of vitamin B6 that we need on a daily basis (Kumar et al., 2012). Vitamin B6 is 
important for thyroid function because it’s involved in manufacturing T4, and it’s deficiency 
can lead to hypothyroidism (Sworczak and Wisniewski, 2011). Also, banana is an excellent 
source of vitamin C (Kumar et al., 2012). Vitamin C is an essential antioxidants that help 
the thyroid gland to neutralize the oxidative stress that promoted by hypothyroidism 
(Sworczak and Wisniewski, 2011). In addition, bananas contain L tyrosine and iodine, which 
are essential for thyroid hormone, and both were used as integrative treatment of 
hypothyroidism (WUSC, 2011). Therefore, these studies supported our results that 
consumption of bananas may reduce the risk of hypothyroidism. 
Another finding in our study showed that consuming more carrots weekly increase the risk 
to develop hypothyroidism by 15 times compared to those consuming less amounts weekly.  
Carrot is the best source of beta carotene which is converted to vitamin A (Lee et al., 2011). 
Contradicting our results, a previous studies, revealed that vitamin A is necessary to  regulate 
thyroid hormone metabolism (Farhangi et al., 2012). In addition, vitamin A supplements was 
also found to improve thyroid function without a change in iodine nutrition (Zimmermann 
et al., 2007).  A cross-sectional study of African children  found that vitamin A deficiency 
in children with severe iodine deficiency disorders  was associated with an increase in TSH 
stimulation and thyroid size and a reduced risk of hypothyroidism (Zimmermann et al., 
2004). Another study performed in Iran, found that vitamin A supplementation might reduce 
the risk of subclinical hypothyroidism in premenopausal women (Farhangi et al., 2012). 
More consumption of red meat weekly in our study was shown to increase the risk for 
hypothyroidism by 15 times compared to those consuming less amounts weekly. The 
available epidemiologic evidence between red meat or processed meat intake and 
hypothyroidism is limited. Also, few epidemiologic studies investigated the association 
between red meat and thyroid cancer and showed conflict results. A case-control study in 
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Uruguay found that total meat intake was associated with increased risk of thyroid cancer 
(OR = 2.38; p <0.039) (Aune et al., 2009). Also, another case-control study in Italy found 
marginally significant increased risk of thyroid cancer among high consumers of red meat 
(OR = 1.5, 95% CI: 1.0-2.1) (Tavani et al., 2000). In contrast, a prospective study in USA 
showed  a negative association between red meat intake and thyroid cancer (Cross et al., 
2007).  Another study in Netherlands found that a diet consisting of green vegetables, beef, 
full fat milk and butter for 3 month decrease significantly the TSH levels among patients 
with subclinical hypothyroidism risk ratio of 2.8 (Kuiper and Gaag, 2012). Several potential 
mechanisms could explain the association between red meat intake and increased cancer 
risk, for example,  red meat are sources of saturated fat and iron, which have  been an 
established risk factor for several different cancer sites (Aune et al., 2009) 
6.4.3 Hypothyroidism and supplementation 
6.4.3.1 Iron supplement 
Our results showed that the risk to develop hypothyroidism is lower among those taking 
iron supplements compared to those not taking it (OR= 0.123, 95% CI=0.029-0.519).  
Iron deficiency anemia and thyroid disorders tend to coexist in patients, and influence each 
others. Previous studies in animals and humans, iron deficiency anemia was shown to impair 
thyroid metabolism through decreasing plasma total thyroxin (T4) and triiodothyronine (T3) 
concentrations (Hess et al., 2002). A randomized double-blind study in Iran found that 
combination of levothyroxine and iron salt is better for patients 
with subclinical hypothyroidism and iron-deficiency anemia (Ravanbod et al., 2013). Also, 
a Turkish  study results showed that secondary and subclinical hyperthyroid developed in a 
significant portion of patients with iron deficiency anemia,  and these abnormalities can 
recover after iron replacement therapy without additional thyroid hormone replacement 
(Gokdeniz et al., 2010). 
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6.4.4 Hypothyroidism and patients’ chronic diseases 
6.4.4.1 Turner syndrome 
Our prevalence study results (stage 1) showed that 0.5% of patients with turner syndrome 
had hypothyroidism, which is lower than reported by other studies. A study  in the UK found 
that 15% of women with  turner syndrome were hypothyroidism (Elsheikh et al., 2001). In 
Sweden, a follow-up study showed that 37% of women with turner syndrome had 
hypothyroidism after five years follow-up. (El Mansoury et al., 2005a). Possible explanation 
is that a gene on the long arm of X chromosome (Xq) may play an important pathogenic role 
in the development of autoimmune hypothyroidism in patients with turner syndrome 
(Elsheikh et al., 2001). 
6.4.4.2 Diabetes type 1 and type 2 
Our study results found that 1.1% of patients with diabetes type 1 had hypothyroidism, while, 
in the case-control study(stage 2), 2.9% of study cases had diabetes type 1 compared to none 
in the control group (P >0.05).  Our results are lower than that reported by other studies. In 
Germany, a cross-sectional analysis showed that the prevalence rate of subclinical 
hypothyroidism was 7.2% in children, adolescents, and young adults (age <25 years) 
with type 1 diabetes (Denzer et al., 2013). In the USA, a longitudinal study found  that  
hypothyroidism was more common in female (41%) than in male (19%) with type 1 diabetes 
(Umpierrez et al., 2003). In Iran, a cross-sectional study showed that children and 
adolescents with diabetes type 1 had higher prevalence of subclinical hypothyroidism than 
nondiabetic (Ardestani et al., 2011). In Saudi Arabia 15.8% of children and adolescents with 
type 1 diabetes had hypothyroidism (Al-Agha et al., 2011). Explanations for the coexistence 
of diabetes type 1 and hypothyroidism involve immunological disturbances in B and T 
lymphocytes, a trend to react abnormally in the presence of an antigen and a genetic 
susceptibility (Raterman and Nurmohamed, 2012b). 
Our prevalence study results (stage 1) found that no patients had diabetes type 2, while in 
the case-control study (stage 2) 14.6 % of study cases had diabetes type 2 compared to none 
in the control group (P <0.05), but the association is not statistically significant after 
adjustment. A study in Mexico  found that hypothyroidism was 5.7% in type 2 diabetic 
patients (Tamez-Perez et al., 2012). In Greece, a study showed the prevalence of subclinical 
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hypothyroidism was 5.2% in males and 8.4% in females with type 2 diabetes 
(Papazafiropoulou et al., 2010). Our study results are lower compared  with study in  India 
that showed that 23.7 % of  type 2 diabetic patients had hypothyroidism (Singh et al., 2011). 
In Kuwait, a study found that the prevalence rate of hypothyroidism in type 2 diabetic 
patients was 20.1% (Al wazan et al., 2010). Hypothyroidism have been associated with 
insulin resistance which was reported to be the major cause of impaired glucose metabolism 
in diabetes type 2 (Wang, 2013). 
6.4.4.3 Pituitary disease 
Our prevalence results (stage1) showed that 54.2% of patients with hypopituitarism 
developed central hypothyroidism, while the case-control results (stage 2) showed that 5.8% 
of study cases suffered from pituitary disease compared to none in the control group (P 
<0.05). But the association is not statistically significant after adjustment.  
According to the American thyroid association (ATA),  damage of pituitary by radiation, 
surgery, or especially tumor are the most common causes of central “secondary’ 
hypothyroidism (ATA, 2012a). Several studies found that 15% of patients with  pituitary 
adenoma had  central hypothyroidism (Yamada and Mori, 2008). In India, 83.2% of patients 
with hypopituitarism had hypothyroidism (Gundgurthi et al., 2012). The discrepancy 
between our study 2 stages could be related to the under-reporting of patients with other 
diseases in their  files which was our source of information in the prevalence study (stage 1), 
and could be an over-reporting by patients in the interviews. 
6.4.4.4 Thalassemia  
Our prevalence study results (stage 1) found that 4.2% of patients with beta thalassemia 
major had hypothyroidism. However, the frequency of hypothyroidism in thalassemic 
patients ranges from 6% to 30% among different countries depending on chelating regimens 
(De, V et al., 2004).  It gives impression that hypothyroidism is rare in thalassemic patients 
and its prevalence was lower than that reported by others. Our results is comparable  to  
cohort study in Greece, which reported low prevalence of hypothyroidism (4.0%) in beta-
thalassemia (Zervas et al., 2002). Also, in Oman primary hypothyroidism was   3.3% in 
thalassemic patients (Mula-Abed et al., 2008). However,  in Iran  the prevalence of 
hypothyroidism among  patients with beta-thalassemia was 14.6% (Eshragi et al., 2011). 
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This is due to iron overload which causes tissue damage of the thyroid gland, that affects 
thyroid hormones production and manifests varying degrees of primary hypothyroidism 
(Malik et al., 2010). 
6.4.4.5 Hyperthyroidism 
Our prevalence study results (stage 1) showed that 0.5% of patients with hyperthyroidism 
developed hypothyroidism, while  the case-control study (stage 2) showed that 4.5% of the 
study cases suffered from hyperthyroidism compared to none in the control group (P <0.05), 
but the association is not statistically significant in the logistic regression model. In comparison, 
our results seem far lower than reported by other studies. Umra et. al found that 
approximately 15-20% patients with Graves’ hyperthyroidism develop spontaneous 
hypothyroidism after discontinuation of anti-thyroid treatment or following subtotal 
thyroidectomy (Umar et al., 2010). This is due to the fact that patients are no more having 
thyroxin which led to hypothyroidism (Umar et al., 2010). 
6.4.4.6 Goiter 
Our prevalence study results (stage 1) showed that 1.6% of patients with goiter developed 
hypothyroidism, while the case-control study (stage 2) showed that 31.1% of the study cases 
had goiter compared to none in the control group (P <0.05), but the association is not 
statistically significant after adjustment.  In India, a study found that hypothyroidism 
(subclinical and clinical) was  3.2% in children with goiter and 2.4% in children without 
goiter (Das et al., 2011). In  Iran, a study showed the prevalence of subclinical 
hypothyroidism in goiter grade 1 and grade 2 in children was 9.9% and 16.3% respectively 
(Aminorroaya et al., 2010). In Palestine, a cross-section study showed the prevalence of 
goiter among primary school students aged 8-10 years in the West Bank and Gaza Strip 
(grade 1 and 2) was 14.9% (Ramlawi and Abdeen, 1997). The discrepancy between our two 
study stages could be related to the under-reporting of patients with other diseases in patients 
file which was our source of data in the prevalence study (stage 1). Also, could be an over-
reporting by patients in the interviews. 
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6.4.4.7 Thyroid cancer  
Our prevalence study results (stage 1) showed that 2.2% of patients had thyroid cancer. A 
recent study in the USA found that history of hypothyroidism was associated with 
significantly increased risk of thyroid cancer (Balasubramaniam et al., 2012).  A meta-
analysis of ten studies showed a 2.77-fold increased incidence of thyroid cancer in patients 
with antibody evidence of Hashimoto's thyroiditis, compared to controls (Singh et al., 1999). 
A study in Saudi Arabia  reported that malignant thyroid cancer among patients with 
hypothyroidism was 7.4 % in males, and 4.9% in females (Lamfon, 2008). Moreover, several 
studies demonstrated that hypothyroidism developed after  radiation therapy or surgical 
treatment for thyroid cancer (Lankarani et al., 2008). 
6.4.4.8 Congenital hypothyroidism  
Our prevalence results (stage 1) showed the prevalence of congenital hypothyroidism was 
7.8%, while our case-control study (stage 2) showed that 5.8% of the study cases had 
congenital hypothyroidism compared to none in the control group (P <0.05), but the 
association was not statistically significant after adjustment. Our study results  was higher than 
reported by a study performed in Denmark, which reported the prevalence  of congenital 
hypothyroidism was 1.6% (Carle et al., 2006), and lower than study in Saudi Arabia that 
found congenital hypothyroidism rate was 14.8% among males and 9.8% among females 
(Lamfon, 2008). Another study in Sudan found that patients with congenital hypothyroidism 
constitute 26.3% of the clinic thyroid cases (Mohd et al., 2012). The variation between 
prevalence our two study stages could be under-reporting in patients' files. Also, could be an 
over-reporting by patients in the interviews. 
6.4.5 Women’s health 
Our results in stage 2  found that 15.0% of the study subjects  had no period in the past 12 
months (22% of study cases and 11% of control group, p<0.05).  But, 23 women of the 31 
women were 45 years and more.  Also 68.4% of women were pregnant at least once, and 
22.8% of them were affected with postpartum thyroiditis. 
Our study is in consistent with results from hospital based study in India which showed 
irregular menstrual cycles in 31% of cases with hypothyroidism (Binita et al., 2009). Another 
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study in Greece found that 23.4% of hypothyroid patients  had irregular periods before 6 
months of  the discovery of the hypothyroidism (Krassas et al., 1999). 
Our prevalence study results (stage 1) found that 0.5% of women with postpartum thyroiditis 
developed hypothyroidism, while in case-control part (stage 2), 8.8% of the  study cases had 
postpartum thyroiditis compared to none in the control group (P <0.05). According to a 
publication of the American thyroid association, postpartum thyroiditis occurs in 
approximately 5-10% of women, and approximately 20% of those women with postpartum 
thyroiditis that go into hypothyroidism phase will remain hypothyroid (ATA, 2012d). 
Furthermore, another report showed that 20–40% of women with postpartum thyroiditis 
developed permanent hypothyroidism over the ensuing 3–12 years (Stagnaro-Green, 2012). 
A study in Australia found that hypothyroidism was present in 38% (71 women) who had 
postpartum thyroiditis (PPTD) at baseline  with a significant adjusted odds ratio 9.7 for 
postpartum hypothyroidism (Stuckey et al., 2010). Moreover, a follow up study in Iran found 
that 64% of women with hypothyroid postpartum thyroid dysfunction became permanent  
hypothyroid when thyroxin treatment was subsequently withdrawn (Azizi, 2005). A study 
performed in Jordan, found that 20.8% of women during early pregnancy were diagnosed 
with sub-clinical hypothyroidism (Alkafajei et al., 2012).  
6.4.6 Family history of autoimmune thyroid diseases (AITD) and 
hypothyroidism 
Our study cases indicated more family history of autoimmune diseases including vitiligo and 
thyroid diseases (hypothyroidism and hyperthyroidism) compared to the control group. 
Furthermore, the study cases had more first-degree relatives with thyroid diseases than 
second-degree relatives with thyroid diseases compared to the control group. That means, 
study cases with history of first-degree relatives who have thyroid diseases significantly 
differ from those having second-degree relatives of AITD, but the association was not 
statistically significant after adjustment to age and gender. A familial study in Germany 
showed an increased familial risk of developing autoimmune thyroid disease (AITD), 
especially for first-degree relatives with (AITD) in comparison with the general population 
(Dittmar et al., 2011). Moreover, a prospective cohort study in the Netherlands found that 
the  prevalence of autoimmune thyroid disease AITD was 27% among first- and second-
degree relatives of AITD patients (Strieder et al., 2003). In addition, a study performed in 
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Egypt demonstrated that associated factors for the development of neonatal hypothyroidism 
included positive family history of hypothyroidism and hypothyroidism of the mother 
(Abdel-Rasoul et al., 2011). 
6.4.7 Thyroidectomy, medication use and hypothyroidism 
Our prevalence study results (stage 1) found that 1.1% of patients had thyroidectomy and 
developed hypothyroidism, while in the case-control study (stage 2) 6.8% of the study cases 
had thyroidectomy compared to none in the control group (P <0.05).   
Our results are lower than that reported by others. Several studies showed that 
hypothyroidism following lobectomy or hemi-thyroidectomy, with  rates between 6.5 and 
45% (Cho et al., 2011b). A study in Australia found that hypothyroidism was diagnosed in 
10.9% of 294 patients after hemi-thyroidectomy (Su et al., 2009). But, a retrospective study 
in Korea found that the incidence of hypothyroidism following thyroid lobectomy was 
21.1% within 35.7 months of follow-up (Cho et al., 2011a). Another study in Iran reported 
that 35.2% of cases of thyroidectomy developed hypothyroidism on average 5 ± 3.2 months 
(mean ± S.D) after surgery (Lankarani et al., 2008). 
6.4.7.1 Propylthiouracil medication and hypothyroidism 
In our study, 5% of the  study cases take Propylthiouracil compared to none in the control 
group (P <0.05). 
According  previous studies, Thionamides (Methimazole,  Propylthiouracil, Carbimazole) is 
a major anti-thyroid drug  used for  treatment of Graves hyperthyroidism, and these  anti-
thyroid drugs  are  associated with the development of  hypothyroidism (Cho et al., 2011e). 
A prospective randomized study in Thailand found that the incidence of hypothyroidism 
among  hyperthyroidism patients treated with a fixed-15 mg daily dosage of  Methimazole  
for 12 weeks was  31.4% (Homsanit et al., 2001).  
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6.4.8 History of diagnosis: age of diagnosis 
In our study, the mean age at diagnosis of the study cases was 33.3 ± 14.5 years (mean ± S.D) 
and 68.9% of the study cases were diagnosed with hypothyroidism. The diagnosis was based 
on the presence of hypothyroidism symptoms and blood TSH, T3 and T4 levels and 50% 
was diagnosed by an endocrinologist 
The mean age of our study diagnosis is higher than reported by a study performed  in Turkey, 
which found 24.5% of patients with Hashimoto’s thyroiditis had subclinical hypothyroidism 
with the mean age at diagnosis 11.5±2.2 years, and 29% of patients with Hashimoto’s 
thyroiditis had overt hypothyroidism with the mean age 10.4±2.6 years (mean ± S.D) 
(Demirbilek et al., 2007).  Another study in Pakistan that included 100 consecutive cases of 
hypothyroidism from birth to twelve years, found that delayed diagnosis was among 42%  
(n=100) of cases and were between 1-5 years, and 66% of these cases had developmental 
delay (Malik and Butt, 2008b). A study in Turkey, revealed that height prognosis in late 
diagnosed congenital hypothyroidism (Kandemir and Yordam, 2001). 
6.5 Study bias and limitation  
1. Recall bias might be a major bias in our study. A lot of questions answered by 
patients about their health status, medication, family history,  life style as well as 
types of food consumed. This type of design has its limitations and possible not to 
give the correct information 
2. The present study was case control- clinical based study; and does not represent the 
whole population. 
3. The present study was based on TSH only. Therefore, the present study could have 
been strengthened if free T
3
, free T
4, 
Total T
4
, Total T
3
,  anti-thyroperoxidase (anti-
TPO) and anti-thyroglobulin (anti Tg) were included. 
4. A possibility that TSH cut-offs values which was used in the present study may have 
underestimated health risk. The values used were those recommended by the 
manufacturer of the kit and other studies because Palestine does not have its own 
reference interval for thyroid function test panel. 
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5. Our study cases were not homogenizes ( because included primary hypothyroidism, 
secondary hypothyroidism and congenital hypothyroidism). 
6.6  Conclusion  
The present study was a case control- clinical based study and cannot represent the whole 
Palestinian population. The study identified possible risk factors associated with 
hypothyroidism among patients attending the primary health care clinics in Hebron 
governorate and can be used as baseline for future work on thyroid diseases.  Also, the study 
revealed that hypothyroidism appears to be quite common in Palestine.  Although the 
prevalence of hypothyroidism was based on files presented in endocrinology clinics, 
however 17.4% is considered high in comparison to other endocrine disorders. This could 
be associated to iodine deficiency because of the lower consumption of iodized salt, and 
other congenital factors like autoimmune diseases a potential reason too. Moreover, the 
present study demonstrated that living area, working status household monthly income, rate 
of daily physical activity, smoking by others in closed places, consumption of carrots, 
banana, and iron supplement intake were associated with hypothyroidism. Better 
understanding of these factors and how they impact on hypothyroidism manifestation may 
allow preventive measures or better tailoring of therapies.   Therefore, our results are 
important for future planning of policies such as setting a national screening program that 
will prevent and/or delay the complication of hyperthyroidism related disabilities. 
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6.7   Recommendations 
Recommendations for policy makers 
1. A national screening program for thyroid disorders is needed to help in preventing 
and/or delaying thyroid disorders and its complication or any of its other related 
disabilities recommended for high risk individuals who might have goiter, iodine 
deficiency disorder, family history of autoimmune disease………etc. 
2. A comprehensive health education program is needed to educate people on the 
importance of using iodized salt and the importance to care for eating foods that help 
preventing such disorder, in addition to the role of physical activity in preventing it 
occurrence.  
3. To incorporate the TSH, T3, and T4 measurement at the MOH laboratory testing.  
Recommendations for doctors and health staff 
1. To participate in increasing the awareness of their patients on the role of changes in 
lifestyle in delaying the occurrence of hypothyroidism and its complications.  
2. To encourage and order the TSH blood level for patients at risk to develop thyroid 
diseases, and to refer these patients to endocrine clinic if needed.   
3. More focus in reporting and filing information in patients files about  patients health 
situation and follow up. 
Recommendations for future research and researchers 
1. Further population based epidemiological studies are needed to establish the 
accurate prevalence and predominant etiological factors of thyroid disorders. 
2. Additional studies will be needed to determine the iodine level spectrum for the 
Palestinian population. 
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 1 :xennA
 
 العامة الصحة كلية
يعد مرض قصور الغدة الدرقية من الأمراض الشائعة، وهو يصيب النساء أكثر من الرجال، ويزداد المرض مع تقدم 
( هرمونات الثايرويد) أقل من المعدل الطبيعي،  العمر، وهو حالة مرضية يكون فيها إنتاج هرمونات الغدة الدرقية
وهناك أسباب عدة تؤدي للإصابة بقصور الغدة الدرقية من أهمها: أمراض المناعة الذاتية، والاستئصال الجراحي للغدة 
الذاكر  قصور الدرقية، والعلاج الإشعاعي للغدة الدرقية، وقصور الغدة الدرقية يؤدي إلى العديد من المضاعفات منها:
 المفاصل الخصوبة، والآم مشاكل أو/و الشهرية الدورة مواعيد اضطراب الوزن الاكتئاب فقدان صعوبة أو الوزن زيادة
 . العضلات أو
معرفة العوامل المرتبطة بقصور الغدة الدرقية بين المرضى الذين يراجعون عيادات  إلى البحث هذا ومن هنا يهدف
 عند هذا المرض مضاعفات شارانت من والحد الوقاية على العمل أجل من في محافظة الخليل الرعاية الصحية الاولية
 . المرضى هؤلاء
الأسئلة كافة، آملين أن تكون إجابتكم  على الإجابة من حضرتكم لدرجة الماجستير؛ لذا نرجو تأتي هذه الاستبانة استكمالاا 
 لأغراض ستستخدم الاستبيان في الواردة المعلومات إن سؤال، علما كل قبل الواردة التعليمات وحسب بموضوعية
 إجابة أسئلة هذه الاستبانة. على بالموافقة التوقيع من حضرتكم نرجو تمام ا، كما سرية فقط، وسيتبقى العلمي البحث
 
 
 تعاونكم حسن لكم شاكرين
 الباحث: مصطفى برهم        
 
 وتوقيعي اسميوجود  الدراسة، وان هذه في المشاركة قررت وعليه الاستبيان هذا في الواردة التعليمات جميع على  اطلعت
 .الدراسة هذه في للمشاركة قبولي على دليل هو
 __________________التاريخ
 __________________الساعة
 
 _________________التوقيع                                                                      :المشارك اسم
 _________________التوقيع                             مصطفى برهم                              :الباحث اسم
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 2 :xennA
  الاول: بيانات المبحوثالقسم 
 |___|___|/|___|___|/|___|___||___|___| تاريخ تعبئة الاستمارة 1.Q
 يوم            / شهر        / عام
  :العيادة اسم 2.Q
 |___|___||___|___|___| :الطبي الملف رقم 3.Q
  الرباعي:  الاسم الشخصي 4.Q
 الجوال التلفون 5.Q
  العنوان 6.Q
 ضابطة -6 حالة -3 المقابل  7.Q
 أنثى -6 ذكر -3 الجنس 8.Q
 سنة|___|___|  العمر  9.Q
 |___|___|/|___|___|/|___|___||___|___| تاريخ الميلاد 01.Q
 / عام  يوم            / شهر      
 |___|___||___| الطول سم 11.Q
 |___|___||___| الوزن كغم 21.Q
  |___|___|8|___||___|  level HST 31.Q
|___|___|/|___|التاريخ41.Q
 ___|/|___|___||___|___|
يوم            /                   
 شهر        / عام
  |___|___|8|___||___| level 4T eerF 51.Q
|___|___|/|___|التاريخ61.Q
 ___|/|___|___||___|___|
يوم            /                     
 شهر        / عام
 مطلق-2 أرمل -1 أعزب-6 متزوج-3 الحالة الاجتماعية 71.Q
   لا -6 نعم -3 هل تعمل (ي) 81Q
المهنة خلال عشرة  91.Q
 الأعوام الماضية
 
 سنة|___|___|  عدد سنوات الدراسة 02.Q
 خربة او بيت شعر-2 مخيم-1 قرية-6 مدينة-3 مكان السكن 12.Q
الدخل الشهري للعائلة  22.Q
 بالشيكل
 0009-3001 -2 0001-3006-1 0006-0003-6 شيكل  0003أقل من -3
عدد افراد الاسرة المقيميين  32.Q
 في المنزل حاليا
 |___|___| فرد
 لا-6 نعم-3 هل أنت مدخن   42.Q
(متعدد ماذا تدخن يوميا؟  
 الاجابات)
 سيجارة مع فلتر -3
سيجارة بدون -6
 فلتر 
 ارجيلة               -9 غليون                -2 سيجار               -1
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ماهو معدل تدخينك اليومي  
 لأي من هذه الأنواع
 |___|___|   |___|___|
     
 |___|___|
       
 |___|___|
 |___|___|
 |___|___| سنة ما هو عدد سنوات التدخين 52.Q
هل يدخن أحد من اسرتك  62.Q
 في البيت اثناء وجودك؟
 لا-6 نعم -3
هل يدخن أحد اثناء  72.Q
وجودك في مكان مغلق 
 مثل مكان العمل؟
 لا-6 نعم-3 
 82.Q
هل سبق وأن تناولت 
مشروبا كحوليا مثل البيرة 
أو النبيذ او الويسكي خلال 
 حياتك؟
 لا-6 نعم-3
 92.Q
هل تناولت المشروبات 
الكحولية مثل البيرة أو 
 النبيذ او الويسكي:
 .   يوميا3
 مرات 2- 9.     6
 في الأسبوع 
مرات  2-3.     1
 في الأسبوع
 مرات في الشهر 1-3  .2
أقل من  - 9
مرة في 
 الشهر
 03.Q
عندما تشرب الكحول في 
المتوسط كم كأسا تشرب 
 يوميا؟
    العدد   
 |___|___|
 لا أعلم
 13.Q
منذ كم سنة وأنت تشرب 
 الكحول؟
سنوات    
 |___|___|
 لا أعلم
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حسب تقييمك ما هو مستوى نشاطك  23.Q
 اليومي (مشي، ركض، اعمال منزلية..
 غير ذلك حدد-2 منخفض-1 متوسط-6 عالي-3
 لا-6 نعم  -3 هل تمارس الرياضة؟ 33.Q
 
 مدتها في كل مرة كم مرة في الأسبوع تمارس هذه الرياضة  الرياضةنوع  
نصف ساعة أو  أو أكثر 2 مرات 9-2 مرات 1-6 أو اقل مرة  
 اقل
 -ساعة ساعة  -نصف ساعة
 ساعتين
أكثر من 
 ساعتين
         المشي 43.Q
        الركض 53.Q
        تمارين عامة بدون أجهزة 63.Q
باستخدام أجهزة تمارين  73.Q
 رياضية
       
        غير ذلك: 83.Q
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 : لائحة الاغذيةالثانيالقسم 
 هل تتناول ملح الطعام المضاف باليود 93.Q
 
 لا -6 نعم-3
 
 التحضير:  لا يتناول الوحدة  
 .طازجة3
 .معلبة 6
 .مجففة1
 +6
 لليوم
 
 - 4
 6
 لليوم
 3-2
 لليوم
 
 مرة
 لليوم
 
 6-5
في 
 الأسبوع
 4-2
 في الأسبوع
 في الشهر 3-1 مرة  في الأسبوع
           حبة الفواكة بشكل عام 04.Q
           حبة المشمش 14.Q
           حبة الأناناس 24.Q
           حبة الفراولة 34.Q
           حبة الموز 44.Q
           حبة الخوخ 54.Q
           ك½  الخضروات بشكل عام 64.Q
            ك½  الملفوف  74.Q
            ك½  الزهرة (القرنبيط) 84.Q
            ك½  بروكلي 94.Q
           حبة البندورة  05.Q
           حبة الخس 15.Q
 
 
 001
           حبة الجزر 25.Q
           حب بطاطا 35.Q
           ك½  الفول السوداني 45.Q
           ك½  فول الصويا 55.Q
           ك3 حليب كامل الدسم 65.Q
            ك3 حليب منزوع الدسم 75.Q
            ك3 لبن رائب كامل الدسم 85.Q
            ك3 لبن رائب منزوع الدسم 95.Q
           غم 003 جبنة بيضاء بلدية 06.Q
           غم 003 جبنة بيضاء مصنعة 16.Q
           غم 003 زبدة بلدية 26.Q
           غم 003 زبدة مصنعة 36.Q
            ك3 بوظة 46.Q
            ك3 لبن مخيض 56.Q
 
  الوحدة  66.Q
 لا يأخذ
 .طازجة3
 .مشوية1.مقلية 6
 .مغلية2
 +6
 لليوم
 
 6 - 4
 لليوم
 3-2
 لليوم
 
 مرة
 لليوم
 
 6-5
 في الأسبوع
 4-2
 في الأسبوع
 في الشهر 3-1 مرة  في الأسبوع
           بيضة البيض 76.Q
           غم093 اللحوم الحمراء (الخروف، العجل) 86.Q
           غم093 لحم الدجاج 96.Q
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           غم 093 لحم الحبش 07.Q
اللحوم المصنعة المطبوخة مثل  17.Q
 السلامي، المرتديلا، البسطرمة
           شريحة
           حبة السجقالنقانق أو  27.Q
           شريحة اللحوم المدخنة 37.Q
           غم 093 السمك الطازج  47.Q
           غم 093 السمك المملح 57.Q
           غم 093 السلمون 67.Q
           غم 093 الجمبري 77.Q
           علبة السردين المعلب 87.Q
           علبة التونا المعلبة 97.Q
           غم 093 الطحالب والأعشاب البحرية 08.Q
           كأس المشروبات الغازية (الكولا) 18.Q
           كأس المشروبات الغازية بدون سكر 28.Q
           فنجان القهوة 38.Q
           كأس الشاي العادي 48.Q
           كأس الشاي الأخضر 58.Q
           كأس الماء 68.Q
           ك½  المكسرات (لوز) 78.Q
           رغيف الخبز ومشتاقتة  88.Q
           بكيت الموالح (شيبس 8 بسكويت مالح) 98.Q
 
 
 201
 الغذائية:لائحة المكملات  الثالثالقسم 
 هل تتناول التالي: 
 
 كم ابرة كم حبة بالأسبوع نعم- 3 لا-6
 بالاسبوع
في العام الماضي كم 
 شهر تقريبا استخدمته
 هل تعرف نوعها
) snimatiV-itluMالفيتامينات ( 09.Q
 المضافة باليود
      
       عادي snimativitluM 19.Q
       enidoi muissatop 29.Q
       xelpmoc Bفيتامين  39.Q
       21Bفيتامين  49.Q
       6Bفيتامين  59.Q
       Aفيتامين  69.Q
       cفيتامين  79.Q
       Eفيتامين  89.Q
       Dفيتامين   99.Q
       البوتاسيوم 001.Q
       الكالسيوم 101.Q
       السيلينيوم 201.Q
       الزنك 301.Q
       حامض الفوليك 401.Q
       الحديد 501.Q
       D tiv + muiclaC 601.Q
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 الوضع الصحي القسم الرابع: 
اذا نعم،  تاريخ  . لا اعرف1 .نعم3 .لا6 المرض 
 التشخيص
     الذاتيةأمراض المناعة  701.Q
     مرض السكري  801.Q
     أمراض القلب 901.Q
     السرطان 011.Q
     أمراض الغدة الدرقية 111.Q
     أمراض الغدة النخامية 211Q
     الكبدأمراض  311.Q
     امراض الكلية 411.Q
     أمراض نفسية 511.Q
     ؟ هل  تم تشخيصك أوعلاجك لأمراض الغدة الدرقية 611.Q
     ؟  ))msidioryhtopyhبقصور الغدة الدرقية    هل تم تشخيصك 711.Q
     ) ؟msidioryhtrepyhبفرط نشاط الغدة الدرقية (  هل تم تشخيصك 811.Q
     ؟retiogهل كان لديك  تضخم في  الغدة الدرقية  911.Q
 enummiotuAهل كان لديك في أي وقت مضى التهاب الدرقية المنيع الذات  021.Q
 ؟sitidioryhT
    
 latinegnocهل كنت تعاني من قصور الغدة الدرقية  الخلقي  121.Q
 منذ بداية الحياة ؟ msidioryhtopyh
    
     3نوع مرض السكري  221.Q
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     فقر الدم 321.Q
     البلاهة المنغولية 421.Q
     البهاق 521.Q
     متلازمة شيجرن 621.Q
     الاعتلال المعوي 721.Q
     مرض اديسون 821.Q
 
 : الأدوية الخامسالقسم 
 لا-6 نعم-3 هل قمت بعملية إزالة الغدة الدرقية 921.Q
  enidoi evitcaoidaRهل تم علاجك باليود الإشعاعي  031.Q
 
 لا-6 نعم-3
 المدة الزمنية لا نعم هل تتناول أي من هذة الادوية؟ 
         muihtiL        الليثيم 131.Q
         enoradoimA أمايودارون  231.Q
     norefretnI     الإنترفيرون 331.Q
    elozamibraC     كاريبمازول  431.Q
    الميتازول        elozamihteM 531.Q
    بروبيلثيوراسيل licaruoihtlyporP 631.Q
    أخرى 731.Q
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 : للنساء فقطالسادسالقسم 
 أحيانا-1 لا -6 نعم-3  
    شهر الماضية هل انقطعت دورتك الشهرية كاملا؟ 63خلال  831.Q
    ؟الشهرية  منتظمة  هل الدوره 931.Q
    كنت حامل على الأقل مرة واحدة  ؟   هل 041Q
    هل حصل لك نزيف بعد الولادة؟ 141.Q
    ؟  هل حصل لك اجهاض 241.Q
 
 للحالات فقط اسئلة: لسابعالقسم ا
 |___|___|/|___|___|/|___|___||___|___| تاريخ تشخيص قصور الغدة 341.Q
 يوم            / شهر        / عام
 |___|___| سنة كم عمرك عندما تم تشخيصك بقصور الغدة 441.Q
  كم وزنك عندما تشخيصك بقصورة الغدة 541.Q
 كيف تم اكتشاف قصور الغدة لديك؟ 641.Q
 
 لا أذكر-2 وجود أعراض -1 الفحص الدوري-6 بالصدفة -3
أخصائي -1 أخصائي غدد-6 طبيب عام -3 من قام بتشخيصك؟ 741.Q
 باطني
غير -2
 ذلك
 لا أذكر-9
 الجرعة:   _______1_841.Q   اول علاج  تم اعطاؤه لك 841.Q
 الجرعة: __________1_941.Q   العلاج الحالي  941.Q
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 التاريخ العائلي المرضي:: الثامنالقسم 
 صلة القرابة: 
 احد الوالدان  .3
 كلا الوالدان  .6
 أخت او/و  أخ .1
 عم8 او/و  عمة .2
 خال او/و  خالة .9
 او كلاهماأحد الجدان  .2
 اّخرون من  ..
 صلة القرابة: استخدام الارقام اعلاه .لا6 .نعم3  
     esaesid enummiotuA   من أمراض المناعة الذاتية  يعاني 051.Q
    1مرض السكري نوع  151.Q
    فقر الدم 251.Q
    البلاهة المنغولية 351.Q
    البهاق 451.Q
    متلازمة شيجرن 551.Q
    الاعتلال المعوي 651.Q
    مرض اديسون 751.Q
    مصاب بأمراض في الغدة الدرقية 851.Q
    ؟ msidioryhtopyhبقصور الغدة الدرقية    مصاب بمرض 951.Q
    ؟msidioryhtrepyhبفرط الغدة الدرقية    مصاب بمرض 061.Q
    أمراض اخرى 161.Q
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 لك هل تود (ي) اضافة اي معلومة لم اسألها
 
 _______________________________________________________________________________________________
 ______________________________________________________________________________________________
 _______________________________________________________________________________________________
 _______________________________________________________________________________________________
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 Figure 1: distribution of patients attending Karantina endocrinology clinic 
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Figure 1: distribution of patients attending Karantina endocrinology clinic 
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Figure 5.5: Association between types of hypothyroidism and endocrine disorders in Karantina endocrinology clinic 
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Figure 4:  Distribution of patients attending Dura endocrinology clinic 
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Figure 4:  Distribution of patients attending Dura endocrinology clinic 
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Annex: 8  
 
 
Figure 5.6: Association between types of hypothyroidism and endocrine disorders in Dura endocrinology clinic 
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Annex: 9 
Table 5.2: Association between study cases and control groups’ BMI, physical activity, smoking status and alcohol consumption. 
 Case 
N=103 
Control group 
N=103 
Total (%) 
N=206 
Chi Square 
N (%) N (%) N (%) P value 
BMI 
Underweight < 18.5 8 (7.8%) 3 (2.9%) 11 (5.3%) 
0.001 
Normal  18.5-24.99 21 (20.4%) 34 (33.3%) 55 (26.7%) 
Overweight   ≥25-29.99 26 (25.2%) 44 (43.1%) 70 (34.0%) 
Obese   ≥30 48 (46.6%) 22 (21.4%) 70(34.0%) 
Rate of your daily 
activity 
High 20 (19.4%) 41 (39.8%) 61 (29.6%)  
0.001 Medium 64 (62.1%) 59 (57.3%) 123 (59.7%) 
Low 19 (18.4%) 3 (2.9%) 22 (10.7%) 
Physical activity 
Yes 68 (66.0%) 76 (73.8%) 144 (69.9%) 0.224 
No 35 (34.0%) 27 (26.2%) 62 (30.1%) 
Walking per week 
Less <1 8 (11.8%) 3 (3.9%) 11 (5.3%)  
0.004 3-2 35 (51.5%) 24 (31.6%) 59 (28.6%) 
4-5 4 (5.9%) 15 (19.7%) 19 (9.2%) 
>6 21 (30.9%) 34 (44.7%) 55 (26.7%) 
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Frequency walking 
Less half an hour 35 (51.5%) 32 (42.1%) 67 (32.5%)  
0.375 Half an hour 20 (29.4%) 31 (40.8%) 51 (24.8%) 
1-2 hours 13 (19.1%) 12 (15.8%) 25 (12.1%) 
> 2 hours 0 (0.0%) 1 (1.3%) 1 (0.5%) 
Running per week 
less <1 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 
NA 
3-2 3 (100.0%) 1 (100.0%) 4 (1.9%) 
4-5 0 (0.0%) 0 (0.0%) 0 (0.0%) 
>6 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Frequency running 
Less half an hour 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA Half an hour 3 (100.0%) 1 (100.0%) 4 (1.9%) 
1-2 hours 0 (0.0%) 0 (0.0%) 0 (0.0%) 
> 2 hours 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Exercises without 
equipment per week 
less <1 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA 3-2 2 (100.0%) 0 (0.0%) 2 (1.0%) 
4-5 0 (0.0%) 0 (0.0%) 0 (0.0%) 
>6 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Frequency exercises 
without equipment 
Less half an hour 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA Half an hour 1 (50.0%) 0(0.0%) 1 (0.5%) 
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1-2 hours 1 (50.0%) 0 (0.0%) 1 (0.5%) 
> 2 hours 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Exercises with 
equipment per week 
less <1 0 (0.0%) 0 (0.0%) 0(0.0%)  
NA 3-2 1 (100.0%) 0 (0.0%) 1 (0.5%) 
4-5 0 (0.0%) 0 (0.0%) 0 (0.0%) 
>6 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Frequency exercises 
with equipment 
Less half an hour 1 (100.0%) 0 (0.0%) 1 (0.5%)  
0.157 Half an hour 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-2 hours 0 (0.0%) 1 (100.0%) 1 (0.5%) 
> 2 hours 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Smoking Yes 4 (3.9%) 1 (1.0%) 5 (2.4%) 0.174 
 No 99 (96.1%) 102 (99.0%) 201 (97.6%) 
Smoking  while you at 
home 
Yes 64 (62.1%) 48 (46.6%) 112 (54.4%) 0.025 
No 39 (37.9%) 55 (53.4%) 94 (45.6%) 
Smoking by others in 
closed places 
Yes 56 (54.4%) 38 (36.9%) 94 (45.6%) 0.012 
No 47 (45.6%) 65 (63.1%) 112 (54.4%) 
Alcohol consumption 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
*NA: not available 
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Annex: 10 
         Table 5.3: Differences between study cases and control group in food intake  
 Study cases 
N=103 
Control group  
N=103 
Total (%) 
N=206 
Chi 
Square 
N (%) N (%) N (%) P value 
Iodized salt 
Yes 103 (100.0%) 103 (100.0%) 206 (100.0%) NA 
NO 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Fruits 
(Preparation
) 
Fresh 103 (100.0%) 103 (100.0%) 206 (100.0%)  
NA Bottled 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Dried 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Fruits 
<1 per week 3 (2.9%) 2 (1.9%) 5 (2.4%)  
0.005 5-7 per week 26 (25.2%) 44 (42.7%) 70 (34.0%) 
2-3 times daily 7 (6.8%) 0 (0.0%) 7 (3.4%) 
1-4 per week 67 (65.0%) 57 (55.3%) 124 (60.2%) 
Apricot 
<1 per week 32 (31.1%) 24 (23.3%) 56 (27.2%)  
0.441 5-7 per week 8 (7.8%) 10 (9.7%) 18 (8.7%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 63 (61.2%) 69 (67.0%) 132 (64.1%) 
Pineapple 
<1 per week 98 (95.1%) 93 (90.3%) 191 ( 92.7%)  
0.180 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 5 (4.9%) 10 (9.7%) 15 (7.3%) 
Strawberry 
<1 per week 69 (67.0%) 47 (45.6%) 116 (56.3%)  
0.002 
 
5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 34 (33.0%) 56 (54.4%) 90 (43.7%) 
Banana 
<1 per week 33 (32.0%) 23 (22.3%) 56 (27.2%)  
 
0.001 
5-7 per week 7 (6.8%) 30 (29.1%) 37 (18.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 63 (61.2%) 50 (48.5%) 113 ( 54.9%) 
 Vegetables 
(Preparation
) 
Fresh 103 (100.0%) 103 (100.0%) 206 (100.0%)  
Bottled 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Dried 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Vegetable 
<1 per week 0 (0.0%) 0 (0.0%) 0 (0.0%)  
0.001 5-7 per week 60 (58.3%) 89 (86.4%) 149 ( 72.3%) 
2-3 times daily 17 (16.5%) 0 (0.0%) 17 ( 8.3%) 
1-4 per week 26 (25.2%) 14 (13.6%) 40 ( 19.4%) 
Cabbage 
<1 per week 65 (63.1%) 71 (68.9%) 136 (66.0%)  
0.377 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0(0.0%) 0 (0.0%) 
1-4 per week 38 (36.9%) 32 (31.1%) 70 (34.0%) 
Cauliflower 
<1 per week 23 (22.3%) 22 (21.4%) 45 (21.8%)  
0.866 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 80 (77.7%) 81 (78.6%) 161 (78.2%) 
Tomato 
<1 per week 2 (1.9%) 1(1.0%) 3 (1.5%)  
0.082 5-7 per week 72 (69.9%) 83 (80.6%) 155 (75.2%) 
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2-3 times daily 5 (4.9%) 0 (0.0%) 5 (2.4%)  
1-4 per week 24 (23.3%) 19 (18.4%) 43 (20.9%) 
Lettuce 
<1 per week 64 (62.1%) 64 (62.1%) 128(  
0.840 5-7 per week 8 (7.8%) 6 (5.8%) 14 ( 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 31 (30.1%) 33 (32.0%) 64 ( 
Carrot 
<1 per week 59 (57.3%) 42 (40.8%) 101 (49.0%)  
0.034 
 
5-7 per week 11 (10.7%) 10 (9.7%) 21 (10.2%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 33 (32.0%) 51 (49.5%) 84 (40.8%) 
Potato 
<1 per week 24 (23.3%) 16 (15.5%) 40 (19.4%)  
0.088 5-7 per week 17 (16.5%) 29 (28.2%) 46 (22.3%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 62 (60.2%) 58 (56.3%) 120 (58.3%) 
Full fat milk 
<1 per week 64 (62.1%) 58 (56.3%) 122 (59.2%)  
0.344 5-7 per week 14 (13.6%) 22 (21.4%) 36 (17.5%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 25 (24.3%) 23 (22.3%) 48 (23.3%) 
Yogurt 
<1 per week 37 (35.9%) 25 (24.3%) 62 (30.1%)  
0.036 5-7 per week 13 (12.6%) 26 (25.2%) 39 (18.9%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 53 (51.5%) 52 (50.5%) 105 (51.0%) 
Local cheese 
<1 per week 67 (65.0%) 67 (65.0%) 134 (65.0%)  
0.262 5-7 per week 8 (7.8%) 3 (2.9%) 11 (5.3%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 28 (27.2%) 33 (32.0%) 61 (29.6%) 
Local butter 
<1 per week 84 (81.6%) 94 (91.3%) 178 (86.4%)  
0.088 5-7 per week 5 (4.9%) 1 (1.0%) 6 (2.9%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 14 (13.6%) 8 (7.8%) 22 (10.7%) 
Ice-cream 
<1 per week 46 (44.7%) 42 (40.8%) 88 (42.7%)  
0.850 5-7 per week 9 (8.7%) 10 (9.7%) 19 (9.2%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 48 (46.6%) 51 (49.5%) 99 (48.1%) 
Shake milk 
<1 per week 74 (71.8%) 62 (60.2%) 136 (66.0%)  
0.204 5-7 per week 7 (6.8%) 11 (10.7%) 18 (8.7%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 22 (21.4%) 30 (29.1%) 52 (25.2%) 
Animal 
product 
(Preparation
) 
Boiled 101 (99.1%) 103 (100.0%)  
204 (99.0%)  
Animal 
product 
<1 per week 9 (8.7%) 3 (2.9%) 12 (5.8%)  
0.154 5-7 per week 5 (4.9%) 8 (7.8%) 13 (6.3%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 89 (86.4%) 92 (89.3%) 181 (87.9%) 
Egg 
<1 per week 28 (27.2%) 19 (18.4%) 47 (22.8%)  
0.121 5-7 per week 15 (14.6%) 25 (24.3%) 40 (19.4%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 60 (58.3%) 59 (57.3%) 119 (57.8%) 
Red meat <1 per week 72 (69.9%) 85 (82.5%) 157 (76.2%)  
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5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 0.033 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 31 (30.1%) 18 (17.5%) 49 (23.8%) 
Chicken 
<1 per week 9 (8.7%) 3 (2.9%) 12 (5.8%)  
0.085 5-7 per week 4 (3.9%) 9 (8.7%) 13 (6.3%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 90 (87.4%) 91 (88.3%) 181 (87.9%) 
Turkey meat 
<1 per week 59 (57.3%) 60 (58.3%) 119 ( 57.8%)  
0.369 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 44 (42.7%) 43 (41.7%) 87 (42.2%) 
Processed  
meats ( 
Salami,  
Mortadella) 
<1 per week 73 (70.9%) 76 (73.8%) 149 (72.3%)  
0.831 5-7 per week 8 (7.8%) 6 (5.8%) 14 (6.8%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 22 (21.4%) 21 (20.4%) 43 (20.9%) 
Sausage 
<1 per week 92 (89.3%) 95 (92.2%) 187 (90.8%)  
0.338 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 11 (10.7%) 8 (7.8%) 19 (9.2%) 
Smoked 
meats 
<1 per week 101 (98.1%) 102 (99.0%) 203 (  
0.561 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 2 (1.9%) 1 (1.0%) 3 (1.5%) 
Fish 
<1 per week 56 (54.4%) 59 (57.3%) 115 (55.8%)  
0.674 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 47 (45.6%) 44 (42.7%) 91 (44.2%) 
Canned 
sardines 
<1 per week 78 (75.7%) 90 (87.4%) 168 (81.6%)  
0.031 5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 25 (24.3%) 13 (12.6%) 38 (18.4%) 
Canned tuna 
<1 per week 70 (68.0%) 85 (82.5%) 155 (75.2%)  
0.015 
 
5-7 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 33 (32.0%) 18 (17.5%) 51 (24.8%) 
Soft drinks 
<1 per week 48 (46.6%) 48 (46.6%) 96 (46.6%)  
0.617 5-7 per week 13 (12.6%) 19 (18.4%) 32 (15.5%) 
2-3 times daily 2 (1.9%) 1 (1.0%) 3 (1.5%) 
1-4 per week 40 (38.8%) 35 (34.0%) 75 (36.4%) 
Coffee 
<1 per week 41 (39.8%) 39 (37.9%) 80 (38.8%)  
0.010 
 
5-7 per week 24 (23.3%) 17 (16.5%) 41 (19.9%) 
2-3 times daily 21 (20.4%) 40 (38.8%) 61 (29.6%) 
1-4 per week 17 (16.5%) 7 (6.8%) 24 (11.7%) 
Tea 
<1 per week 5 (4.9%) 12 (11.7%) 17 (8.3%)  
0.269 5-7 per week 28 (27.2%) 21 (20.4%) 49 (23.8%) 
2-3 times daily 59 (57.3%) 58 (56.3%) 117 (56.8%) 
1-4 per week 11 (10.7%) 12 (11.7%) 23 (11.2%) 
Water 
<1 per week 0 (0.0%) 0 (0.0%) 0 (0.0%)  
0.367 5-7 per week 13 (12.6%) 9 (8.7%) 22 (10.7%) 
2-3 times daily 90 (87.4%) 94 (91.3%) 184 (89.3%) 
1-4 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
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Nuts 
<1 per week 60 (58.3%) 49 (47.6%) 109 (52.9%)  
0.231 5-7 per week 8 (7.8%) 7 (6.8%) 15 (7.3%) 
2-3 times daily 0 (0.0%) 0 (0.0%) 0 (0.0%) 
1-4 per week 35 (34.0%) 47 (45.6%) 82 (39.8%) 
Bread 
<1 per week 0 (0.0%) 0 (0.0%) 0 (0.0%)  
0.818 5-7 per week 11 (10.7%) 10 (9.7%) 21 (10.2%) 
2-3 times daily 92 (89.3%) 93 (90.3%) 185 (89.8%) 
1-4 per week 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Salty snacks 
<1 per week 50 (48.5%) 35 (34.0%) 85 (41.3%)  
0.165 5-7 per week 13(12.6%) 21 (20.4%) 34 (16.5%) 
2-3 times daily 6 (95.8%) 7 (6.8%) 13 (6.3%) 
1-4 per week 34 (33.0%) 40 (38.8%) 74 ( 35.9%) 
*NA: not available 
 
 
Annex: 11 
Table 5.4:  Association between study cases and control group by using supplements. 
 Study cases 
N=103 
Control group 
N=103 
Total 
N=206 
Chi Square 
N (%) N (%) N (%) P value 
Multi-
Vitamins 
added 
iodine 
Yes 1 (1.0%) 0 (0.0%) 1 (0.5%) 0.316 
No 102 (99.0%) 103 (100.0%) 
205 (99.5%) 
Multivitam
ins  
Yes 7 (6.8%) 3 (2.9%) 10 (4.9%) 0.195 
No 96 (93.2%) 100 (97.1%) 196 (95.1%) 
Vitamin B 
complex 
Yes 2 (1.9%) 3 (2.9%) 5 (2.4%) 0.651 
No 101 (98.1%) 100 (97.1%) 201 (97.6%) 
Vitamin 
B12 
Yes 6 (5.8%) 15 (14.6%) 21 (10.2%)      0.038 
No 97 (94.2%) 88 (85.4%) 185 (89.8%) 
Vitamin B6 
Yes 1 (1.0%) 0 (0.0%) 1 (0.5%) 0.316 
No 102 (99.0%) 103 (100.0%) 205 (99.5%) 
Vitamin A 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Vitamin C Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
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No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Vitamin E 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Vitamin D 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Potassium 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Calcium 
Yes 7 (6.8%) 0 (0.0%) 7 (3.4%) 0.007 
No 96 (93.2%) 103 (100.0%) 199 (96.6%) 
Selenium 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Zink 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Folic acid 
Yes 9 (8.7%) 7 (6.8%) 16 (7.8%) 0.603 
No 94 (91.3%) 96 (93.2%) 190 (92.2%) 
Iron 
Yes 8 (7.8%) 18 (17.5%) 26 (12.6%) 0.036 
No 95 (92.2%) 85 (82.5%) 180 (87.4%) 
Calcium + 
vit D 
Yes 9 (8.7%) 19 (18.4%) 28 (13.6%) 0.042 
No 94 (91.3%) 84 (81.6%) 168 (86.4%) 
                                     *NA: not available 
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Annex: 12 
Table 5.15: Differences between study cases and control group by their medical 
conditions. 
 Study cases 
N=103 
Control group 
N=103 
Total (%) 
N=206 
Chi 
Square 
 N (%) N (%) N (%) P value 
 Diabetes 
type 2 
Yes 15 (14.6%) 0 (0.0%) 15 (7.3%)  
0.001* No 88 (85.4%) 103 (100.0%) 191 (92.7%) 
Heart 
Disease 
Yes 12 (11.7%) 5 (4.9%) 17 (8.3%)  
0.076 No 91 (88.3%) 98 (95.1%) 189 (91.7%) 
Cancer  
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Thyroid 
disease 
Yes 103 (100.0%) 0 (0.0%) 103 (50.0%)  
0.001* No 0 (0.0%) 103 (100.0%) 103 (50.0%) 
Pituitary  
Diseases 
Yes 6 (5.8%) 0 (0.0%) 6 (2.9%)  
0.013* No 97 (94.2%) 103 (100.0%) 200 (97.1%) 
Liver 
disease 
Yes 0 (0.0%) 1 (1.0%) 1 (0.5%)  
0.316 No 103 (100.0%) 102 (99.0%) 205 (99.5%) 
Kidney 
disease 
Yes 2 (1.9%) 1 (1.0%) 3 (1.5%)  
0.561 No 101 (98.1%) 102 (99.0%) 203 (98.5%) 
Mental 
illness 
Yes 1 (1.0%) 0 (0.0%) 1 (0.5%)  
0.316 
 
No 102 (99.0%) 103 (100.0%) 205 (99.5%) 
Hyperthyr
oidism 
Yes 5 (4.9%) 0 (0.0%) 5 (2.4%)  
0.024* No 98 (95.1%) 103 (100.0%) 201 (97.6%) 
Goiter 
Yes 32 (31.1%) 0 (0.0%) 32 (15.5%)  
0.001* No 71 68.9% 103 (100.0%) 174 (84.5%) 
Congenital 
hypothyroi
dism  
Yes 6 (5.8%) 0 (0.0%) 6 (2.9%)  
0.013* No 97 (94.2%) 103 (100.0%) 200 (97.1%) 
Yes 3 (2.9%) 0 (0.0%) 3 (1.5%)  
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Diabetes 
type 1 
No 100 (97.1%) 103 (100.0%) 203 (98.5%) 
0.081 
 
Anemia 
Yes 9 (8.7%) 3 (2.9%) 12 (5.8%)  
0.074 No 94 (91.3%) 100 (97.1%) 194 (94.2%) 
Down 
syndrome 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Vitiligo 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Sjögren's 
syndrome 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Addison’s 
disease  
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Celiac 
disease 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
 
*NA: not available 
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Annex: 13 
      Table 5.7: Differences between study cases and control group in their menstrual cycle 
and pregnancy among women 
 Study cases 
N=95 
Control group 
N=100 
Total (%) 
N=195 
Chi Square 
N (%) N (%) N (%) P value 
 During the past 12 months  
menstrual period completely 
gone 
Yes 20 (22.2%) 11 (11.1%) 31 (15.0%)  
0.039 No 70 (77.8%) 88 (88.9%) 158 (76.7%) 
Regular menstrual cycle 
Yes 51 (75.0%) 78 (89.7%) 129 (62.6%) 0.015 
No 17 (25.0%) 9 (10.3%) 26 (12.6%) 
Pregnant at least once 
Yes 68 (85.0%) 73 (98.6%) 141 (68.4%) 0.002 
No 12 (15.0%) 1 (1.4%) 13 (6.3%) 
Postpartum Thyroiditis 
 
Yes 6 (8.8%) 0 (0.0%) 47 (22.8%)           0.009 
 No 62 (91.2%) 73 (100.0%) 106 (51.5%) 
Bleeding after childbirth 
Yes 30 (37.5%) 17 (23.3%) 47 (22.8%) 0.057 
No 50 (62.5%) 56 (76.7%) 106 (51.5%) 
 
Abortion 
Yes 31 (38.8%) 27 (37.0%) 58 (28.2%) 
 
0.822 
 No 49 (61.2%) 46 (63.0%) 95 (46.1%) 
 
Annex: 14 
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Table 5.8: Association between study cases and control group by medication  
 
Case 
N=103 
Control 
N=103 
Total (%) 
N=106 
Chi 
Square 
 N (%) N (%) N (%) P value 
Thyroidectomy 
Yes 7 (6.8%) 0 (0.0%) 7 (3.4%)  
0.007* No 96 (93.2%) 103 (100.0%) 199 (96.6%) 
Radioactive 
iodine 
Yes 2 (1.9%) 0 (0.0%) 2 (1.0%)  
0.155 No 101 (98.1%) 103 (100.0%) 204 (99.0%) 
Lithium 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Amiodarone 
Yes 4 (3.9%) 1 (1.0%) 5 (2.4%)  
0.174 No 99 (96.1%) 102 (99.0%) 201 (97.6%) 
Interferon 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Carbimazole 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
Methimazole 
Yes 0 (0.0%) 0 (0.0%) 0 (0.0%)  
NA No 103 (100.0%) 103 (100.0%) 206 (100.0%) 
 
Propylthiouracil 
 
 
Yes 5 (4.9%) 0 (0.0%) 5 (2.4%)  
.024* 
No 98 (95.1%) 103 (100.0%) 201 (97.6%) 
*NA: not available 
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Annex: 15 
Table 5.3: Associations between study cases and control groups by family history of 
autoimmune diseases 
 
  Study cases 
N=103 
Control 
group 
N= 103 
Total (%) 
N=206 
Chi 
Square 
N (%) N (%) N (%) P value 
Diabetes type 1 
Yes   19 (18.4%) 15 (14.6%) 34 (16.5%) 0.453 
No 84 (81.8%) 88 (85.4%) 172 (83.5%) 
Family history 
First degree relative 19 (100.0%) 12 (80.0%) 31 (15.1%) 0.053 
Second degree 
relative 
0 (0.0%) 3 (20.0%) 
3 (1.5%) 
 Vitiligo 
 
Family history 
Yes   5 (4.9%) 0 (0.0%) 5 (2.4%) 0.024 
No 98 (95.1%) 
103 
(100.0%) 
201 (97.6%) 
First degree relative 4 (800.0%) 0 (0.0%) 4 (1.9%) NA 
Second degree 
relative 
1(20.0%) 0 (0.0%) 
1 (0.5%) 
Sjögren's 
syndrome 
Family history 
 
Yes   0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 
103 
(100.0%) 
103 
(100.0%) 
106 
(100.0%) 
First degree relative 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
Second degree 
relative 
103 
(100.0%) 
103 
(100.0%) 
106 
(100.0%) 
Celiac disease 
 
Family history 
Yes   0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 
103 
(100.0%) 
103 
(100.0%) 
106 
(100.0%) 
First degree relative 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
Second degree 
relative 
103 
(100.0%) 
103 
(100.0%) 
106 
(100.0%) 
Addison’s disease 
 
Yes   0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
No 
103 
(100.0%) 
103 
(100.0%) 
106 
(100.0%) 
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*NA: not available 
 
 
 
 
 
 
 
  
Family history First degree relative 0 (0.0%) 0 (0.0%) 0 (0.0%) NA 
Second degree 
relative 
103 
(100.0%) 
103 
(100.0%) 
106 
(100.0%) 
 Thyroid disease 
Yes   45 (63.4%) 26 (36.6%) 71 (34.5%) 0.005 
No 58 (43.0%) 77 (57.0%) 135 (65.5%) 
Family history 
First degree relative 31 (75.6%) 10 (24.4%) 41 (19.9%) 0.043 
Second degree 
relative 
14 (51.9%) 13 (48.1%) 
27 (13.1%) 
Hypothyroidism 
Yes   45 (66.2%) 23 (33.8%) 68 (33.0%) 0.001 
No 58 (42.0%) 80 (58.0%) 138 (67.0%) 
Family history 
First degree relative 31 (75.6%) 10 (24.4%) 41 (19.9%) .074 
Second degree 
relative 
13 (54.2%) 11 (45.8%) 
24 (11.7%) 
Hyperthyroidism 
yes   4 (100.0%) 0 (0.0%) 4 (1.9%) .043 
no 99 (49.0%) 103 (51.0%) 202 (98.1%) 
Family history 
first degree relative 2 (100.0%) 0 (0.0%) 2 (1.0%) NA 
second degree 
relative 
2 (100.0%) 0 (0.0%) 
2 (1.0%) 
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